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Abstract 
The directed-assembly of small molecular building-blocks into discrete 
supermolecules or extended networks through non-covalent intermolecular interactions is 
an on-going challenge in the field of crystal engineering.  This synthetic challenge may 
be overcome by identifying or establishing a hierarchy of intermolecular interactions 
which, in turn, may facilitate a modular supramolecular assembly process producing final 
products in high yields. 
A family of three 3-pyridine/amino-pyrimidine supramolecular reactants (SR’s) 
was prepared and allowed to react with aromatic carboxylic acids producing nine 1:1 
molecular co-crystals and four 1:1 ionic salts through heteromeric O-H···N/N-H···O or 
charge-assisted N–H+···O-/N–H···O- hydrogen bonds with the amino-pyrimidine binding 
site. We introduced a Q-value, based on AM1 calculations, to show that the amino-
pyrimidine moiety is a superior hydrogen-bond acceptor for an incoming carboxylic acid. 
The amino-pyrimidine/carboxylic acid synthon resulted 13/13 times (100 % yield) even 
in the presence of other potentially disruptive intermolecular interactions.  However, 
reacting a 4-pyridine/amino-pyrimidine SR and a carboxylic acid in a 1:2 ratio, resulted 
in structures containing both acid/amino-pyrimidine and acid/pyridine synthons. 
The same family of pyridine/amino-pyrimidine SR’s were allowed to react with 
halogentated benzoic acids in which the amino-pyrimidine/carboxylic acid synthon 
formed 7/7 times (100 % yield) and halogen bonds (N···I or N···Br) extended the SR/acid 
dimers into polymeric networks 4/7 times (57 %).  These results were rationalized 
through a hierarchical view of intermolecular interactions consisting of hydrogen and 
halogen bonds. 
Four bifunctional 3-pyridine/amino-pyrimidine or amino-pyridine SR’s were 
reacted with neutral metal complexes producing thirteen crystal structures in which the 
pyridyl moiety coordinates to the metal center 13/13 times (100 % yield) and amino-
pyrimidine···amino-pyrimidine hydrogen bonds link the neighboring metal-ligand 
complexes 10/13 times (77 % yield) into 1-D or 2-D extended architectures.   
Finally, we synthesized and characterized a series of tetra-substituted hydrogen 
bond donor and acceptor functionalized, i.e. pyridyl, amino-pyridine, carboxylic acid, 
resorcinarene-based cavitands forming deep-walled cavitands through amino-
pyridine···carboxylic acid heteromeric synthons and a heterodimeric molecular capsule 
through pyridyl···carboxylic acid hydrogen bonds. The heterodimeric capsule is only one 
of three, of its type, characterized crystallographically. 
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CHAPTER 1 - Assembly of molecular solids via non-covalent 
interactions 
1.1 Introduction 
1.1.1 How do we design and build a molecular crystal? 
A central aspect of crystal engineering, which in itself can be viewed as a sub-discipline 
of supramolecular chemistry, concerns the construction of crystalline materials from discrete 
molecular building blocks using non-covalent interactions.1,2 An overriding goal for such efforts 
is to acquire and develop reliable and practical means for the synthesis of molecular materials 
with specific and tunable properties.3  For example, we may want to design materials that can 
perform chemical separations, or that have non-linear optical,4 magnetic,5 or catalytic 
properties.6 In order to obtain non-linear optical materials, individual molecules must be 
organized in a non-centrosymmetric arrangement with appropriately aligned dipole moments, for 
magnetic materials they must be positioned so that communication between spins is facilitated 
and optimized, and for chemical separations the host-material must be able to selectively entrap 
molecules or ions.  In other words, if we wish to build functional materials, we must be able to 
control how molecular building blocks can be assembled into architectures with desirable 
connectivity and precisely defined metrics.  Supramolecular synthesis is a pro-active process – 
molecular building blocks are typically designed such that directional intermolecular interactions 
are expressed as specific structural consequences and it may therefore be more appropriate to 
describe targeted supramolecular synthesis as “directed-assembly” instead of “self-assembly”.  
1.1.2 The power of covalent synthesis 
For more than a century, synthetic chemists have devised a vast number of reactions 
allowing more and more complicated compounds to be made using elaborate processes.7  Today 
we are capable of making extraordinary molecules that rival some of Nature’s best efforts when 
it comes to structural complexity.8,9 Covalent synthesis has become such a powerful discipline8,9 
partly because organic chemists have been able to establish reproducible links between 
molecular structure, reactivity, and reaction pathways through systematic studies of organic 
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reactions. The explicit correspondence between molecular structure and function has provided a 
plethora of “named reactions” that collectively create an invaluable toolbox for covalent 
synthesis. Individual reactions can often be described in a brief, yet fully comprehensive manner 
-- "…this is the transformation of A into B, by treatment with X and Y".  These recipes, often 
involving specific catalysts and reagents that facilitate coupling reactions between two different 
molecular fragments through the making and breaking of covalent bonds, play an essential role 
in every aspect of synthetic chemistry. In contrast, supramolecular synthesis8 has yet to reach 
the same level of sophistication,2,10,11 and despite much progress we do not yet have access to a 
‘dictionary’ that allows us to translate from molecular structure to supramolecular assembly. 
Chemistry is the science of communication and change, and these interrelated processes 
are primarily initiated and controlled by reversible interactions between molecules. 
Consequently, the behavior of an assembly of molecules, be it in solution or in the solid phase, is 
determined by cooperative intermolecular communication.  Unfortunately, our understanding of 
many fundamental physical properties as displayed by relatively simple crystalline materials, e.g. 
color, solubility, and thermal stability, is still rudimentary.  This lack of comprehension and 
control stems from an incomplete insight into the forces that determine molecular recognition, 
binding, and multi-molecular association.12,13,14,15,16  Crystal engineering is still at the stage 
where much experimentation is concerned with how to control assembly.10,17  Thus, predicting 
and controlling the competition between intermolecular forces such as weak and strong hydrogen 
bonds, halogen-halogen interactions, π···π contacts, van der Waals forces, etc. are part of every 
crystal engineering effort.  The challenge comes down to the following: how do we unravel the 
bundle of often inter-related interactions and identify strong, directional, reliable non-covalent 
interactions? How do we develop a reliable synthetic protocol for supramolecular synthesis? 
1.1.3 The case for supramolecular chemistry 
"…the emerging science of supramolecular chemistry represents a natural extension of 
the science of molecular chemistry”.18 
Nicholas J. Turro 
Despite the inherent difficulties with using weak forces as primary synthetic tools, 
considerable progress has been made, and the preponderance of strategies for supramolecular 
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synthesis prompted Desiraju19 to introduce the term "supramolecular synthon".  Synthons 
describe the precise recognition events that take place when molecules assemble into 
supermolecules and provide an important illustration of the conceptual similarities between 
retrosynthetic organic synthesis and supramolecular assembly.20 
Identifying supramolecular synthons is clearly as important to crystal engineering as is an 
understanding of reaction mechanisms and reagents in conventional covalent synthesis.  It is 
essential to find the limits and conditions under which intermolecular recognition can be used to 
reliably assemble structures with specific topologies.  Such insight is most effectively obtained 
through systematic structural studies, and recent developments in crystallography/diffraction 
hardware and software have provided unprecedented access to structural information both in 
terms of sheer numbers of new crystal structures and the type (size/quality) of samples that can 
be examined.  
This introductory Chapter outlines some advances that have been made specifically 
through the use of hydrogen-bond interactions in the directed assembly of organic molecular 
solids with desirable and well-defined supramolecular connectivity.21  However, the scope of this 
Chapter allows us to mention but a fraction of the many efforts that have been put forth, and the 
main focus will be on extended networks and infinite architectures; directed assembly of discrete 
entities has been reviewed extensively elsewhere.22 
This Chapter is broadly divided into two subject areas.  First, an overview of strategies 
for the directed assembly of homomeric 0-D, 1-D, 2-D, and 3-D molecular architectures with 
specific, pre-determined, and desirable connectivities and metrics is offered. Second, a 
description of some design principles that have been devised and tested for the assembly of 
heteromeric molecular solids, is given. 
1.1.4 Supramolecular synthesis 
Conventional synthesis relies on covalent bonds, which makes it possible to devise 
assembly processes composed of several independent steps performed in a sequential manner, 
e.g. protection of active groups, followed by coupling reaction, then deprotection, etc. In 
supramolecular synthesis, on the other hand, the desired product is typically held together by 
reversible intermolecular interactions2,10,11 and solution-phase supramolecular chemistry is 
therefore normally restricted to one-pot processes.  A supramolecular “intermediate” cannot 
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ordinarily be prepared, isolated and then added to another solution in order to perform sequential 
synthesis and herein lies a challenge at the core of supramolecular synthesis: How to devise 
reliable synthetic pathways towards sophisticated supramolecular structures if we are frequently 
confined to one-pot reactions?  Is it somehow possible to develop a ‘dictionary’ that allows us to 
translate from molecular structure to supramolecular assembly?19 
1.2 Directed assembly of homomeric molecular solids 
1.2.1 Hydrogen-bond interactions – Essential tools for constructing molecular solids 
The intermolecular interaction that lends itself most readily to chemical or geometric 
fine-tuning is, arguably, the hydrogen bond, and the strength and directionality of this 
interaction, as compared to most other intermolecular forces, account for its significance in 
supramolecular synthesis of molecular solids.23,24 Many design strategies have relied upon 
hydrogen-bond complementarity,2,7,11,10,13,14,15,16,25 which can involve both geometric factors and 
a suitable balance between the number of hydrogen-bond donors and hydrogen-bond acceptors. 
Self-complementary homomeric interactions have been studied extensively and they include the 
well-known carboxylic acid dimer, although other homomeric synthons have also been employed 
in crystal engineering, Figure 1.1. 
R 
R 
HR O ON N N OH 
N HO HH HO H H H NH H 
O R N N O N 
OH 
R 
R 
Figure 1.1 Examples of self-complementary (homomeric) hydrogen-bond interactions. 
Not only do these synthons bring molecules together, they also constrain the relative 
orientation of those components in much the same way as carbon-carbon double bonds impart 
specific stereochemistry to individual molecules.  An increased degree of complementarity 
(triple,26 quadruple,27 or quintuple28) will increase selectivity but may also present considerable 
covalent synthetic challenges; a balance has to be struck in order to develop cost-effective and 
versatile supramolecular synthesis. 
The importance of complementary hydrogen bonds for providing selectivity and 
specificity in biological processes is also well documented.  A crucial consequence of the 
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commonly occurring eight-membered hydrogen-bonded rings in such systems is that the 
participating molecules only fit together in one orientation, thereby providing a mechanism for 
coding and encoding information onto the resulting assembly (cf. base pairing in DNA). 
1.2.2 Hydrogen-bond based assemblies 
1.2.2.1 Homomeric 0-D assemblies constructed from hydrogen-bonds 
Carboxylic acids, oximes, diones, and amino-pyridines can all form homomeric 0-D 
motifs through self-complementary and frequently, symmetry-related hydrogen-bond 
interactions, Figure 1.2. 
Cl Cl 
Cl 
Cl 
N 
N HO O H N H HO H N
H N
H O ON H H HH O NO O 
H 
N 
Cl 
Cl Cl 
Cl 
Figure 1.2 Homomeric 0-D motifs formed from acid, oxime, pyridone, and amino-pyridine 
dimers. 
4-Chlorophenylcarboxylic acid produces a dimer through O-H···O hydrogen bonds,29 
while 4-chlorophenyloxime dimerizes through O-H···N hydrogen bonds.30  Similarly, 5-chloro­
2-pyridone forms a dimer through N-H···O hydrogen bonds,31 while 2-amino-5-chloropyridine 
forms a dimer through N-H···N hydrogen bonds.32  In the absence of other strong hydrogen-bond 
donors or acceptors such as a pyridine or an –OH moiety, these interactions can be relied upon to 
appear regardless of the overall shape and size of the molecule to which they are covalently 
attached. All four functionalities could, in principle, also lead to infinite 1-D assemblies without 
altering hydrogen-bond connectivities, but such aggregates are generally far less common than 
their dimeric counterparts.  One exemption is noteworthy however.  If the oxime is equipped 
with a strongly electron-withdrawing group on the imine moiety (such as -C≡N) the most likely 
motif is a 1-D chain (O-H···N≡C-) instead of a dimeric motif involving the imine nitrogen atom 
as the hydrogen-bond acceptor. 
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1.2.2.2 Hydrogen-bonded homomeric 1-D architectures 
Amides,33 pyrimidines,34 dicarboxylic acids,35 dioximes,36,37 and dipyridones38 can all 
form homomeric 1-D motifs through self-complementary interactions, Figure 1.3.   
H O 
N 
H 
O N N 
H 
O N H H O H H O O H O O H
O N H OH H N O H N H O OH H H O ON O 
H
N O 
NH 
HO 
N O 
NO 
H 
H 
N O 
NO 
H 
H 
Cl 
N 
H 
O 
H 
Cl 
N 
H 
O 
H Cl 
N 
H 
O 
H 
Cl 
N 
H 
O 
H N N 
Br 
N 
H H 
NN 
Br 
N 
HH 
N N 
Br 
N 
H H 
Figure 1.3 Homomeric 1-D motifs formed from a variety of hydrogen-bond synthons. 
Amides frequently combine two unique structural motifs, dimers and catemers, into a 
well-known 1-D ribbon-like structure. The dimer is constructed from self-complementary N­
H···O hydrogen bonds, while the catemeric N-H···O hydrogen bonds result from the anti-proton 
of the amine and the bifurcated carbonyl oxygen atom.   
Symmetric dipyridones form 1-D arrays through pairs of N-H···O interactions.  Similarly, 
diacids, both aliphatic and aromatic, commonly produce infinite 1-D chains in the absence of 
competitive hydrogen-bond acceptors.   
Oxime functionalities have the capability of forming either dimers or catemers, both of 
which result from O-H···N hydrogen bonds. The balance between the two types of motifs is 
subtle which is illustrated by the fact that 4-chlorophenylaldoxime, which is known to be 
dimorphic, appears both in a dimeric as well as in a catemeric version in the solid state.30,37 A 
search through the CSD of aromatic molecules containing the oxime fragment, revealed 
approximately twenty 1-D chain motifs, two cyclic motifs, and forty-five dimeric motifs, in the 
absence of competing moieties. 
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1.2.2.3 Hydrogen-bonded homomeric 2-D architectures 
Any supramolecular synthon can, in principle, provide the basis for molecular building 
blocks capable of creating extended 2-D architectures. For example, trimesic acid (benzene­
1,3,5-tricarboxylic acid) forms hexagonal networks with the aid of self-complementary O-H···O 
hydrogen bonds,39 Figure 1.4. These hexagonal sheets are catenated leading to an interpenetrated 
3-D framework. Extended 2-D arrays are produced from a variety of symmetrical and 
unsymmetrical substituted urea and oxalamidecarboxylic acids utilizing acid-acid dimers to form 
the 1-D chains while further propagation is achieved in two-dimensions through multiple N­
H···O hydrogen bonds,24,40 Figure 1.4. Not surprising, when the acid moiety of the symmetrical 
substituted ureas and oxalamides is changed to a phenol group, a 2-D sheet is once again formed 
through a series of O-H···O and N-H···O hydrogen bonds.41 It has also been shown that 
pyrazinecarboxamide forms 2-D architectures through multiple N-H···O and C-H···N hydrogen 
bonds.42 
H

O
 O
O
O X X OO O
H HH N NH HO O O H H OO O O O
HH O H H OHO O O O H N NH
O X XO O
O OO X X O

H

O O O
H HN NHHH O H H O
O OO O O H H O
N NH H
O X X O
O OO O H OH H
O O O O O O
HH H
O O
O O

H

Figure 1.4 Hydrogen-bonded 2-D architectures comprised of multiple O-H···O and N-H···O 
hydrogen bonds. 
1.2.2.4 Hydrogen-bonded homomeric 3-D architectures 
Carboxylic acids, such as adamantane-1,3,5,7-tetracarboxylic acid43 and tetrapyridones 
(silane and carbon based),44,45 have been employed in the construction of 3-D diamondoid 
networks through self-complementary interactions, Figure 1.5. 
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COOH 
HOOC 
COOH ≡COOH 
Si O C O 
4 
N 
4
N 
H H 
Figure 1.5 Examples of molecules that form 3-dimensional self-complementary hydrogen-
bonded networks. 
1.2.3 Halogen-bond based assembly strategies 
This section covers structures and assemblies that have been constructed principally 
through X···X , N···X, and C≡N···X (where X is either Br or I).  For information on the nature of 
such interactions, see recent review articles.46 
1.2.3.1 Halogen bonds through N···X (X = Br or I) 
4-Iodobenzonitrile and 4-bromobenzonitrile form head-to-tail chains through C≡N···X 
interactions, Figure 1.6.47,48 
X N X N X N 
X=I, Br 
Figure 1.6 Homomeric 1-D chains formed from nitrile···halogen interactions. 
Fluorination of 4-iodobenzonitrile or 4-bromobenzonitrile molecules leads to shorter 
C≡N···X distances.  This is expected, since the Lewis acidity of the halogen atoms increases due 
to the electron-withdrawing effects of the four fluorine substituents on the phenyl ring.  In 
changing the halogen to a chloro group, the nitrile···chloro interaction does not form, even with 
the ring being flourinated. 
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4-iodopyridine forms 1-D head-to-tail chains through N···I interactions, Figure 1.7.49 
Similarly, 4’-bromo-2’,3’,5’,6’-tetrafluorostilbazole forms 1-D head-to-tail chains through N···Br 
interactions, Figure 1.7.50 The N···I and N···Br interactions are fundamentally similar, but the 
former are significantly stronger. Calculated bond dissociation energies (kcal) display a 2-fold 
increase for interactions between 1,4-diiodotetrafluorobenzene and a nitrogen containing 
heterocycle compared to the 1,4-dibromotetrafluorobenzene analog.51 
N I N I N I 
F F 
N F F 
Br N 
Br 
F F 
F F 
Figure 1.7 Homomeric 1-D chains formed from nitrogen···iodo or bromo interactions. 
1.2.3.2 Halogen···halogen interactions 
A variety of halogen···halogen interactions have been used to guide the orientation of 
molecular building blocks in homomeric solids. For example, 1,4-dihalogenated aryls (X = Cl, 
Br, I) often give rise to two-dimensional sheets through bifurcated halogen···halogen interactions, 
Figure 1.8.52,53,54 
X 
X X 
X X 
X X 
X X 
X X 
X X 
X X 
X X 
X X 
X X 
X X 
X 
Figure 1.8 Extended 2-D sheets produced from bifurcated halogen···halogen interactions.  
Fluorinated compounds do behave much differently compared to their heavier congeners. 
Desiraju has proposed that F···F interactions are unlikely to play a structure-directing role and, 
instead, fluorine atoms prefer to interact weakly with neighboring C-H protons forming C-H···F 
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 interactions.55 Interestingly, Dunitz has reported, based on molecular modeling and CSD 
searches, that organic fluorine atoms hardly ever accept a hydrogen atom to form C-H···F 
interactions and therefore, should not be regarded as a weak hydrogen bond.56 
Halogen···halogen interactions have also been used to design more complex architectures, 
and the crystal structure determination of 1,3,5,7-tetraiodoadamantane reveals the presence of a 
3-D diamondoid-like network established through multiple iodo···iodo interactions.57,58 
1.3 Design and synthesis of heteromeric solids 
1.3.1 Co-crystals: Solid-state targets for non-covalent synthesis 
What is the most likely outcome when a solution containing different molecular solutes is 
allowed to evaporate to dryness?  Unless a chemical reaction driven by the formation of covalent 
bonds takes place between the solutes, one would normally expect the appearance of separate 
molecular solids.  This is a demonstration of the innate structural selfishness of molecules,59 and 
it is utilized every time recrystallization is employed as a method of purification. 
Recrystallizations are performed on a daily basis in every synthetic laboratory around the world 
but in the supramolecular laboratory, however, the very same process provides the 
supramolecular chemist with an opportunity to move in a completely different direction.  A co­
crystallization is an attempt at bringing together different molecular species within one periodic 
crystalline lattice without making or breaking covalent bonds.  Recrystallization and co­
crystallization processes are essentially only distinguishable by their intents.  The goal of the 
former is a homomeric product, whereas the latter procedure strives for a heteromeric product. 
In general, the odds are stacked firmly in favor of the former, Figure 1.9, so how do we go about 
developing reliable, effective, and versatile synthetic methods for the directed assembly of 
molecular co-crystals? 
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Homomeric intermolecular 
forces dominate 
Heteromeric intermolecular 
forces dominate 
Figure 1.9 Recrystallization (homomeric) or co-crystallization (heteromeric)? 
Since a crystalline material can be constructed in an enormous number of ways, these 
recognition mechanisms are extraordinarily selective and, consequently, each crystal structure 
contains important information about the way in which intermolecular forces compete and 
collaborate and eventually create an energetically balanced system.  The use of co­
crystallizations for studying hydrogen-bond motifs and intermolecular forces, was brought to the 
forefront by Etter and co-workers.60,61,62,63  By introducing several molecular species to the same 
solution, followed by systematic structural studies, one can begin to identify patterns of behavior, 
structural selectivity, and trends in recognition and binding that will furnish an improved 
understanding of the balance between solvent-solute and solute-solute interactions. 
1.3.1.1 Nomenclature 
Crystal engineering is a highly interdisciplinary area, which to some extent explains why 
unambiguous definitions and systematic nomenclatures have yet to be fully developed.  The term 
co-crystal is not well-defined, and the existing literature contains terms such as molecular 
complexes, co-crystals, molecular adducts, molecular salts, clathrates, inclusion compounds, etc., 
that are often meant to describe one and the same family of chemical compounds.  The purpose 
of this Chapter is not to suggest definitions or to comment on the recent debate on 
nomenclature,64 but it is necessary to define the scientific scope of this overview.  Thus, the 
primary subject matter of this next section will be delineated with the aid of the following 
provisions: 
1. 	 Only compounds constructed from discrete neutral molecular species will be considered 
as co-crystals and solids containing ions, including complex transition-metal ions, are 
excluded from this overview. 
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2. 	 Co-crystals are made from reactants that are solids at ambient conditions.65 Therefore all 
hydrates and other solvates are excluded which, in principle, eliminates compounds that 
are typically classified as clathrates or inclusion compounds (where the guest is a solvent 
or a gas molecule). 
3. 	 A co-crystal is a structurally homogeneous crystalline material that contains two or more 
neutral building blocks that are present in definite stoichiometric amounts. 
At this point we are essentially left with two families of compounds: binary charge-
transfer complexes and hydrogen-bonded or halogen-bonded co-crystals.  This section will focus 
almost exclusively upon representatives from the latter categories.66  The terms “binary/ternary 
supermolecule” indicates a discrete species with predictable and desirable connectivity, 
constructed from two/three different molecular species and assembled via directional non-
covalent forces.67,68,69,70,71,72,73,74,75,76,77 
Despite the abundance of papers dealing with all aspects of design and assembly of 
organic extended networks with desirable connectivities and shapes, it remains exceedingly 
difficult to bring more than two different molecular species into one crystalline lattice, without 
making or breaking covalent bonds. 
1.3.2 Developing hydrogen-bond design strategies for synthesis of co-crystals 
The reliability of and competition between synthons are most effectively determined 
through systematic database studies,42,78,79 not through detailed analyses of individual structures. 
Etter and co-workers62,80 were pioneers in this area, and after extensive studies of preferential 
hydrogen-bond patterns in organic crystals they presented the following empirical ‘rules’ as a 
guide to the deliberate design of hydrogen-bonded solids; 
(i) 	 All good proton donors and acceptors are involved in hydrogen bonding.81 
(ii)	 Six-membered ring intramolecular hydrogen bonds form in preference to intermolecular 
hydrogen bonds. 
(iii)	 The best proton donor and acceptor remaining after intramolecular hydrogen bond 
formation will form intermolecular hydrogen bonds. 
These guidelines are based upon observed correlations between hydrogen-bond patterns 
and functional groups and generally, as a proton increases in acidity, its donor properties will 
improve. The second rule derives from competition studies showing that intramolecular 
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hydrogen bonds are more difficult to break than comparable intermolecular bonds formed from 
similar donors. The third rule can be illustrated by examining the structure of 2­
aminopyrimidine/carboxylic acid co-crystals, where the best donors (acidic proton) are paired 
with the best acceptors (ring nitrogen atom),60 Figure 1.10. 
N H O H 
N O H N 
ON H N 
H O H N 
Figure 1.10 The primary hydrogen bonds in co-crystals of 2-aminopyrimidine and dicarboxylic 
acids. 
1.3.2.1 Examples of binary hydrogen-bonded co-crystals 
There are, strictly speaking, no “discrete” aggregates within a solid-state framework but it 
is nevertheless convenient to classify an assembly as being 0-D, 1-D, 2-D, or 3-D depending 
upon the type of intermolecular interactions that are present between and within an array of 
molecules. 
Some examples of 0-D assemblies, Figure 1.11, in co-crystals include heteromeric 
carboxylic acid:carboxylic acid dimers (1:1),82 pyridine:carboxylic acid dimers (1:1),83 2­
aminopyrimidine:carboxylic acid trimers (1:2),84 pyridine:dihydroxybenzene trimers (2:1),85 
bipyridine:carboxylic acid trimers (1:2),72 2-aminopyrimidine:carboxylic acid tetramers 
(2:2),84,86 bipyridine:resorcinol tetramers (2:2),73 3,5-dinitrobenzoic acid:nicotinic acid tetramers 
(2:2),87 isonicotinamide:carboxylic acid tetramers (2:2),88 2-pyridone:carboxylic acids pentamers 
(4:1),89 melamine:thymine tetramers (1:3),90 melamine:barbital hexamers (3:3),91 and 
tripenylphosphine oxide with a variety of hydrogen-bond donors (1:1).61,92,93 
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Figure 1.11 Four 0-D motifs found in co-crystals created by heteromeric hydrogen-bond 
interactions. 
Examples of co-crystals containing chains, ribbons, and other infinite 1-D motifs, Figure 
1.12, include: bipyridine:dihydroxybenzene,94 melamine:cyanuric acid,95 
bipyridine:(fluorinated)dibromobenzene,96 bipyridine:(diiodobenzene, tetraiodoethylene or 
diiodine),97 2-aminopyridine:dicarboxylic acids,98 triaminopyrimidine:barbituric acid,71 2­
aminopyrimidine:dicarboxylic acid,60 1,2,3-trihydroxybenzene:hexamethylenetetramine,99 
diols:diamines,100 bis-benzimidazole:dicarboxylic acids,101 and 2-amino-5-nitropyrimidine:2­
amino-3-nitropyridine.102 
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Figure 1.12 Examples of 1-D motifs generated by heteromeric hydrogen-bond interactions. 
Many infinite 2-D assemblies have also been constructed including (but not limited to): 
piperazine:carboxylic acid,103 trithiocyanuric:bipyridine,104 pyridyloxamide:dicarboxylic acid,105 
picolylaminocyclohexenone:dicarboxylic acid,106 triazine:uracil,107 tris-(4­
14 
pyridyl)triazine:trimesic acid,108 bipyridine:ureylene dicarboxylic acid,75 and 
isonicotinamide:dicarboxylic acid,88,109 Figure 1.13. 
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Figure 1.13 A central hexameric motif in the hydrogen-bonded 2-D network in a 
diaminotriazine:uracil co-crystal.107 
Finally, carbamazepine:tetracarboxylic acid-adamantane110 represents one of the few 
examples of clearly defined and predictable 3-D motif observed in a hydrogen-bond based binary 
co-crystal. 
1.3.3 Heteromeric halogen-bonded co-crystals 
Intermolecular interactions of the type D···X-C, where D = electron donor/halogen-bond 
acceptor and X = halogen atom/halogen-bond donor, are known to be reliable supermolecular 
synthons. The strength of the halogen-bond increases with the increase of the Lewis acidity of 
the acceptor atom, thus I > Br > Cl.  Likewise, an increase of the electron density on the electron 
donor, will strengthen its donor ability, as a result N > O > S.  Additionally, many halogen-bond 
acceptor molecules will contain fluorine atoms; this enhances the acceptor strength of the 
halogen nuclei, thus strengthening the overall halogen-bond. As shown previously, nitrile 
moieties can also act as halogen-bond acceptors.  An example of this is shown in the 1:1 binary 
co-crystal of 1,4-dicyanobutane and diiodoperfluorohexane, Figure 1.14.111 
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Figure 1.14 The primary halogen bonds in co-crystals of dicyanoalkyls and 
diiodoperfluoroalkanes. 
4,4’-Bipyridine and 1,4-diiodobenzene crystallize in a 1:1 ratio forming 1-D chains 
through nitrogen-iodine interactions with N···I distances of 3.023 Å.51 Similarly, 4,4’-bipyridine 
and 1,4-diiodotetafluorobenzene produce 1-D chains with N···I distances of 2.851 Å, which is 
considerably shorter than for the non-fluorinated derivative.  Not surprisingly, 4,4’-bipyridine 
and 1,4-dibromotetrafluorobenzene also form a 1:1 co-crystal containing 1-D chains constructed 
from nitrogen-bromine interactions with N···Br distances of 2.878 and 2.979 Å, respectively, 
Figure 1.15.96 
H H F F 
N I I NN N I I 
H H F F 
F F 
Figure 1.15 1-D motifs in co-crystals of 4,4’-bipyridine and 1,4-dihalogenated aryls. 
The number of co-crystals assembled primarily through nitrile-halogen or nitrogen-
halogen interactions is still small.  A search through the CSD showed a total of ten co-crystals 
containing C≡N···X (X=Br or I) interactions, thirteen with Br···N interactions and fifty-three co­
crystals containing N···I contacts. 
Finally, some examples of 3-D motifs in halogen-based binary co-crystals include 
tetrabromoadamantane:hexamethylenetetramine112 and iodoform:hexamethylenetetramine.113 
1.3.4 Synthesis of co-crystals and the supramolecular yield 
The fact that in the crystal structures of 4-bromo-4’-cyanobiphenyl114 and 4­
bromobenzonitrile115 the molecular components are aligned in a head-to-tail fashion with 
N N Br Br 
FF 
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relatively short Br···N contacts indicates that there are stabilizing intermolecular interactions 
between cyano and bromo moieties,116 Figure 1.16. However, there is still no example of 
successful synthesis of binary co-crystals driven by CN···Br interactions.  Such interactions can 
organize molecules within a lattice but have yet to bring about the assembly of heteromeric co­
crystals. There is clearly a difference between observing a large number of short-contacts in 
molecular crystal structures composed of only one type of building blocks and translating such 
interactions into useful synthetic tools for constructing heteromeric architectures. 
Br N Br N Br N 
Figure 1.16 A chain of 4-bromobenzonitrile molecules organized in a head-to-tail manner. 
Much current work in organic crystal engineering is now geared towards synthesizing co­
crystals using supramolecular reactions based upon reliable synthons and, so far, the vast 
majority of organic molecular co-crystals has been assembled via conventional, strong hydrogen 
bonds.117,118 Weaker hydrogen bonds and many other intermolecular interactions such as 
nitro···iodo, cyano···nitro, halogen···halogen, etc., have not yet been found to be useful tools for 
constructing co-crystals.  The success and efficiency for any set of supramolecular reactions can 
be judged by the frequency of occurrence of desired intermolecular interactions and 
connectivities in the resulting solid. The probability that a certain motif will appear in a 
crystalline lattice is, in many ways, a measure of the yield of a supramolecular reaction. Just as 
a covalent synthetic chemist searches for ways in which a specific reaction can be promoted or 
prevented, a supramolecular chemist tries to identify the experimental regime where a synthon 
prevails despite competition from other non-covalent forces. 
1.3.5 Heteromeric interactions are better than homomeric interactions 
A survey of hydrogen bonded co-crystals in the CSD119 reveals that most of them have 
been prepared using strategies that utilize suitable combinations of chemical entities (or 
functional groups) located on different molecules, such that they would prefer to interact and 
bind heteromerically, Figure 1.17, rather than with themselves.70,74,76,77,120 
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Figure 1.17 Four dimeric motifs constructed via heteromeric intermolecular interactions. 
The most widely used synthons for the directed assembly of binary co-crystals have 
contained a carboxylic acid in combination with a suitable N-containing heterocycle.  For 
example, there are currently three co-crystals in the CSD with pyrazine,121 seven with 
phenazine,122 sixteen with 4,4’-bipyridine,123 one with pyrimidine,124 and nine co-crystals with 
either azapyrine, quinoline, phenantroline125 and a benzoic acid-based counterpart.  In every 
case, the expected/intended carboxylic acid···N(heterocycle), O-H···N, hydrogen bond is present. 
For slightly more complex heterocycles (i.e. with added substituents capable of hydrogen 
bonding) the results are still very consistent; 11 of 12 carboxylic acid:isonicotinamide co-crystals 
contain an acid···pyridine interaction126 – a good example of a high-yielding supramolecular 
reaction. 
There are, in fact, very few occurrences of binary hydrogen-bond based co-crystals that 
do not contain a primary intermolecular interaction between the two different molecules.  Two 
such examples include 4-nitrobenzamide:pyrazinecarboxamide (1:1)69 and 3,5-dintrobenzoic 
acid:4-(N,N-dimethylamino)benzoic acid (1:1).127  The latter is a rare example of a carboxylic 
acid···carboxylic acid co-crystal that contains two homomeric dimers instead of one heteromeric 
dimer.128 
The overriding conclusion from the extensive data available in the CSD is clear.  In order 
to convince two different discrete chemical species to coexist in a molecular co-crystal there 
needs to be some specific molecular-recognition based reason for their solid-state union.88 
Although individual structures that defy rationalization will appear from time to time, there is no 
doubt that the important 'big picture' reveals structural trends, patterns of behavior, and 
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reproducible motifs that, when combined, can be developed into a library of high-yielding 
supramolecular reactions.  
1.4 Functional materials from supramolecular chemistry 
1.4.1 Co-crystalline Active Pharmaceutical Ingredients (API’s) 
 Drug bioavailability is governed by solubility, tableting behavior, filterability, and bulk 
density of a drug, which are determined by size and particle shape, and all these aspects are 
related to the internal structure of the solid. Thus, developing versatile approaches for 
modulating the internal structure of solid-API’s, without compromising the overall structural 
integrity through breaking or forming covalent bonds, is advantageous.  Such approaches have 
traditionally included crystal form manipulations i.e. polymorph, hydrate, and salt formations in 
order to improve physiochemical properties.129 Another technique, although in its infancy, is the 
engineering of pharmaceutical co-crystals, through directed-supramolecular synthesis.130 
Forming API containing co-crystals has a number of potential advantages over the previously 
mentioned approaches, in which a few are listed; (1) potentially all API’s (basic, acidic, and non-
ionizable) may be used within a co-crystalline reaction, not just ionizable species which are 
necessary in salt-formation, (2) products obtained from a co-crystallization experiment are often 
controllable and reliable, while the formation of polymorphs, hydrates, and solvates are usually 
serendipitous, and (3) a large number of non-toxic co-crystal formers (chemicals included within 
the GRAS, Generally Recognized As Safe, list)131 can be incorporated within the crystalline or 
amorphous solid.   
Thus, co-crystallization reactions between predesigned, inexpensive, and readily 
available small molecules (co-crystal formers), combined with API’s may allow for subtle 
changes in bulk-physical properties, i.e. solubility, morphology, and stability, without altering 
the inherent biological activity in the API.  Furthermore, the following case study displays how 
co-crystalline products formed from various API’s and suitable co-crystal formers alter the 
overall physiochemical properties of the bulk starting material. 
1.4.1.1 Improving caffeine hydration stability through co-crystals  
Caffeine (1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione) is a central nervous system and 
metabolic stimulant, which can temporarily increase alertness and reduce fine motor 
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coordination. This particular compound exhibits instability, with regards to humidity, changing 
from either of the anhydrous forms (α or β) to the nonstoichiometric hydrate when the relative 
humidity (RH) is between 75 and 98 %.132 Therefore, atmospheric moisture is of considerable 
concern and must be controlled throughout each stage of processing, formulation, packaging, and 
storage in order not to jeopardize the desired solid drug substance.    
Pure caffeine is known to exist in two anhydrous crystal forms and one crystalline 
nonstoichiometric hydrate form.133  Furthermore, one pharmaceutically acceptable caffeine salt 
has been generated, a hydrochloride dihydrate,134 as well as several pharmaceutically active co­
crystals (1:1 caffeine:sulfacetamide,135 1:1 caffeine:sulfaproxyline,136 and a 1:1 
caffeine:barbital).137  Recently, a systematic study was carried out to test the stability of co­
crystals containing caffeine and pharmaceutically acceptable co-crystal formers, upon exposure 
to various RH percentages.  Anhydrous caffeine was allowed to co-crystallize with di-aliphatic 
carboxylic acids, Figure 1.18, and their RH stability was determined.                   
O OO OH 
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Figure 1.18 API, caffeine 1 (showing hydrogen bonding acceptor site), alongwith co-crystal 
formers oxalic acid 2, malonic acid 3, maleic acid 4, and glutaric acid 5. 
Co-crystals, caffeine:oxalic acid A and caffeine:malonic acid B crystallized in a 2:1 
stoichiometric ratio, while caffeine:maleic acid C and caffeine:glutaric acid D crystallized in a 
1:1 ratio. RH stability results were carried out on each co-crystal A-D and compared to the 
standard anhydrous β-caffeine sample.  Pure caffeine exhibits instability between 75 and 98 % 
RH after just one day, however, co-crystal A showed a high stability even after 7 weeks at 98% 
RH. Co-crystalline product B, displayed a slightly improved stability compared to pure caffeine, 
whereas C and D did not improve the overall moisture absorption, compared to anhydrous 
caffeine. 
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1.4.2 Porous materials 
Up to this point, the focus has been on assembling purely-organic based building blocks 
into solid-state architectures through robust hydrogen bond interactions, however the metal-
ligand coordination bond is another type of interaction utilized in binding and organizing 
individual entities into supermolecules.  Over the past several decades porous supramolecular 
networks have been extensively studied,138 and potential properties for such networks lie in, but 
are not limited to, molecular storage or separations, magnetism, conductivity, and catalysis.139 
Porous architectures have primarily been constructed through connecting ligands (linkers) to 
metal ions (nodes), forming the desired discrete or extended topological product.  This type of 
design rational becomes very powerful, due to the vast variety of ligand designs, i.e. placement 
and number of donor atoms on the linkers, and the large number of metal ions and clusters at 
ones disposal. 
A decade ago, Fujita et. al constructed a M6L4 discrete octahedron complex140 from four 
exo-tridentate triangular ligands, 2,4,6-tris(4-pyridyl)-1,3,5-triazine, and six cis-capped square 
planar units, [enPdX2] (en = ethylenediamine, X = Cl, NO3 etc.), Figure 1.19. This compound is 
now commercially available,141 and has found applications in size-selective molecular storage142 
and catalysis.143 
Figure 1.19 Cartoon displaying the structural arrangement of the four 2,4,6-tris(4-pyridyl)-1,3,5­
triazine ligands and the six cis-capped palladium units within the octahedron complex. 
In 1998, Yaghi reported his first crystalline porous metal-organic framework (MOF).144 
MOF’s are very attractive compounds due to their high surface area 2000-7000 m2/g, stability at 
high temperatures > 450 °C, isolation in high yields using inexpensive starting materials, and 
ability to capture gases, such as CH4, CO2, N2, H2, and Ar.145  More recently, Yaghi’s group 
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constructed crystalline metal-organic polyhedra (MOP) where the pore size and functionality can 
be systematically varied.  The design strategy includes the directed-assembly of sulfate-capped 
oxygen-centered iron-carboxylate trimers, Fe3O(CO2)3(SO4)3 as nodes and either phenyl, 
biphenyl, tetrahydropyrene, or terphenyl as the organic linker, Figure 1.20. 
      Truncated tetrahedron 
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Figure 1.20 Formation of a truncated tetrahedron upon mixing a stoichiometric ratio of nodes 
and linkers. 
It is reported that the total open space (including inside the pore and between pores) in 
these crystals ranges from 46.3 to 76.4 %!146 
Even within the crystalline phase, coordination networks can exhibit dynamic porosity, 
Figure 1.21, due to their construction not only through coordinate covalent bonds, but also in 
combination with much weaker intermolecular interactions e.g. hydrogen bonds, π-π stacking 
etc. 
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Figure 1.21 An example of a dynamic framework.  In the top example, the gaps are created with 
respect to the incoming guest molecules, while in the bottom example the framework interunit 
space depends solely on the guest molecules. 
One such 3-dimensional network, consisting of CuII, benzene-1,4-dicarboxylate, and 
4,4’bipyridine, reported by Kitagawa et al., displays dynamic porous properties upon gas-
adsorption (CO2, CH4, O2, and N2) and desorption.147,148 
Although less abundant, purely organic-based porous assemblies have also been 
constructed, primarily through self-complementary hydrogen-bonds.  Wuest et al. have designed 
a series of tetrasubstituted silanes, Figure 1.22, which form 3-dimensional porous networks.149 
1 2 3 
Figure 1.22 Three tetrasubstituted silanes: 1 tetrakis(3,5-dihydroxyphenyl)silane, 2 tetrakis(4­
pyridone)silane, 3 tetrakis(4-phenylboronic acid)silane. 
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  Upon recrystallization, 1 forms an open diamondiod framework in which 45 % of the 
crystalline volume is accessible to guests, while 2 has ~60 % and 3 has 64 % of its internal 
volume accessible to guest molecules, Figure 1.23. 
Figure 1.23 Open frameworks constructed through recrystallization of ligand 1 (left) and ligand 
2 (right). 
1.5 In summary… 
Even though molecular recognition is typically associated with molecules in solution, 
such interactions are also responsible for organizing molecules in the solid state.  Translating 
principles of molecular recognition to solid-state assembly of heteromeric molecular solids is of 
key importance to the development of versatile and reliable strategies for practical 
supramolecular synthesis. In this Chapter we have tried to present some transferable 
supramolecular design strategies based upon a hierarchy of intermolecular interactions. The 
effectiveness of these strategies can eventually be evaluated and quantified using the 
supramolecular yield, Figure 1.24. 
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Figure 1.24 Design, implementation, and evaluation of supramolecular synthesis. 
Inevitably, any supramolecular synthetic strategy will fail at some point, but through the 
power of covalent synthesis we have access to refined tools for modulating the electronic and 
geometric details of each binding site on a supramolecular reagent such that a variety of 
chemical functionalities can be targeted for binding.  By carefully examining the connections 
between molecular chemistry and supramolecular reactivity, it may be possible to build a library 
of SR’s that, collectively, is capable of affecting the assembly of new supermolecules with a high 
degree of specificity and reliability.  If we can clear a path towards practical and transferable 
guidelines for versatile supramolecular synthesis through an improved awareness of the balance 
and competition between intermolecular interactions, then it is inevitable that much more 
complex supermolecules and higher-order co-crystals will be synthesized. 
1.5.1 Goals 
The goals of this thesis center on predictably organizing molecular building-blocks into 
supermolecules through reliable and robust intermolecular interactions.  A theme throughout the 
following Chapters will be to establish a better understanding of the directed-assembly process 
as it pertains to: 1) supramolecular synthetic strategies based upon a hierarchy of hydrogen-bond 
driven patterns, 2) establishing a hierarchical assembly approach through hydrogen and halogen 
bonding, 3) constructing inorganic-organic hybrid materials, and 4) designing hydrogen-bond 
functionalized cavitand-based capsules. 
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1.5.1.1 Supramolecular synthetic strategies based upon a hierarchy of hydrogen-bond driven 
patterns 
One of Etters rules states that all hydrogen bonds will form in a hierarchical fashion i.e. 
best-donor to best acceptor, second-best donor to second best-acceptor, etc.  We plan to examine 
the competition and balance between a family of ditopic pyridine/amino-pyrimidine based 
molecular SR’s and their hydrogen bonding ability with various aromatic mono-carboxylic acids 
(Chapters 2 and 3). This study will allow us to determine hydrogen-bond preferences in the 
presence of multiple competing synthons.   
1.5.1.2 Establishing a hierarchical assembly approach through hydrogen and halogen 
bonding 
A hierarchical approach must be established in order to rationally design any 
supramolecular product in which multiple and thus competing synthons exist. Within the 
literature, only one example exists of an architecture in which its assembly is driven by the 
formation of primary hydrogen bonds and secondary halogen interactions.  We will employ the 
family of pyridine/amino-pyrimidine SR’s in attempts to form predictable supermolecular 
products through combinations of both hydrogen and halogen bonds (Chapter 4). Within these 
systems, we want to determine if iodine acts as a better halogen bond donor than bromine, as 
well as if binding abilities increase upon fluorination of the aryl ring.   
1.5.1.3 Constructing inorganic-organic hybrid materials 
Directed assembly of linear M(II)-complexes (M = Cu, Co and Ni) into infinite chains by 
combining anionic chelating ligands (for controlling the coordination geometry) with bi­
functional ligands containing a metal-coordinating pyridyl moiety and a self-complementary 
amino-pyrimidine hydrogen-bonding moiety will be explored (Chapter 5).  We plan to employ 
anionic ligands for the four equatorial-coordination sites leaving room for the bi-functional 
ligand to coordinate in the two axial positions, while further extending the ligand-metal complex 
into infinite 1-D chains through amino-pyrimidine/amino-pyrimidine self-complementary 
hydrogen bonds. 
1.5.1.4 Designing hydrogen-bond functionalized cavitand-based capsules 
26 
Molecular capsules containing enforced cavities possess many useful properties within 
host-guest chemistry namely: catalysis, molecular sensing, molecular transport, stabilization of 
reactive intermediates, et cetera. The construction of cavity-bearing compounds has primarily 
been achieved through metal-ligand interactions or hydrogen bonds, although the latter has been 
much less explored. Cavitands are a class of rigid, bowl-shaped molecules, which will be 
appended with hydrogen bond functionalities and utilized in the building of heteromeric nano­
sized molecular capsules (Chapter 6 and 7).   
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CHAPTER 2 - Bifunctional pyridine/amino-pyrimidine 
supramolecular reagents used for designing binary and ternary co­
crystals 
2.1 Introduction 
When it comes to the assembly of purely organic supramolecular architectures, synthetic 
strategies including, but not limited to, hydrogen bonding,1 halogen bonding,2 π- stacking,3 have 
been employed.  The hydrogen bond is a particularly powerful tool due to its strength and 
directionality, but it can also be fine-tuned electronically and geometrically.4  For example, a 
systematic IR study of a series of carboxylic acid···pyridine complexes (in chloroform) showed 
that even the weakest acid in this sequence, acetic acid, forms a 1:1 dimer with pyridine held 
together by a short O-H···N hydrogen bond.5 The potential energy of this hydrogen bond is 
described by a highly asymmetrical double-minimum curve. With increasing acidity the O-H···N 
hydrogen bond becomes stronger and the potential energy curve has a more symmetric 
appearance.  For intermolecular interactions of this type, correct qualitative interpretations and 
trends within related chemical systems can frequently be extracted from a relatively simple 
electrostatic description of the hydrogen bond.6 
Etter suggested,7 that in a system with multiple hydrogen-bond donors and acceptors, the 
best hydrogen donor will interact with the best hydrogen bond acceptor, and the second-best 
donor will interact with the second-best acceptor and so forth.  To further develop this idea into 
versatile and reliable synthetic strategies, we have examined the structural reactivity and 
behavior of a family of new supramolecular reagents (SR’s) containing two competing and 
tunable hydrogen-bonding sites, Figure 2.1.  In each case, one end of the molecule contains a 
pyridine or methoxy-substituted pyridine moiety while the other end contains an amino-
pyrimidine functionality. 
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NH2 
NH2 NH2 N N 
N N 
MeO 
N N 
N MeO N N 
1 2 6 
Figure 2.1 A series of bifunctional ligands with two distinctly different hydrogen-bonding 
moieties. 
Pyridine is significantly more basic than both pyrimidine and 2-aminopyrimidine, Figure 
2.2, and consequently, the former would be expected to form stronger N···H-O hydrogen bonds 
with an incoming carboxylic acid.   
NH2 
N N N N 
N 
pKa  5.17 1.23 3.45 
Figure 2.2 Three nitrogen-containing heterocycles, pyridine, pyrimidine and 2-aminopyrimidine, 
and their experimental pKa values.8 
However, since an approaching carboxylic acid can also interact with the hydrogen-bond 
donor adjacent to the heterocylic nitrogen atom (C-H in the case of pyridine and N-H in the case 
of 2-aminopyrimidine) it is important to try to quantify the combined effect of both the donor 
and the acceptor within each hydrogen-bonding functionality. Since hydrogen bonds are 
primarily electrostatic in nature, the magnitude of the charge on each participating atom is 
expected to play an important role in determining the structural outcome of any intermolecular 
event where a variety of different hydrogen-bond interactions may form. 
Electrostatic potential surface calculations offer readily available information about the 
relative differences in charge in the vicinity of all atoms within a molecule, and such data may 
provide a better indicator than pKa values for ranking relative hydrogen-bonding abilities of a 
series of related chemical moieties.6  For example, AM1-based calculations of the electrostatic 
potential surfaces of pyridine and 2-aminopyrimidine, Figure 2.3, indicate that the nitrogen 
atoms in both molecules display electrostatic minima at around -275 kJ/mol, which would make 
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them equally attractive as hydrogen-bond acceptors.  However, if the positive potential for the 
hydrogen atom on the auxillary hydrogen-bond donor is taken into account (71 kJ/mol for the C­
H group on pyridine, and 133 kJ/mol for the N-H proton on 2-aminopyrimidine), the latter 
functionality has, overall, a significant advantage and would offer a better binding site for any 
approaching carboxylic acid. 
Emin  -275 kJ/mol -263 kJ/mol -275 kJ/mol 

Figure 2.3 AM1 calculated electrostatic potential surfaces of pyridine (left), pyrimidine (center), 

and 2-aminopyrimidine (right).   

Based on an electrostatic argument pyridine is expected to form significantly stronger 
N···H-O hydrogen bonds with an incoming carboxylic acid than is pyrimidine.  There is, in fact, 
only one reported co-crystal that has been constructed using an O-H···N hydrogen bond between 
a carboxylic acid and unsubstituted pyrimidine,9 whereas there are more than one hundred co­
crystals in the CSD that have been synthesized primarily via an carboxylic acid···pyridine 
synthon.10  However, if the less basic nitrogen atom in pyrimidine is accompanied by a strong 
hydrogen-bond donor, such as an amino group, in the appropriate location, it may become a 
better hydrogen-bonding moiety than a pyridine nitrogen atom only supported by an adjacent C­
H donor. 
To further probe the electrostatic nature of the two individual hydrogen bonding sites, i.e. 
pyridine/adjacent C-H and pyrimidine/amino-group, we assigned a relative hydrogen-bonding 
ability value, Q, to each site. This value can be compared in families of compounds with closely 
related functional groups containing well-defined donor/acceptor sites. The Q-value is based on 
calculated electrostatic potential surfaces, as indicated in Equation 2.1, where A1 is the maximum 
positive potential, and A2 is the minimum negative potential. 
Q = A1 – (A2) (2.1) 
In order to determine the limits and limitations of the best-donor/best-acceptor concept 
and the Q-value in the context of supramolecular assembly, we have allowed three SR’s 1, 2, and 
40                  
6 to react with a range of substituted aromatic carboxylic acids in a variety of stoichiometric 
ratios. Calculated electrostatic potential surfaces were employed to rank the hydrogen-bond 
ability of the different binding sites on 1, 2, and 6 and single-crystal structure determinations 
were carried out in order to establish if the proposed modular supramolecular strategy provides 
an effective guideline for constructing supermolecules with predictable connectivity. 
2.2 Experimental 
2.2.1 Synthesis 
All chemicals, unless otherwise noted, were purchased from Aldrich and used without 
further purification. The catalyst, bis(triphenylphosphine)palladium(II) dichloride, was 
purchased from Strem chemicals.  Trimethylsilylacetylene was purchased from GFS chemicals. 
3-Pyridylboronic acid was synthesized according to previous literature.11 3,5-Dibromopyridine 
was purchased from Acros chemicals. Column chromatography was carried out on silica gel (150 
Å pore size) from Analtech Inc. Melting points were determined on a Fisher-Johns melting point 
apparatus and are uncorrected. 1H and 13C NMR spectra were recorded on a Varian Unity plus 
400 MHz or 200 MHz spectrometer in CDCl3 or D6-DMSO.  Compounds were prepared for 
infrared spectroscopic (IR) analysis as a mixture in KBr. Electrospray Ionization – Ion-Trap 
Mass Spectrometry (ESI-IT-MS) was carried out on a Bruker Daltonics Esquire 3000 Plus. 
MALDI-TOF / TOF-MS was carried out on a Bruker Daltonics Ultraflex TOF/TOF. 
2.2.1.1 Synthesis of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine, 1 
N 
NN 
NH2 
N 
B(OH)2 
N N 
NH2 
Cl 
+ PdCl2(PPh3)2 / Na2CO3 
MeCN / H2O 
A mixture of 2-amino-4-chloro-6-methylpyrimidine (1.468 g, 10.3 mmol), 3-pyridyl 
boronic acid (1.403 g, 11.41 mmol), sodium carbonate (0.600 g, 5.66 mmol), and 
bis(triphenylphosphine)palladium(II) dichloride (180 mg, 0.256 mmol, 2.5 mol %) were added to 
a round bottom flask.  Acetonitrile (35 mL) and water (35 mL) were added and dinitrogen 
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bubbled through the resultant mixture for 10 minutes.  A condenser was attached and the mixture 
heated at 70 ˚C under a dinitrogen atmosphere. The reaction was monitored by TLC and allowed 
to cool to room temperature on completion (48 hours).  The solution was then diluted with ethyl 
acetate (150 mL), washed with water (3 x 100 mL) then washed with saturated aqueous sodium 
chloride (1 x 100 mL).  The organic layer was separated and dried over magnesium sulfate.  The 
solvent was removed on a rotary evaporator and the residue chromatographed on silica with a 
hexanes/ethyl acetate mixture (1/1) as the eluant. The product was isolated as a light 
yellow/white solid. The product 1 was then recrystallized from an ethanol/chloroform mixture as 
colorless block-shaped crystals, (1.40 g, 74 %). M.p. 192 – 194 ºC; 1H NMR (δH; 400 MHz, D6­
DMSO): 9.18 (d, J = 2Hz, 1H), 8.63 (dd, J = 4.8Hz, J = 1.6Hz, 1H), 8.33 (dt, J = 8Hz, J = 1.6Hz, 
1H), 7.48 (dd, J = 8Hz, J = 4.8Hz, J = 0.8Hz, 1H), 7.09 (s, 1H), 6.65 (s, 2H), 2.28 (s, 3H); 13C 
NMR (δC; 400 MHz, D6-DMSO): 168.52, 163.61, 161.43, 150.88, 147.89, 134.05, 132.66, 
123.64, 105.41, 23.66; IR (KBr pellet): υ 3324, 3154, 1576, 1345 cm-1, MALDI-TOF / TOF-MS 
m/z 187 ([1 + H]+). 
2.2.1.2 Synthesis of 4-methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine, 2  
N 
NN 
NH2 
N 
B(OH)2 
N N 
NH2 
Cl 
+ PdCl2(PPh3)2 / Na2CO3 
MeCN / H2OMeO 
MeO 
A mixture of 2-amino-4-chloro-6-methylpyrimidine (1.534 g, 10.73 mmol), 2­
methoxy-5-pyridylboronic acid (1.90 g, 12.42 mmol), sodium carbonate (0.700 g, 6.60 
mmol), and bis(triphenylphosphine)palladium(II) dichloride (180 mg, 0.256 mmol, 2.4 mol 
%) were added to a round bottom flask. Acetonitrile (35 mL) and water (35 mL) were added 
and dinitrogen bubbled through the resultant mixture for 10 minutes.  A condenser was 
attached and the mixture heated at 65 ˚C under a dinitrogen atmosphere. The reaction was 
monitored by TLC and allowed to cool to room temperature on completion (24 hours). A 
portion of the product precipitated from the reaction mixture, thus the precipitate was filtered 
and the remaining reaction mixture worked up accordingly.  The solution was diluted with 
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ethyl acetate (150 mL), washed with water (3 x 100 mL) then washed with saturated aqueous 
sodium chloride (1 x 100 mL).  The organic layer was separated and dried over magnesium 
sulfate. The solvent was removed on a rotary evaporator and the residue chromatographed 
on silica with a hexane/ethyl acetate mixture (1/3) as the eluant.  The isolated product was 
then combined with the filtered portion.  The tan solid 2 was then recrystallized from ethanol 
as colorless bar-shaped crystals, (1.44 g 64 %).  M.p. 163 - 165 ºC; 1H NMR (δH; 400 MHz, 
CDCl3): 8.74 (d, J = 2.8Hz, 1H), 8.22 (dd, J =8.8Hz, J = 2.4Hz, 1H), 6.87 (s, 1H), 6.82 (d, J 
= 8.8Hz, 1H), 5.11 (s, 2H), 4.00 (s, 3H), 2.41 (s, 3H); 13C NMR (δC; 400 MHz, CDCl3): 
168.62, 165.55, 163.14, 162.93, 146.33, 137.26, 126.51, 110.83, 106.30, 53.75, 24.13; IR 
(KBr pellet): υ 3449, 3317, 1583, 1367, 1290, 1013 cm-1, MALDI-TOF / TOF-MS m/z 203 ([2 
+ H]+). 
2.2.1.3 Synthesis of 3-methoxy-5-bromopyridine, 312 
OMeBr Br Br 
NaOMe in 25 % MeOH 
N N
DMF

A solution of sodium methoxide in 25% methanol (6.83 mL, 31.6 mmol) was combined 
with DMF (anhydrous 20 mL) under an inert N2 atmosphere in a round bottom flask. 3,5­
Dibromopyridine (5.00 g, 21.1 mmol) was then added and stirred at 65 ºC for 24 hours.  An 
additional equivalent of sodium methoxide in 25% methanol (2.33 mL) was added after 4 hours. 
The reaction was monitored by TLC and allowed to cool to room temperature upon completion. 
The reaction was then diluted with water (50 mL) and extracted with diethyl ether (3 x 50 mL). 
The organic extractions were combined and washed with brine then dried over magnesium 
sulfate. The solvent was removed on a rotary evaporator and the residue chromatographed on 
silica with a hexanes/ethyl acetate mixture (1:1) as the eluant. The product 3 was isolated as a 
yellow oil. Hexanes (20 mL) was then added to the product and placed in the refrigerator. 
Colorless crystals precipitated from the mother liquor, which were isolated and dried, (2.82 g, 71 
%). M.p. 27 – 29 ºC; 1H NMR (δH; 400 MHz, CDCl3): 8.29 (d, J = 1.6Hz, 1H), 8.25 (d, J = 
2.4Hz, 1H), 7.36 (dd, J = 2.6Hz, J = 1.8Hz, 1H), 3.86 (s, 3H); 13C NMR (δC; 400 MHz, CDCl3): 
155.83, 142.70, 136.01, 123.01, 120.18, 55.61 cm-1. 
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2.2.1.4 Synthesis of 3-methoxy-5-trimethylsilanylethynylpyridine, 4   
N 
Br OMe 
+ 
TMS 
N 
OMe 
TMS 
PdCl2(PPh3)2 / CuI / PPh3 
THF / NEt3 
A mixture of 3 (3.26 g, 17.31 mmol), trimethylsilylacetylene (2.05 g, 20.9 mmol), 
copper(I) iodide (0.100 g, 0.590 mmol), triphenylphosphine (0.420 g, 1.60 mmol),  and 
bis(triphenylphosphine)palladium(II) dichloride (0.360 g, 0.510 mmol) were added to a round 
bottom flask.  Tetrahydrofuran (75 mL) and triethylamine (75 mL) were added and dinitrogen 
bubbled through the resultant mixture for 10 minutes.  A condenser was attached and the mixture 
heated at 65 ˚C under a dinitrogen atmosphere. The reaction was monitored by TLC and allowed 
to cool to room temperature on completion (26 hours).  The solution was then diluted with ethyl 
acetate (100 mL), washed with water (3 x 100 mL) then washed with saturated aqueous sodium 
chloride (1 x 100 mL).  The organic layer was separated and dried over magnesium sulfate.  The 
solvent was removed on a rotary evaporator and the residue chromatographed on silica with n-
pentane as the eluant. The product 4 was isolated as a light yellow oil, (4.25 g, 86 %). 1H NMR 
(δH; 200 MHz, CDCl3): 8.27 (d, 1.6Hz, 1H), 8.21 (d, J = 5.2Hz, 1H), 7.20 (dd, J = 6Hz, J = 2.8, 
1H), 3.81 (s, 3H), 0.24 (s, 9H). 
2.2.1.5 Synthesis of 3-methoxy-5-ethynylpyridine, 5 
TMS H 
K2CO3OMe OMe 
N N 
MeOH 
A mixture of 4 (4.25 g, 14.9 mmol) and potassium carbonate (3.00 g, 21.7 mmol) were 
stirred in methanol (80 mL) at room temperature for 1 hour.  The solution was then diluted with 
ethyl ether (100 mL) and washed with water (4 x 100 mL).  The solvent was removed on a rotary 
evaporator and the residue chromatographed on silica with a n-pentane/ethyl acetate (10:1) as 
eluant. The product 5 was isolated as a white solid, (1.72 g, 87 %). 1H NMR (δH; 200 MHz, 
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N 
OMe 
H 
PdCl2(PPh3)2 / CuI / PPh3 
THF / NEt3 
N N 
NH2 
Cl 
+ 
NN 
NH2 
N 
MeO 
CDCl3): 8.21 (d, J = 2.8Hz, 1H), 8.16 (d, J = 4Hz, 1H), 7.15 (dd, J =5.8Hz, J = 3Hz, 1H), 3.72 (s, 
3H), 3.17 (s, 1H). 
2.2.1.6 Synthesis of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, 6 
A mixture of 2-amino-4-chloro-6-methylpyrimidine (360 mg, 2.50 mmol), 5 (400 mg, 
3.01 mmol), copper(I) iodide (12.0 mg, 0.0710 mmol), triphenylphosphine (50.0 mg, 0.191 
mmol), and bis(triphenylphosphine)palladium(II) dichloride (50.0 mg, 0.071 mmol) were added 
to a round bottom flask.  Tetrahydrofuran (12 mL) and triethylamine (12 mL) were added and 
dinitrogen bubbled through the resultant mixture for 10 minutes.  A condenser was attached and 
the mixture heated at 70 ˚C under a dinitrogen atmosphere. The reaction was monitored by TLC 
and allowed to cool to room temperature upon completion (48 hours).  The solution was then 
diluted with ethyl acetate (50 mL), washed with water (3 x 100 mL) then washed with saturated 
aqueous sodium chloride (1 x 100 mL).  The organic layer was separated and dried over 
magnesium sulfate.  The solvent was removed on a rotary evaporator and the residue 
chromatographed on silica with a hexanes/ethyl acetate mixture (1:1) as the eluant.  The product 
6 was isolated as a light brown solid and recrystallized from chloroform producing colorless 
block shaped crystals, (426 mg, 72 %). M.p. 171-173 ºC; 1H NMR (δH; 400 MHz, CDCl3): 8.39 
(d, J = 2Hz, 1H), 8.30 (d, J = 2.8Hz, 1H), 7.36 (dd, J = 3Hz, J = 1.4Hz, 1H), 6.70 (s, 1H), 5.43 (s, 
2H), 3.85 (s, 3H), 2.35 (s, 3H), 13C NMR (δC; 400 MHz, CDCl3): 168.88, 162.83, 154.99, 
150.37, 144.92, 138.72, 122.61, 118.80, 113.48, 89.78, 87.66, 55.60, 23.81; IR (KBr pellet): υ 
3326, 3171, 2229, 1652, 1558, 1423 cm-1, MALDI-TOF / TOF-MS m/z 241 ([6 + H]+). 
2.2.2 Synthesis of co-crystals and salts 
2.2.2.1 Synthesis of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-nitrobenzoic acid, 1a 
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3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (19 mg, 0.10 mmol) and 4-nitrobenzoic 
acid (17 mg, 0.10 mmol) were placed in a vial containing ethanol (6 mL) and heated until a clear 
homogeneous solution was obtained.  After four days of slow evaporation, colorless rod-shaped 
crystals were obtained. M.p. 188-190 °C; IR (KBr pellet): υ 3308 and 3083 cm-1 (NH2, m), 2254 
and 1900 cm-1 (O-H···N, br), 1696 cm-1 (C=O, m). 
2.2.2.2 Synthesis of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:pentamethylbenzoic acid, 1b 
3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 
pentamethylbenzoic acid (21 mg, 0.10 mmol) were placed in a vial containing an ethanol/ethyl 
acetate mixture (5:5 mL) and heated until a clear homogeneous solution was obtained.  After two 
days of slow evaporation, yellow/orange prism-shaped crystals were obtained.  M.p. 155-157 °C; 
IR (KBr pellet): υ 3331 and 3198 cm-1 (NH2, m), 2442 and 1912 cm-1 (O-H···N, br), 1635 cm-1 
(C=O, m). 
2.2.2.3 Synthesis of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-hydroxybenzoic acid, 1c 
3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (11 mg, 0.06 mmol) and 4-hydroxybenzoic 
acid (16 mg, 0.12 mmol) were placed in a vial containing ethanol (10 mL) and heated until a 
clear homogeneous solution was obtained.  After two days of slow evaporation, yellowish/orange 
cube-shaped crystals were obtained. M.p. 195-197 °C; IR (KBr pellet): υ 3432 (OH, s), 3314 
and 3191 cm-1 (NH2, m), 2494 and 1875 cm-1 (O-H···N, br), 1655 cm-1 (C=O, m). 
2.2.2.4 Synthesis of 3-(2-amino-4-methylpyrimidinium-6-yl)pyridine:2,6-difluorobenzoate, 1d  
3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (13 mg, 0.07 mmol) and 2,6­
difluorobenzoic acid (22 mg, 0.14 mmol) were placed in a vial containing methanol/ethyl acetate 
(3:6 mL) and heated until a clear homogeneous solution was obtained.  After four days of slow 
evaporation, orange plate-shaped crystals were obtained.  M.p. 168-170 °C; IR (KBr pellet): υ 
3339 and 3001 cm-1 (NH2, m), 2423 and 1957 cm-1 (O-H···N, br), 1684 cm-1 (C=O, m). 
2.2.2.5 Synthesis of 4-methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-N,N­
dimethylaminobenzoic acid, 2a 
4-Methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 4-N,N­
dimethylaminobenzoic acid (8 mg, 0.05 mmol) were placed in a vial containing ethyl acetate (10 
mL) and heated until a clear homogeneous solution was obtained.  After one day of slow 
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evaporation, colorless cube-shaped crystals were obtained.  M.p. 173-175 °C; IR (KBr pellet): υ 
3317 and 3204 cm-1 (NH2, m), 2455 and 1872 cm-1 (O-H···N, br), 1705 cm-1 (C=O, m). 
2.2.2.6 Synthesis of 4-methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine:2,4­
difluorobenzoic acid, 2b 
4-Methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 2,4­
difluorobenzoic acid (15 mg, 0.10 mmol) were placed in a vial containing methanol (10 mL) and 
heated until a clear homogeneous solution was obtained.  After two days of slow evaporation, 
colorless rod-shaped crystals were obtained.  M.p. 165-167 °C; IR (KBr pellet): υ 3350 and 3191 
cm-1 (NH2, m), 2372 and 1880 cm-1 (O-H···N, br), 1685 cm-1 (C=O, m). 
2.2.2.7 Synthesis of 4-methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine: 
pentamethylbenzoic acid, 2c 
4-Methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine (13 mg, 0.06 mmol) and 
pentamethylbenzoic acid (23 mg, 0.12 mmol) were placed in a vial containing ethanol (6 mL) 
and heated until a clear homogeneous solution was obtained.  After two days of slow 
evaporation, colorless rod-shaped crystals were obtained.  M.p. 181-183 °C; IR (KBr pellet): υ 
3385 and 3206 cm-1 (NH2, m), 2429 and 1926 cm-1 (O-H···N, br), 1653 cm-1 (C=O, m). 
2.2.2.8 Synthesis of 4-methoxy-3-(2-amino-4-methylpyrimidinium-6-yl)pyridine:3,5­
dinitrobenzoate, 2d 
4-Methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 3,5­
dinitrobenzoic acid (19 mg, 0.09 mmol) were placed in a vial containing ethyl acetate (6 mL) and 
heated until a clear homogeneous solution was obtained.  After two days of slow evaporation, 
colorless rod-shaped crystals were obtained. Dec. 195 °C; IR (KBr pellet): υ 3298 and 3099 cm-1 
(NH2, m), 2356 and 1977 cm-1 (O-H···N, br), 1701 cm-1 (C=O, m). 
2.2.2.9 Synthesis of 4-methoxy-3-(2-amino-4-methylpyrimidinium-6-yl)pyridine:2,5­
dichlorobenzoate, 2e 
4-Methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 2,5­
dichlorobenzoic acid (18 mg, 0.09 mmol) were placed in a vial containing methanol (10 mL) and 
heated until a clear homogeneous solution was obtained.  After two days of slow evaporation, 
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colorless plate-shaped crystals were obtained. M.p. 167-169 °C; IR (KBr pellet): υ 3334 and 
3063cm-1 (NH2, m), 2366 and 1972 cm-1 (O-H···N, br), 1665 cm-1 (C=O, m). 
2.2.2.10 Synthesis of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5­
yl)ethyne:3,5-dinitrobenzoic acid, 6a 
1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne (10 mg, 0.04 
mmol) and 3,5-dinitrobenzoic acid (9 mg, 0.04 mmol) were placed in a vial containing an 
ethanol/ethyl acetate mixture (15:15 mL) and heated until a clear homogeneous solution was 
obtained. After one day of slow evaporation, colorless plate-shaped crystals were obtained. 
M.p. 235-237 °C; IR (KBr pellet): υ 3314 and 3145 cm-1 (NH2, m), 2479 and 1890 cm-1 (O­
H···N, br), 2223 cm-1 (C≡C), 1690 cm-1 (C=O, m). 
2.2.2.11 Synthesis of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne:4­
nitrobenzoic acid, 6b 
1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne (10 mg, 0.04 
mmol) and 4-nitrobenzoic acid (14 mg, 0.08 mmol) were placed in a vial containing an 
ethanol/ethyl acetate mixture (10:10 mL) and heated until a clear homogeneous solution was 
obtained. After one day of slow evaporation, colorless plate-shaped crystals were obtained. 
M.p. 196-198 °C; IR (KBr pellet): υ 3385 and 3304 cm-1 (NH2, m), 2428 and 1885 cm-1 (O­
H···N, br), 2222 cm-1 (C≡C), 1697 cm-1 (C=O, m). 
2.2.2.12 Synthesis of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne:3­
N,N-dimethylaminobenzoic acid, 6c 
1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne (12 mg, 0.06 
mmol) and 3-N,N-dimethylaminobenzoic acid (18 mg, 0.12 mmol) were placed in a vial 
containing ethanol (6 mL) and heated until a clear homogeneous solution was obtained.  After 
three days of slow evaporation, yellow block-shaped crystals were obtained.  M.p. 168-170 °C; 
IR (KBr pellet): υ 3324 and 3140 cm-1 (NH2, m), 2413 and 1895 cm-1 (O-H···N, br), 2228 cm-1 
(C≡C), 1655 cm-1 (C=O, m). 
2.2.2.13 Synthesis of 1-(2-amino-4-methylpyrimidinium-6-yl)-2-(3-methoxypyridin-5­
yl)ethyne:pentafluorobenzoate, 6d 
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1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne (10 mg, 0.04 
mmol) and pentafluorobenzoic acid (9 mg, 0.04 mmol) were placed in a vial containing ethyl 
aceate / ethanol (6:3 mL) and heated until a clear homogeneous solution was obtained.  After 
three days of slow evaporation, colorless rod-shaped crystals were obtained.  M.p. 176-178 °C; 
IR (KBr pellet): υ 3283 and 3048 cm-1 (NH2, m), 2433 and 1952 cm-1 (O-H···N, br), 2223 cm-1 
(C≡C), 1701 cm-1 (C=O, m). 
2.2.3 AM1 Calculations 
Ligands 1, 2, and 6, pyridine, pyrimidine, and 2-aminopyrimidine (Figure 2.3) molecular 
structures were constructed using Spartan ’04 (Wavefunction, Inc. Irvine, CA).  All six 
molecules were optimized using AM1, with the maxima and minima in the electrostatic potential 
surface (0.002 e/au isosurface) determined using a positive point charge in the vacuum as a 
probe. 
2.3 Results 
A summary of the crystallographic information for 1, 2, 6, 1a-1d, 2a-2e, and 6a-6d is 
displayed in Table B.1 and all hydrogen-bond geometries for 1, 2, 6, 1a-1d, 2a-2e, and 6a-6d are 
listed in Table 2.1. 
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Table 2.1  Hydrogen-Bond Geometries for 1, 2, 6, 1a-1d, 2a-2e, and 6a-6d 
Structure   D-H•••H d(D-H)/Å  d(H•••A)/Å  d(D•••A)/Å    <(DHA)/º 
1i  N(12)-H(12A)...N(21)#1  0.892(18)   2.154(19)  3.0450(17)   176.4(15)
 N(12)-H(12B)...N(11)#2 0.897(18) 2.206(19) 3.1013(17) 175.3(14) 
2ii	 N(12)-H(12A)...O(26)#1        0.97(3)    2.10(3)   3.062(3) 170(2)
 N(12)-H(12B)...N(11)#2 0.88(3)       2.17(3)    3.047(3) 177(3) 
6iii   N(12)-H(12A)...N(21)#1    0.88    2.12 2.993(2)  171.5 
 N(12)-H(12B)...N(11)#2 0.88    2.21 3.086(2)  172.7 
1aiv   N(12)-H(12B)...O(32) 0.90(2)       2.14(2)    3.034(2)  170.9(19)
 N(12)-H(12A)...N(21)#1 0.87(2)       2.14(2)   3.015(2)  177.4(19) 
O(31)-H(31)...N(11) 1.17(2)    1.36(2)    2.5274(18)   174.4(19)
  1bv	 O(41)-H(41)...N(11)    0.90(3)       1.72(3)   2.599(2)   164(3)
 N(12)-H(12A)...O(42) 0.87(3)   2.15(3)    3.013(2)   176(3)
 N(12)-H(12B)...N(21)#1 0.88(3)    2.46(3) 3.112(3) 132(2)
  1cvi	 N(12)-H(12A)...O(32)  0.83(4)    2.08(4)    2.906(3)   170(3)
 N(12)-H(12B)...O(34)#1   0.93(3)    2.28(4)  3.163(3)  157(3)
 O(31)-H(31)...N(11) 0.91(4)    1.75(4)    2.656(3)  173(3)
 O(34)-H(34)...N(21)#2    0.93(3)    1.80(4)    2.728(3) 169(3)
  1dvii   N(11)-H(11)...O(31)    0.88(2)    1.78(2) 2.6608(17) 178(2)
 N(12)-H(12A)...O(32)   0.88(2)    1.94(2)    2.8161(18)   175.7(19)
 N(12)-H(12B)...N(21)#1   0.91(2)    2.29(2)    2.9888(19)   132.9(17)
  2aviii   O(31)-H(31)...N(11)   0.951(17)   1.690(17) 2.6321(14)   170.0(15)
 N(12)-H(12A)...O(32)   0.894(17)   2.026(17) 2.9173(15)   174.3(14)
 N(12)-H(12B)...O(32)#1 0.862(16) 2.110(16) 2.8925(15)   150.8(14)
  2bix   N(12)-H(12A)...O(32)   0.92(3)    2.02(3)    2.925(3)   170(2)
 N(12)-H(12B)...N(11)#1   0.94(3) 2.16(3)    3.085(3)   172(2)
 O(31)-H(31)...N(13)    0.91(3)    1.70(3) 2.604(3) 174(3)
  2cx   N(12)-H(12A)...O(42)  0.91(2)    2.05(2)   2.9519(19)   173.1(19)
 N(12)-H(12B)...N(21)#1   0.85(2)    2.25(2)    3.080(2)   165.3(19)
 O(41)-H(41)...N(11)    0.90(2) 1.77(2)    2.6515(18)   167(2)
  2dxi   N(13)-H(13)...O(31)    0.97(3)    1.60(3)  2.569(3)  173(3)
 N(12)-H(12A)...O(32)   0.91(4)    1.92(4)   2.833(4) 176(3)
 N(12)-H(12B)...N(21)#1   0.86(4)    2.22(4)    3.060(4)   163(3)
  2exii  N(11)-H(11)...O(31) 0.94(2)    1.62(2)    2.5486(19)  174(2) 
N(12)-H(12A)...O(32)   0.91(2)    2.03(2)    2.932(2)   173.2(19) 
N(12)-H(12B)...N(21)#1  0.83(2)  2.36(2) 3.008(2) 136(2)
  6axiii  N(12)-H(12A)...O(32)  0.88   2.19  3.049(9)  165.6 
N(12)-H(12B)...N(13)#1 0.88   2.24     3.121(12)  175.3 
O(31)-H(31)...N(11) 0.84   1.84     2.633(9)  157.2 
  6bxiv	 N(12)-H(12A)...O(32) 0.91(3)    2.22(3)    3.109(3)   168(2) 
O(31)-H(31)...N(11)   0.99(3)    1.67(3) 2.652(3)   173(3) 
N(12)-H(12B)...N(13)#1  0.90(3)    2.24(3) 3.122(3)    168(2) 
6cxv  O(31)-H(31)...N(11)    0.96(4)    1.67(4) 2.625(3)    170(3) 
N(12)-H(12A)...O(32) 0.99(3)   1.92(3)    2.908(4)   177(3) 
N(12)-H(12B)...N(21)#1 0.95(3)       2.09(3)    3.023(4)    171(3) 
  6dxvi  N(12)-H(12A)...O(32)    0.925(17)    1.933(17) 2.8551(15)    174.4(15) 
N(12)-H(12B)...N(13)#1     0.888(17)    2.216(18) 3.0941(16)    170.2(15) 
i) #1 -x+2,-y+1,-z+1 #2 -x+1,-y+1,-z  ii)  #1 -x,y-1/2,-z+1/2  #2 -x,-y,-z+1 iii) #1 -x+2,-y+2,-z+1 #2 -x+1,-y+1,-z  iv) #1 -x,-y,-z+1  v) #1 
x+1,y+1,z vi) #1 x,y,z-1 #2 x+1,y-1,z+1 vii) #1 x+1,y,z+1  viii) #1 -x+1,-y+1,-z+1 ix) #1 -x+1,y,-z+1/2  x) #1 -x+1,-y+2,-z+1  xi) #1 -x,-y+1,­
z-1 xii) #1 x,y,z+1 xiii) #1 -x+2,-y+1,-z+1 xiv) #1 -x+1,-y,-z+1  xv) #1 -x,y-1/2,-z+1/2  xvi) #1 -x+1,-y,-z+1 
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As mentioned earlier, pKa/pKb values have been used quite successfully for predicting 
and rationalizing hydrogen bonding patterns in the crystalline solid-state.13  However, in order to 
apply predictable supramolecular strategies to a wider range of chemical functionalities under a 
variety of reaction conditions, it would be extremely useful if we could find a more satisfactory 
way of ranking intermolecular hydrogen-bond interactions that would take into account the many 
different factors that influence the molecular recognition behavior in any system.  Accordingly, 
electrostatic potential surfaces for SR’s 1, 2, and 6 were calculated using, Equation 2.1, and the 
Q values for each binding site were determined. Ligand 1 has two amino-protons (H1), two 
pyrimidine nitrogen atoms (N1), one pyridine nitrogen atom (N2) and two ortho-protons (H2 and 
H6) nearest the pyridyl-nitrogen, that are of particular interest.  Both the amino protons, both H2 
and H6 on the pyridyl moiety, and both pyrimidine nitrogen atoms display similar values, 
respectively, so only one atom in each pair will be discussed, Figure 2.4.   
H H1N Q = 404 kJ/mol 
N N1 
H2 N2 H6 
Q = 339 kJ/mol 
Figure 2.4 Molecular structure and the electrostatic potential surface map of ligand 1. 
The basic nitrogen atom sites in both pyrimidine and pyridine, display similar numerical 
values ~ -266 and -268 kJ/mol, respectively.  The positive potentials on the auxillary hydrogen-
bond donors, N-H and C-H, were calculated at 138 and 71 kJ/mol, respectively.  Consequently, 
the Q values for the two binding sites are 404 and 339 kJ/mol for the pyrimidine and pyridine 
sites, respectively, Table 2.2. Based upon these results, it is expected that the former moiety 
would be a more effective hydrogen-bonding site, and therefore a better competitive match for 
an approaching carboxylic acid. 
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Table 2.2 Calculated electrostatic potentail values (kJ/mol) of ligands 1, 2, and 6 using AM1 
Ligand N1  H1  N2  H2 Q (N1 + H1) Q (N2 + H2) 
1 -266 138 -268 71 404 339 
2 -255 142 -251 55 397 301 
6 -272 134 -251 75 406 326 
A similar analysis of the two binding sites in 2 again shows that there is a significant 
difference between the two binding sites, Figure 2.5. 
H H1N 
Q = 397 kJ/mol 
N N1 
Me0 N2 H2 
Q = 301 kJ/mol 
Figure 2.5 Molecular structure and the electrostatic potential surface map of ligand 2. 
For this SR, the Q-value for the N/N-H moiety on pyrimidine is 397 kJ/mol, whereas the 
value for the N/C-H moiety on the pyridine site is only 301 kJ/mol, Table 2.2.  The addition of a 
methoxy-substituent, next to the pyridyl nitrogen atom, reduces its negative charge and this is 
also as reflected by the pKa value 3.25 (compared to 5.17 for pyridine).8 Again, these 
calculations indicate that the amino-pyrimidine site should offer a more favorable match than the 
pyridyl moiety.    
SR 6 is structurally similar to 1, with the exception that a triple bond is now connecting 
the two aromatic rings and the methoxy group has been moved to the meta-position, Figure 2.6. 
However, neither of these changes significantly alter the overall electrostatic balance between 
the two binding sites. The pyrimidine moiety, N/N-H, has a Q-value of 406 kJ/mol, whereas the 
pyridine, N/C-H, site has a Q-value of 326 kJ/mol.  Again, the former moiety is expected to be 
the more effective and competitive hydrogen-bonding site on 6. 
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H H1N 
Q = 406 kJ/mol 
N N1 
MeO 
H2 N2 H 
Q = 326 kJ/mol 
Figure 2.6 Molecular structure and the electrostatic potential surface map of ligand 6. 
In all three SR’s, 1,  2, and 6 the overall electrostatic charges show that the amino-
pyrimidine moiety is a superior hydrogen-bond site, compared to either the pyridine or the 
methoxy-substituted pyridine site.  This hypothesis only holds true if electrostatics are playing a 
dominant role in the assembly process.    
1 2 6 
Figure 2.7 Thermal-ellipsoids plots (50% probability level) of ligands 1, 2, and 6. 
2.3.1 Crystal structure of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine, 1 
The crystal structure of 1 displays one molecule within the asymmetric unit and extension 
of the architecture shows individual ligands forming a 1-D strand through multiple N-H···N 
hydrogen bonds. The amino-pyrimidine moiety forms self-complementary N-H···N hydrogen 
bonds (N12···N11, 3.1013(17) Å) with a neighboring ligand producing a dimeric unit, which is 
further extended by secondary N-H···N hydrogen bonds from the anti-amino proton to the 
pyridyl nitrogen atom (N12···N21, 3.0450(17) Å) in a head-to-tail arrangement, Figure 2.8. 
53                  
Figure 2.8 1-D strands formed through multiple N-H···N hydrogen bonds of ligand 1. 
2.3.2 Crystal structure of 4-methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine, 2 
The crystal structure of 2 displays one molecule within the asymmetric unit, orientated 
with the two heterocycles in a relatively planar fashion.  Individual molecules form dimeric units 
through self-complementary amino-pyrimidine N-H···N/N···H-N (N12···N11, 3.047(3) Å) 
hydrogen bonds, Figure 2.9. The motif is extended into a 2-D sheet through N-H···O hydrogen 
bonds from the anti-amino proton and the oxygen atom of the methoxy group with an 
N(12)···O(26) distance of 3.062(3) Å. 
Figure 2.9 1-D strand formed through self-complementary amino-pyrimidine N-H···N hydrogen 
bonds. 
2.3.3 Crystal structure of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5­
yl)ethyne, 6 
The crystal structure of 6 displays one ligand and a 0.5 dichloromethane molecule within 
the asymmetric unit, with the two heterocycles orientated in a relatively planar fashion. 
Extension of the architecture reveals connectivities similar to that of structure 1, Figure 2.10. 
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The amino-pyrimidine moiety forms self-complementary N-H···N hydrogen bonds (N12···N11, 
3.086(2) Å) with a neighboring ligand producing a dimeric unit, which is further extended by 
secondary N-H···N hydrogen bonds from the anti-amino proton to the pyridyl nitrogen atom 
(N12···N21, 2.993(2) Å) in a head-to-tail arrangement.   
Figure 2.10 1-D strands formed through multiple N-H···N hydrogen bonds of ligand 6. 
1a 1b 
1c  1d 
Figure 2.11 Thermal ellipsoid plots (50 % probabilities) and labeling schemes for 1a-1d. 
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2.3.4 Crystal structure of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-nitrobenzoic 
acid, 1a 
The primary motif in the crystal structure of 1a is composed of SR 1 and one 4­
nitrobenzoic acid molecule connected through the acid and amino-pyrimidine moieties. The 
primary synthons are O–H···N and N–H···O hydrogen bonds with O31···N11 and N12···O32 
distances of 2.5274(18) Å and 3.034(2) Å respectively, Table 2.1.  Secondary N–H···N hydrogen 
bonds, N12···N21, 3.015(2) Å, formed from the anti-amino proton and the pyridyl nitrogen atom 
extend the architecture into a four-component supermolecule, Figure 2.12. 
Figure 2.12 A four-component supermolecule in 1a formed through multiple O–H···N, N–H···O 
and N–H···N hydrogen bonds. 
2.3.5 Crystal structure of 3-(2-amino-4-methylpyrimidin-6­
yl)pyridine:pentamethylbenzoic acid, 1b   
The primary motif in the crystal structure of 1b contains SR 1 and one 
pentamethylbenzoic acid molecule, interconnected through the acid and amino-pyrimidine 
moieties.. The primary synthons are O–H···N and N–H···O hydrogen bonds with O41···N11 and 
N12···O42 distances of 2.599(2) Å and 3.013(2) Å, respectively. Secondary N–H···N hydrogen 
bonds, N12···N21, 3.112(3) Å, between the anti-amino proton and the pyridyl nitrogen atom 
extend the architecture into a 1-D strand, Figure 2.13. 
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Figure 2.13 1-D strand formed through secondary N–H···N hydrogen bonds from 1:1 ligand:acid 
dimers of 1b. 
2.3.6 Crystal structure of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:4­
hydroxybenzoic acid, 1c 
In the crystal structure of 1c the main motif consists of SR 1 and one 4-hydroxybenzoic 
acid molecule, assembled via a complementary hydrogen-bond interaction between the 
carboxylic acid and the amino-pyrimidine moiety. The primary hydrogen bonds are O–H···N and 
N–H···O interactions with O31···N11 and N12···O32 distances of 2.656(3) Å and 2.906(3) Å, 
respectively. Secondary O–H···N hydrogen bonds, O34···N21, 2.728(3) Å, formed through the 
hydroxyl proton and the pyridyl nitrogen atom extend the architecture into a 1-D chain, Figure 
2.14. 
Figure 2.14 Infinite 1-D chains formed through acid/amino-pyrimidine and hydroxy/pyridine 
hydrogen bonds in 1c. 
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2.3.7 Crystal structure of 3-(2-amino-4-methylpyrimidinium-6-yl)pyridine:2,6­
difluorobenzoate, 1d 
The 1:1 ionic salt of 1d shows the primary motif composed of a protonated SR 1 and one 
3,5-dinitrobenzoate ion, interlinked through the carboxylate and the amino-pyrimidinium 
moieties. The primary synthons in this structure are charge-assisted N–H+···O- and N–H···O­
hydrogen bonds, with N+11···O-31 and N12···O-32 distances of 2.6608(17) Å and 2.8161(18) Å, 
respectively. The 1:1 ion pairs are linked into a 1-D zig-zag chain through N–H···N hydrogen 
bonds, N12···N21, 2.9888(19) Å, from the anti-amino proton and the pyridyl nitrogen atom, 
Figure 2.15. 
Figure 2.15 1-D strand formed through secondary N–H···N hydrogen bonds from 1:1 ligand:acid 
dimers of 1d. 
2a 2b 
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2e 
2c 2d 
Figure 2.16 Thermal ellipsoid plots (50 % probabilities) and labeling schemes for 2a-2e. 
2.3.8 Crystal structure of 4-methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine:4­
N,N-dimethylaminobenzoic acid, 2a 
The primary supermolecule in the crystal structure of 2a consists of SR 2 and one 4-N,N­
dimethylaminobenzoic acid molecule; the two molecules are again connected through the acid 
and amino-pyrimidine moieties.  The primary synthons in this structure are O–H···N and N– 
H···O hydrogen bonds with O31···N11 and N12···O32 distances of 2.6321(14) Å and 2.9173(15) 
Å, respectively.  Secondary N–H···O hydrogen bonds, N12···O32, 2.8925(15) Å, formed from 
the anti-amino proton and the carboxylic acid oxygen atom extend the structure into a four-
component supermolecule, Figure 2.17. 
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Figure 2.17 Four-component supermolecule in 2a formed through a series of O–H···N and N– 
H···O hydrogen bonds. 
2.3.9 Crystal Structure of 4-methoxy-3-(2-amino-4-methylpyrimidin-6-yl)pyridine:2,4­
difluorobenzoic acid, 2b 
In the crystal structure of 2b, SR 2 and one 2,4-difluorobenzoic acid molecule form the 
primary hydrogen bonds between the carboxylic acid and amino-pyrimidine moieties. The 
primary synthons in this structure are O–H···N and N–H···O hydrogen bonds with O31···N13 
and N12···O32 distances of 2.604(3) Å and 2.925(3) Å, respectively. Secondary N–H···N 
hydrogen bonds, N12···N11, 3.085(3) Å, between the anti-amino proton and the second 
pyrimidine nitrogen atom lead to a four-component supermolecule, Figure 2.18. 
Figure 2.18 Tetrameric supermolecule in 2b formed through a series of O–H···N, N–H···O, and 
N–H···N hydrogen bonds. 
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2.3.10 Crystal structure of 4-methoxy-3-(2-amino-4-methylpyrimidin-6­
yl)pyridine:pentamethylbenzoic acid, 2c 
The 1:1 co-crystal of 2c shows a primary motif composed of SR 2 and one 
pentamethylbenzoic acid molecule, which are interlinked through the carboxylic acid and the 
amino-pyrimidine moieties.  The primary synthons in this structure are O–H···N and N–H···O 
hydrogen bonds with O41···N11 and N12···O32 distances of 2.6515(18) Å and 2.9519(19) Å, 
respectively. Secondary N–H···N hydrogen bonds, N12···N11, 3.080(2) Å, between the anti-
amino proton and the pyridyl nitrogen atom extend the architecture into a four-component 
supermolecule, Figure 2.19. 
Figure 2.19 Four-component supermolecule in 2c formed through a series of O–H···N, N–H···O, 
and N–H···N hydrogen bonds. 
2.3.11 Crystal structure of 4-methoxy-3-(2-amino-4-methylpyrimidinium-6­
yl)pyridine:3,5-dinitrobenzoate, 2d 
The primary motif in the crystal structure of 2d is composed of a protonated SR 2 and 
one 3,5-dinitrobenzoate ion connected through the benzoate and amino-pyrimidinium moieties. 
The primary synthons are charge-assisted N–H+···O- and N–H···O- hydrogen bonds, with 
N+13···O-31 and N12···O-32 distances of 2.569(3) Å and 2.833(4) Å, respectively.  Secondary 
N–H···N hydrogen bonds, N12···N21, 3.060(4) Å, formed from the anti-amino proton and the 
pyridyl nitrogen atom extend the architecture into a four-component supermolecule, Figure 2.20. 
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Figure 2.20 A four-component supermolecule in 2d formed through multiple charge-assisted 
and neutral hydrogen bonds. 
2.3.12 Crystal structure of 4-methoxy-3-(2-amino-4-methylpyrimidinium-6­
yl)pyridine:2,5 dichlorobenzoate, 2e 
The 1:1 ionic salt of 2e shows the primary motif composed of a protonated SR 2 and one 
2,5-dichlorobenzoate ion, interlinked through the carboxylate and the amino-pyrimidinium 
moieties. The primary synthons in this structure are charge-assisted N–H+···O- and N–H···O­
hydrogen bonds, with N+11···O-31 and N12···O-32 distances of 2.5486(19) Å and 2.932(2) Å, 
respectively. The 1:1 ion pairs are linked into 1-D zig-zag chain through N–H···N hydrogen 
bonds, N12···N21, 3.008(2) Å, from the anti-amino proton and the pyridyl nitrogen atom, Figure 
2.21. 
Figure 2.21 1-D strand formed through secondary N–H···N hydrogen bonds from 1:1 ionic 
ligand:carboxylate dimers of 2e. 
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6c                                         6d 
 6a 6b 
6c 6d 
Figure 2.22  Thermal ellipsoid plots (50 % probabilities) and labeling schemes for 6a-6d. 
2.3.13 Crystal structure of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5­
yl)ethyne:3,5-dinitrobenzoic acid, 6a 
The central motif in the crystal structure of 6a contains SR 6 and one 3,5-dinitrobenzoic 
acid molecule, constructed with complementary hydrogen bonds between the carboxylic acid and 
the amino-pyrimidine moieties.  The primary synthons in this structure are O–H···N and N–H···O 
hydrogen bonds with O31···N11 and N12···O32 distances of 2.633(9) Å and 3.049(9) Å, 
respectively. Secondary N–H···N hydrogen bonds, N12···N13, 3.121(12) Å, between the anti-
amino proton and second pyrimidine nitrogen atom extend the structure into a four-component 
supermolecule, Figure 2.23. 
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Figure 2.23 Four-component supermolecule in 6a formed through O–H···N, N–H···O, and N– 
H···N hydrogen bonds. 
2.3.14 Crystal structure of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5­
yl)ethyne:4-nitrobenzoic acid, 6b 
The crystal structure of 6b contains SR 6 and one 4-nitrobenzoic acid molecule that are 
linked through hydrogen bonds between the carboxylic acid and the amino-pyrimidine moieties. 
The primary synthons are O–H···N and N–H···O hydrogen bonds with O31···N11 and N12···O32 
distances of 2.652(3) Å and 3.109(3) Å, respectively. Secondary N–H···N hydrogen bonds, 
N12···N13, 3.122(3) Å, between the anti-amino proton and second pyrimidine nitrogen atom 
extend the structure into a four-component supermolecule, Figure 2.24. 
Figure 2.24 Four-component supermolecule in 6b formed through a series of O–H···N, N–H···O, 
and N–H···N hydrogen bonds. 
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2.3.15 Crystal structure of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5­
yl)ethyne:3-N,N-dimethylaminobenzoic acid, 6c 
The crystal structure of 6c contains a supermolecule constructed with SR 6 and one 3­
N,N-dimethylaminobenzoic acid molecule, held together with hydrogen bonds between the 
carboxylic acid and the amino-pyrimidine site.  The primary synthons are O–H···N and N–H···O 
hydrogen bonds with O31···N11 and N12···O32 distances of 2.625(3) Å and 2.908(4) Å, 
respectively. Secondary N–H···N hydrogen bonds, N12···N21, 3.023(3) Å, between the anti-
amino proton and pyridine nitrogen atom extend the structure into a 1-D strand, Figure 2.25. 
Figure 2.25 1-D strand in 6c formed through secondary N–H···N hydrogen bonds between the 
anti-amino proton and the pyridine nitrogen atom. 
2.3.16 Crystal structure of 1-(2-amino-4-methylpyrimidinium-6-yl)-2-(3­
methoxypyridin-5-yl)ethyne:pentafluorobenzoate, 6d 
The crystal structure of 6d contains a protonated SR 6 and one pentamethylbenzoate ion 
that are linked through charge-assisted hydrogen bonds between the carboxylate and the amino­
pyrimidinium moieties.  The primary synthons are charge-assisted N–H+···O- and N–H···O­
hydrogen bonds, with N+11···O-31 and N12···O-32 distances of 2.597(17) Å and 2.8551(15) Å, 
respectively. Secondary N–H···N hydrogen bonds, N12···N13#1, 3.0941(16) Å, between the 
anti-amino proton and second pyrimidine nitrogen atom extend the structure into a four-
component supermolecule, Figure 2.26. 
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Figure 2.26 Tetrameric supermolecule in 6d formed through multiple charge-assisted and 
neutral hydrogen bonds. 
2.4 Discussion 
2.4.1 Formation of py-pym/carboxylic acid co-crystals and salts 
In every one of the nine co-crystals containing SR’s 1, 2, or 6 and a carboxylic acid that 
we have obtained so far, the intermolecular interaction responsible for the construction of the 
main supramolecular assembly, is a pairwise O-H···N/N-H···O motif between the carboxylic acid 
and the amino-pyrimidine moieties.  While the four ionic salts that were generated, between SR’s 
1, 2, or 6 and a carboxylic acid, formed a pairwise charge-assisted N–H+···O- and N–H···O- motif 
between the amino-pyrimidinium and carboxylate moieties, Figure 2.27. 
N 
NN 
N 
H H 
O 
O 
H 
R 
MeO 
N 
NN 
N 
H H 
O 
O 
R 
H 
MeO 
co-crystals or salts 9 4 
primary synthon  amino-pyrimidine /  amino-pyrimidinium / 
carboxylic acid carboxylate 
# of occurances 9/9 4/4 
supramolecular yield  100 % 100 % 
Figure 2.27 Summary of primary hydrogen bonding between SR’s 1, 2, and 6 and various 
aromatic carboxylic acids. 
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It is possible that SR 2 did not form hydrogen bonds at the pyridyl site because the 
nitrogen atom is somewhat sterically hindered by the neighboring methoxy-group, potentially 
blocking an incoming carboxylic acid.  However upon moving the methoxy-group to the meta­
position, thereby removing any possibility of steric congestion, the approaching carboxylic acid 
still binds to the amino-pyrimidine moiety.   
It is worth emphasizing that the carboxylic acid···pyridine interaction is a very effective 
tool for the assembly of molecular co-crystals,14 and a search of the CSD10 reveals that twenty-
one such co-crystals, assembled via complementary carboxylic acid···amino-pyrimidine 
interactions, exist.15  Clearly, both synthons are suitable supramolecular tools, capable of 
bringing together a variety of discrete molecular building blocks into heteromeric molecular co­
crystals. The competition between the two types of synthons has not yet not been examined in a 
systematic manner, but the structural results presented herein, clearly demonstrate that the 
amino-pyrimidine site is much more competitive for a carboxylic acid than is a pyridine moiety.   
2.4.2 Secondary hydrogen bonding motifs 
Beyond the primary interactions that take place between the carboxylic acid or 
carboxylate and 2-aminopyrimidine or 2-aminopyrimidinium (the dominating receptor in this 
study), we have identified four types of motifs in this series of compounds,  Figure 2.28. For 
simplicity only the carboxylic acid/amino-pyrimidine synthon will be drawn as the model.    
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N N N R 
N O R R N H O N 
N N O 
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H
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H H H 
N O H NH HN N N NO R N N N NRN O
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O H N 
R O N N 
N 
I II  III IV 
Figure 2.28 Observed motifs between supramolecular dimers in co-crystals obtained from 
reactions between SR’s 1, 2, and 6 and a carboxylic acid. 
The frequency of occurrence of each type of motif is summarized in Table 2.3. The 
crystal structure of 2f is somewhat different because the pyridine nitrogen atom is acting as an 
67                  
acceptor for the O-H substituent of the carboxylic acid, which leaves the anti-NH2 proton as a 
donor for the same hydroxyl group.  However, in seven out of the twelve remaining structures, 
the anti-proton prefers to interact with the pyridine nitrogen atom.  On one occasion, the pyridine 
nitrogen atom is engaged in a hydrogen bond with a C-H moiety located next to a nitro groups 
(in 6a). The pyridine site is left alone on four occasions (in 2a-2b, 6b, and 6d) with no short 
contacts to any C-H group. 
Table 2.3 Summary of secondary structural motifs 
SR Carboxylic acid or Carboxylate Structure 
Secondary 
structural motif 
N 
NN 
NH2 
N 
NN 
NH2 
MeO 
NN 
NH2 
N 
MeO 
4-Nitrobenzoic acid 
Pentamethylbenzoic acid 
4-Hydroxybenzoic acid 
2,6-Difluorobenzoate 
4-N,N-Dimethylaminobenzoic acid 
2,4-Difluorobenzoic acid 
Pentamethylbenzoic acid 
3,5-Dinitrobenzoate 
2,4-Dichlorobenzoate 
3,5-Dinitrobenzoic acid 
4-Nitrobenzoic acid 
3-N,N-Dimethylaminobenzoic acid 
Pentafluorobenzoate 
1a 
1b 
1c 
1d 
2a 
2b 
2c 
2d 
2e 
6a 
6b 
6c 
6d 
I 
IV 
IV 
III 
II 
I 
I 
IV 
II 
II 
IV 
I 
----
2.4.3 Q-value determination through AM1 calculations 
We have been able to rationalize the observed structural behavior through a comparative 
analysis of the calculated electrostatic potential surfaces of the two binding sites.  By simply 
subtracting the negative potential of the hydrogen-bond acceptor from the positive potential of 
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the hydrogen-bond donor in each binding site, a numerical value, Q, which represents overall 
hydrogen-bond capability is obtained, Equation 2.1.  A comparison of the two numbers show 
significant differences between the amino-pyrimidine and pyridine sites and indicates that the 
former is likely to be the most effective hydrogen-bonding functionality in all three 
supramolecular reagents 1, 2, and 6, Figure 2.29 
Q, 397 - 406 kJ/mol 
Q, 301 - 339 kJ/mol 
Figure 2.29 Electrostatic potential surface displaying the Q-value ranges of SR’s 1, 2, and 6. 
This ranking of binding sites is reflected by the structural preferences that we have 
observed in nine co-crystals and four ionic salts based upon 1, 2, and 6. In fact, we have yet to 
find any exceptions to the expected behavior, which equates to a high supramolecular yield. 
2.4.4. Product determination through IR spectroscopy 
In addition to determining the hydrogen bonding preference of an incoming acid, 
attempts were also made to characterize the supramolecular products, i.e. neutral co-crystal or 
salt, through infrared spectroscopy (IR), by observing specific stretches and band shifts within 
the spectrum. The classic neutral O-H···N stretches formed between a nitrogen containing 
heterocycle and an –OH group, give rise to pronounced bands in the regions of 2500 and 1900 
cm-1. Unfortunately, specific analysis was inconclusive since all products 1a-1d, 2a-2e, and 6a­
6d display stretches around 2500 and 1900 cm-1, regardless if the final product was a co-crystal 
or salt. 
We also attempted to track the shift of the carbonyl stretch.  A typical monomeric C=O 
stretching band of a carboxylic acid, when on an aromatic ring, appears  around 1760 cm-1, while 
the acid dimeric C=O stretching mode absorbs at a lower frequency in the 1720-1706 cm-1 
region. The carboxylate ion displays a strong asymmetrical stretching band around 1650-1550 
cm-1 and a weaker symmetric stretch ~1400 cm-1.16 A summary of the observed carbonyl 
stretches from 1a-1d, 2a-2e, and 6a-6d are displayed in Table 2.4. The results do not directly 
69                  
correlate with what is expected based on previously reported data, however some trends within 
this set of compounds are identified.16 
The IR spectra of ionic compounds 1d, 2d, 2e and 6d, in which a carboxylate is present, 
all display a strong stretching band around 1700 cm-1, instead of in the 1650 – 1550 cm-1 region. 
Furthermore, neutral structures, containing a relatively strong acid i.e. 1a, 2b, 6a, and 6b, also 
show an increase in wavenumbers of the carbonyl stretch compared to those of weaker acids.     
Table 2.4 Summary of IR data for compounds 1a-1d, 2a-2e, and 6a-6d 
Compound 1a 1b 1c 1d 2a 2b 2c 2d 2e 6a 6b 6c 6d 
Observed 
stretch 
(cm-1) 
1696 1635 1655 1700 1605 1685 1653 1701 1700 1690 1696 1655 1700 
Product C C C S C C C S S C C C S 
Note: product = C, co-crystal; product = S, salt 
It seems, within this system, that the IR data was inconclusive in accurately determining 
whether proton-transfer has occurred or not.  Furthermore, an explanation cannot be given at this 
time as to why the structures containing a carboxylate ion have distinct bands at higher 
wavenumbers (~1700) than a neutral carbonyl moiety.  
Finally, we have been able to establish differences in hydrogen-bond capacity of related 
binding sites by combining readily available and computationally inexpensive semi-empirical 
methods with systematic structural data.  The calculated numbers themselves are not likely to 
offer strict correlations with intermolecular bond-energies or other measurable physical 
quantities. However, they do offer a very useful tool for establishing hydrogen-bond preferences 
in series of related compounds which, in turn, can allow us to predict connectivities, 
stoichiometries and dimensionalities of supramolecular architectures. 
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CHAPTER 3 - Balancing intermolecular hydrogen-bond 
interactions for the directed assembly of ternary co-crystals utilizing 
a 4-pyridyl-aminopyrimidine supramolecular reagent 
3.1 Introduction 
The design of synthetic methodologies, involves not only optimization of the reaction 
conditions i.e. solvent, temperature, reaction time etc., but also an examination of the scope 
and/or limitations of a specific chemical reaction.1  Expansion of the reaction scope usually 
involves subtle modifications to a range of reactants including but not limited to, addition or 
subtraction of electron donating or withdrawing groups and steric modifications, within the 
reactants.  These details can have dramatic effects on formation and yields of the desired 
products. 
The goal of any supramolecular synthesis is a specific target that can be defined in terms 
of its connectivity and function, while the limits/limitations of a specific supramolecular strategy 
can be determined by a range of reaction conditions.   
One such example, of expanding the supramolecular reaction scope, was outlined in 
Chapter 2, with the design and synthesis of three pyridyl/amino-pyrimidine (py-pym) SR’s. In 
each case the 2-amino-4-methylpyrimidin-6-yl fragment remained unchanged, however on SR 2 
a methoxy group was appended to the pyridine ring in the ortho-position, while on SR 6 the 
methoxy substituent was in the meta-position on the pyridine ring. Within this supramolecular 
reaction system, subtle covalent modifications, i.e. addition of methoxy functional groups, were 
used to increase the electron density on the pyridyl nitrogen atom.  However, the hydrogen 
bonding capabilities of the pyridyl nitrogen atom, with respect to incoming aromatic carboxylic 
acid, remained unaffected by the addition.  In each case (13/13, 100% supramolecular yield) the 
1:1 product was constructed through the robust amino-pyrimidine···carboxylic acid or amino­
pyrimidinium···carboxylate synthons, independent of the introduction of an electron-donating 
methoxy substituent.2 
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A search through the CSD for structures containing pyridine···carboxylic acid synthons 
revealed one 1:1 co-crystal of a pyridine/amino-pyrimidine ligand and an aromatic carboxylic 
acid,3 Figure 3.1. 
Figure 3.1 1:1 Tetrameric supermolecule formed through acid···pyridine and amino-
pyrimidine···amino-pyrimidine synthons. 
Surprisingly, compared to our results from Chapter 2, the carboxylic acid forms an O­
H···N hydrogen bond with the 4-pyridyl moiety, leaving the amino-pyrimidine moieties to 
engage in self-complementary N-H···N hydrogen bonds. The hydrogen bonding connectivities 
within the crystal structure, differ from what we observed in our py-pym SR/carboxylic acid 
systems.   
To further probe our supramolecular reaction scope between py-pym SR’s and aromatic 
carboxylic acids, we decided to synthesize a structural analog of 1, Figure 3.2. Supramolecular 
reagent 7 has a similar chemical make-up to SR’s 1, 2, and 6 however the pyridyl nitrogen atom 
has been moved to the 4-position, with respect to the amino-pyrimidine ring, and the methoxy 
substituents have been removed. NH2 NH2 
N N N N 
N 
N 
1 7 
Figure 3.2 Two different SR’s, 3-(2-amino-4-methylpyrimidin-6-yl)pyridine (left) and 4-(2­
amino-4-methylpyrimidin-6-yl)pyridine (right), based purely on the placement of the pyridine 
nitrogen atom. 
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This chapter attempts to answer the following questions, (1) does the overall hydrogen-
bond accepting ability increase in strength, within the py-pym/carboxylic acid systems, if the 
pyridyl-nitrogen is moved from the 3- to the 4-position, and (2) does addition or subtraction of 
the methyl-group on the amino-pyrimidine ring play a role in forming amino-
pyrimidine/carboxylic acid interactions? These questions will be addressed through semi-
empirical AM1 calculations and single-crystal X-ray analysis of molecular co-crystals and salts 
formed from SR 7 and a variety of aromatic carboxylic acids. 
3.2 Experimental 
3.2.1 Synthesis 
All chemicals were purchased from Aldrich and used without further purification.  4­
Pyridylboronic acid was purchased from COMBI-BLOCKS and used as is. Melting points were 
determined on a Fisher-Johns melting point apparatus and are uncorrected.  Compounds were 
prepared for infrared spectroscopic (IR) analysis as a mixture in KBr. 1H and 13C NMR spectra 
were recorded on a Varian Unity plus 400 MHz spectrometer in CDCl3. Electrospray Ionization 
– Ion-Trap Mass Spectrometry (ESI-IT-MS) was carried out on a Bruker Daltonics Esquire 3000 
Plus. 
3.2.1.1 Synthesis of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine, 7 
N 
NN 
NH2 
N 
B(OH)2 
N N 
NH2 
Cl 
+ PdCl2(PPh3)2 / Na2CO3 
MeCN / H2O 
A mixture of 2-amino-4-chloro-6-methylpyrimidine (1.20g, 8.39 mmol), 4­
pyridylboronic acid (1.14g, 9.27 mmol), sodium carbonate (0.500g, 6.03 mmol), 
bis(triphenylphosphine)palladium(II) dichloride (180mg, 0.256 mmol, 2.5 mol %) was added to 
a round bottom flask.  Acetonitrile (50 mL) and water (50 mL) were added and dinitrogen 
bubbled through the resultant mixture for 10 minutes.  A condenser was attached and the mixture 
heated at 80 ˚C under a dinitrogen atmosphere. The reaction was monitored by TLC and allowed 
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to cool to room temperature on completion (48 hours).  The solution was then diluted with ethyl 
acetate (150 mL), washed with water (3 x 100 mL) then washed with saturated aqueous sodium 
chloride (1 x 100 mL).  The organic layer was separated and dried over magnesium sulfate.  The 
solvent was removed on a rotary evaporator and the residue chromatographed on silica with ethyl 
acetate as the eluant.  The product was isolated as a light yellow/white solid.  The product 7 was 
then recrystallized from an ethanol/chloroform mixture as colorless plate-shaped crystals, (1.1g, 
71 %). M.p: 179-181 ºC; 1H NMR (δH; 400 MHz, CDCl3): 8.74 (dd, J = 4.4Hz, J = 2Hz, 2H), 
7.84 (dd, J = 4.4Hz, J = 2Hz, 2H), 6.97 (s, 1H), 5.18 (s, 2H), 2.45 (s, 3H); 13C NMR (δC; 200 
MHz, CDCl3):169.6, 163.4, 162.7, 150.5, 144.7, 121.0, 107.5, 24.2; IR (KBr): 3318, 3151, 1581, 
1376. ESI-IT-MS m/z 187 ([7 + H]+). 
3.2.2 Synthesis of co-crystals and salts 
3.2.2.1 Synthesis of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-hydroxybenzoic acid, 7a 
4-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 4-hydroxybenzoic 
acid (7 mg, 0.05 mmol) were placed in a vial containing ethanol (6 mL) and heated until a clear 
homogeneous solution was obtained.  After one day of slow evaporation, colorless block-shaped 
crystals were obtained.  M.p. 243-245 °C; IR (KBr pellet) υ 3334 and 3160 cm-1 (NH2, m), 2479 
and 1875 cm-1 (O-H···N, br), 1670 cm-1 (C=O, m).   
3.2.2.2 Synthesis of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine:3-hydroxybenzoic acid, 7b 
4-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 3-hydroxybenzoic 
acid (7 mg, 0.05 mmol) were placed in a vial containing ethanol (6 mL) and heated until a clear 
homogeneous solution was obtained.  After one day of slow evaporation, colorless block-shaped 
crystals were obtained.  M.p. 230-232 °C; IR (KBr pellet) υ 3329 and 3211 cm-1 (NH2, m), 2694 
and 1910 cm-1 (O-H···N, br), 1623 cm-1 (C=O, m).   
3.2.2.3 Synthesis of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:3,5-dinitrobenzoate, 7c 
4-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 3,5-dinitrobenzoic 
acid (11 mg, 0.05 mmol) were placed in a beaker containing ethanol (5 mL).  The beaker was 
heated until a clear homogeneous solution was obtained.  After three days, yellow rod-shaped 
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crystals formed.  Dec 208 °C; IR (KBr pellet) υ 3447 and 3176 cm-1 (NH2, m), 1696 cm-1 (C=O, 
m).   
3.2.2.4 Synthesis of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine:3-bromo-4-methylbenzoic 
acid, 7d 
4-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 3-bromo-4­
methylbenzoic acid (23 mg, 0.11 mmol) were placed in a vial containing acetonitrile (6 mL) and 
heated until a clear homogeneous solution was obtained.  After two days of slow evaporation, 
yellow prism-shaped crystals were obtained. M.p. 190-192 °C; IR (KBr pellet) υ 3380 and 3196 
cm-1 (NH2, m), 2387 and 1916 cm-1 (O-H···N, br), 1690 cm-1 (C=O, m). 
3.2.2.5 Synthesis of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:3,5-dinitrobenzoate, 7e 
4-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 3,5-dinitrobenzoic 
acid (22 mg, 0.10 mmol) were placed in a beaker containing ethanol (5 mL).  The beaker was 
heated until a clear homogeneous solution was obtained.  After three days, yellow block-shaped 
crystals formed. M.p. 237-239 °C; IR (KBr pellet) υ 3391 and 3170 cm-1 (NH2, m), 2443 and 
1916 cm-1 (O-H···N, br), 1696 cm-1 (C=O, m).   
3.2.2.6 Synthesis of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:pentamethylbenzoic 
acid:pentafluorobenzoate, 7f 
4-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol), pentamethylbenzoic 
acid (11 mg, 0.06 mmol), and pentafluorobenzoic acid (12 mg, 0.06 mmol) were placed in a 
beaker containing ethanol (5 mL).  The beaker was heated until a clear homogeneous solution 
was obtained. After two days, block-shaped crystals formed. M.p. 136-138 °C; IR (KBr pellet) υ 
3370 and 3083 cm-1 (NH2, m), 1675 cm-1 (C=O, m).   
3.2.3  AM1 Calculations 
Molecular structures of SR’s 7, 2-amino-4-(3-pyridyl)pyrimidine and 2-amino-4-(4­
pyridyl)pyrimidine were constructed using Spartan ’04 (Wavefunction, Inc. Irvine, CA).  The 
geometris of all three molecules were optimized using AM1, with the maxima and minima in the 
electrostatic potential surface (0.002 e/au isosurface) determined using a positive point charge in 
the vacuum as a probe. 
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3.3 Results 
Crystallographic information for 7, 7(1), and 7a-7f displayed in Tables B.2 and 
hydrogen-bond geometries for  7, 7(1), and 7a-7f are listed in Table 3.1 
Table 3.1 Hydrogen-Bond Geometries for 7, 7(1), and 7a-7f 
Structure   D-H•••H 	 d(D-H)/Å d(H•••A)/Å  d(D•••A)/Å    <(DHA)/º 
7i	 N(12)-H(12A)...N(11)#1 0.93(2)    2.17(2)    3.052(2)  159.3(18)
 N(12)-H(12B)...N(13)#2 0.85(2)       2.29(2)    3.1222(19)  166.0(19) 
7(1)ii   N(12-1)-H(12B-1)...N(11-2) 0.86    2.23        3.067(4)   164.4 

 N(12-1)-H(12A-1)...N(21-3) 0.86       2.20        3.033(4)   161.8 

 N(12-2)-H(12B-2)...N(11-1) 0.86       2.20        3.042(4)   168.2 

 N(12-2)-H(12A-2)...N(21-4) 0.86       2.18        3.008(5)   162.6 

 N(12-3)-H(12A-3)...N(21-1)#1 0.86       2.19        3.013(5)   160.3 

 N(12-3)-H(12B-3)...N(11-4)#2 0.86      2.22        3.047(4)   160.9 

 7aiii   O(31)-H(31)...N(11) 0.98(2) 1.76(2)     2.732(2)   173(2)
 N(12)-H(12A)...O(32) 0.89(2) 1.94(2)  2.824(2)   172(2)
 N(12)-H(12B)...N(13)#1 0.94(2)    2.14(2) 3.069(2)  172.6(18)
 O(34)-H(34)...N(21)#2 0.86(2)       1.88(2)     2.724(2)   166(2) 
7biv   O(31)-H(31)...N(11) 1.10(3)    1.56(3)     2.646(3)   169(3)

 N(12)-H(12A)...O(32)  0.97(3) 1.94(3)     2.887(4)   165(3)

 N(12)-H(12B)...O(33)#1 0.94(3) 2.09(3) 2.975(4) 156(3) 

 O(33)-H(33)...N(21)#2 0.99(3) 1.71(3) 2.702(3) 172(3)

7cv   N(11)-H(11)...O(31) 0.88 1.77  2.646(6) 175.2

 N(12)-H(12A)...O(42) 0.88    1.91   2.783(6) 174.2

 N(12)-H(12B)...N(21)#1  0.88 2.12    2.962(7)  158.6 

7dvi	 N(12)-H(12B)...O(42)    0.88 2.08 2.948(7)    168.7 

 N(12)-H(12A)...O(32)#1 0.88 2.14    2.959(9)  154.9 

 O(31)-H(31)...N(21) 0.84 1.77    2.600(8)  170.7 

 O(41)-H(41)...N(11) 0.84 1.79 2.620(7)  167.5 

  7evii	 N(11)-H(11)...O(42) 1.032(16) 1.507(16)  2.5341(14) 172.5(15)
 N(12)-H(12A)...O(41)   0.889(18)  2.169(18)  3.0559(15) 176.3(16)
 N(12)-H(12B)...O(41)#1 0.850(18) 2.115(18) 2.8515(16) 144.8(15)
 O(31)-H(31)...O(21)  0.996(17) 1.603(17)  2.5983(14) 177.6(16) 
7fviii	 N(11)-H(11)...O(31)     0.94(3)  1.72(4)   2.655(4) 173(3) 
N(12)-H(12A)...O(32) 0.92(4)  1.97(4)     2.875(4) 172(3) 
N(12)-H(12B)...O(32)#1   0.91(4)   2.18(4) 2.939(4) 140(3) 
O(51)-H(51)...O(31)   0.80(4) 1.88(4)    2.654(4)    162(4) 
 i) #1 -x,y+1/2,-z+1/2 #2 -x,y-1/2,-z+1/2 ii) #1 x-1,y,z  #2 x-1,y,z+1 iii) #1 -x+1,-y+2,-z+1 #2 x-3/2,-y+3/2,z+1/2  iv) 
#1 -x,-y+1,-z+2,  #2 x, y+1, z+1 v) #1 –x-1,y+1/2,-z-1/2 vi)  #1 –x+1,y-1/2,-z+1 vii) #1 x+1,y,z+1  viii) #1 -x+1,-y+1,­
z+1 
In order to probe the electrostatic nature of SR 7, semi-empirical AM1 calculations were 
carried out and the Q-value determined (eqn. 2.1). The structure of ligand 7 is very similar to that 
of 1, with the pyridyl nitrogen atom moved from the 3- to the 4-position.  Ligand 7 has two 
amino-protons (H1), two pyrimidine nitrogen atoms (N1), one pyridine nitrogen atom (N2) and 
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two ortho-protons (H2 and H3) nearest the pyridyl-nitrogen, that are of particular interest.  Both 
the amino protons, both H2 and H3 on the pyridyl moiety, and both pyrimidine nitrogen atoms 
display similar values, respectively, so only one atom in each pair will be discussed, Figure 3.3.   
N2 
N1N 
N 
H H1 
H3 
H2 
Figure 3.3 Molecular structure and the electrostatic potential surface map of ligand 7. 
The basic nitrogen atom sites in both pyrimidine and pyridine, display similar numerical 
values ~ -260 and -276 kJ/mol, respectively.  The positive potentials on the auxillary hydrogen-
bond donors, N-H and C-H, were calculated at 140 and 65 kJ/mol, respectively.  Consequently, 
the Q values for the two binding sites are 400 and 341 kJ/mol for the amino-pyrimidine and 
pyridine sites compared to 404 and 339 kJ/mol for ligand 1, respectively, Figure 3.4. Based 
upon these results, the former moiety is expected to be the more effective hydrogen-bonding site 
for an approaching carboxylic acid. 
HH H H 
NN 
400 kJ/mol 404 kJ/mol 
N

H

341 kJ/mol

N N N 
N 
H N 
339 kJ/mol 
(7) (1) 
Figure 3.4 A comparison of the Q-values determined for the amino-pyrimidine and pyridine 
binding sites of SR’s 1 and 7. 
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Figure 3.5 Thermal-ellipsoids plots (50% probability level) of ligands 7 and 7a-7f 
3.3.1 Crystal structure of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine,7 
The crystal structure of 7 displays one molecule within the asymmetric unit, orientated 
with the two heterocycles in a relatively planar fashion.  Extension of the architecture shows 
individual ligands forming a 1-D strand through multiple self-complementary amino-pyrimidine 
N-H···N (N12···N11, 3.052(2) Å and N12···N13, 3.1222(19) Å) hydrogen bonds, Figure 3.6. 
Within this arrangement, the pyridine moiety is not participating in hydrogen bonding, possibly 
due to the shortage of hydrogen bond donors.   
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Figure 3.6 1-D strand formed through self-complementary amino-pyrimidine N-H···N hydrogen 
bonds. 
3.3.2 Crystal structure of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine, 7(1) 
A polymorph of 7, 7(1) displays four molecules within the asymmetric unit, orientated in 
a planar fashion, Figure 3.7. 
Figure 3.7 Thermal-ellipsoids plot (50% probability level) of 7(1). 
Multiple N-H···N hydrogen bonds extend the architecture into a 2-D sheet, Figure 3.8. 
The N-H···N hydrogen bonds include a pairwise self-complementary amino-pyrimidine/amino­
pyrimidine (N12-2···N11-1, 3.042(4) Å, N12-1···N11-2, 3.067(4) Å) motif, two different amino-
proton/pyridine (N12-1···N21-3, 3.033(4) Å, N12-2···N21-4, 3.008(5) Å) and two different 
amino-proton/pyrimidine (N12-3···N11-4, 3.047(4) Å, N12-3···N21-1, 3.013(5) Å) interactions. 
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Figure 3.8 Extended architecture of polymorph 7(1). 
3.3.3 Crystal structure of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine:4­
hydroxybenzoic acid, 7a 
In the crystal structure of 7a the main motif consists of SR 7 and one 4-hydroxybenzoic 
acid molecule, assembled via a complementary hydrogen-bond interaction between the 
carboxylic acid and the amino-pyrimidine moieties.  The primary hydrogen bonds are O–H···N 
and N–H···O interactions with O31···N11 and N12···O32 distances of 2.732(2) Å and 2.824(2) Å 
respectively. Secondary O–H···N hydrogen bonds, O34···N21, 2.724(2) Å, formed through the 
hydroxyl proton and the pyridyl nitrogen atom extend the architecture into a one-dimensional 
chain. The 1-D strands are propagated into 2-D sheets through self-complementary N-H···N 
hydrogen bonds, N12···N13, 3.069(2) Å, from the anti-amino proton to the second pyrimidine 
nitrogen atom, Figure 3.9. 
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Figure 3.9 Extended 2-D sheet of 7a formed through a series of O-H···N, N-H···O, and N-H···N 
hydrogen bonds. 
3.3.4 Crystal structure of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine:3­
hydroxybenzoic acid, 7b 
The primary motif in the crystal structure of 7b contains SR 7 and one 3-hydroxybenzoic 
acid molecule, interconnected through the carboxylic acid and the amino-pyrimidine moieties. 
The primary synthons are O–H···N and N–H···O interactions with O31···N11 and N12···O32 
distances of 2.646(3) Å and 2.887(4) Å respectively.  Secondary O–H···N hydrogen bonds, 
O34···N21, 2.702(3) Å, formed through the hydroxyl proton and the pyridyl nitrogen atom 
extend the architecture into a one-dimensional chains which are linked into a double-strand 
arrangement with adjacent chains through additional N–H···O hydrogen bonds, N12···O33, 
2.975(4) Å, from the anti-amino proton and the hydroxyl oxygen atom, Figure 3.10. 
Figure 3.10 Infinite 1-D strand formed through acid···amino-pyrimidine and hydroxy···pyridine 
hydrogen bonds in 7b. 
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3.3.5 Crystal structure of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:3,5­
dinitrobenzoate, 7c 
The 1:1 salt 7c shows the primary motif composed of a protonated SR 7 and one 3,5­
dinitrobenzoate ion, which are interlinked through the carboxylate and the amino-pyrimidinium 
moieties. The primary synthons in this structure are charge-assisted N–H+···O- and N–H···O­
hydrogen bonds, with N···O distances of 2.646(6) Å and 2.783(6) Å, respectively.  Ion pairs are 
linked into a 1-D zig-zag chain through N–H···N hydrogen bonds, N12···N21, 2.962(7) Å, from 
the anti-amino proton and the pyridyl nitrogen atom, Figure 3.11. 
Figure 3.11 1-D strand in 7c formed through secondary N-H···N hydrogen bonds between the 
anti-amino proton and the pyridine nitrogen atom. 
3.3.6 Crystal structure of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:3,5­
dinitrobenzoate, 7d 
The central motif in the crystal structure of 7d is the result of charge-assisted and neutral 
hydrogen-bond interactions between the carboxylic acid and the amino-pyrimidine and the 
pyridine moieties.  The primary synthons in this structure are charge-assisted N–H+···O- and N– 
H···O- and neutral O-H···N hydrogen bonds, with N···O distances of 2.5342(14) Å and 
3.0559(15) Å, formed through the amino-pyrimidinium and carboxylate moieties, while a neutral 
O-H···N hydrogen bond, O31···N21, 2.5979(14) Å, is formed from the second carboxylic acid 
moiety to the pyridine group. The 1:2 ligand-acid trimer is extended into a hexameric 
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supermolecule through secondary charge assisted N–H···O- hydrogen bonds with N12···O-41 
distances of 2.8517(16) Å, Figure 3.12. 
Figure 3.12 Hexameric supermolecule of 7d formed through multiple charge-assisted and 
neutral hydrogen bonds. 
3.3.7 Crystal structure of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine:3-bromo-4­
methylbenzoic acid, 7e 
The primary supermolecule in the crystal structure of 7e consists of SR 7 and two 3­
bromo-4-methylbenzoic acid molecules, constructed through acid···amino-pyrimidine, 
N12···O42, 2.948(7) Å; O41···N11, 2.620(7) Å, and acid···pyridine O31···N21, 2.600(8) Å 
synthons. The 1:2 ligand-acid trimer is further connected into a polymeric network through a 
secondary N–H···O hydrogen bond with a N12···O32 distance of 2.959(9) Å, Figure 3.13. 
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Figure 3.13 One-dimensional zig-zag chain of 7e connected through secondary N-H···O 
hydrogen bonds. 
3.3.8 Crystal structure of 4-(2-amino-4-methylpyrimidinium-6­
yl)pyridine:pentamethylbenzoic acid:pentafluorobenzoate, 7f 
The asymmetric unit of 7f contains a protonated SR 7, one pentafluorobenzoate ion, and 
one pentamethylbenzoic acid molecule constructed through charge-assisted hydrogen-bond 
interactions. The primary synthons in this structure are charge-assisted N–H+···O-, N–H···O-, and 
O-H···O- hydrogen bonds, with N+11···O-31 and N12···O-32 distances of 2.655(4) Å and 
2.875(4) Å, formed through the amino-pyrimidinium and carboxylate moieties, while a charge-
assisted O-H···O- hydrogen bond, O51···O-31, 2.654(4) Å, is formed from the 
pentamethylbenzoic moiety to the carboxylate group of the anion, Figure 3.14.   
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Figure 3.14 Three component ionic supermolecule formed through multiple charge-assisted 
hydrogen bonds 
The three-component ionic complex is further extended into a six-component 
supermolecule through secondary charge-assisted N–H···O- hydrogen bonds from the anti-amino 
proton to a carboxylate oxygen of the pentafluorobenzoate molecule, Figure 3.15. 
Figure 3.15 Six-component supermolecule formed through secondary ionic hydrogen bonds. 
3.4 Discussion 
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3.4.1 Characterization of polymorph 7(1) through powder XRD 
Crystals of 7 were grown from 200 proof ethanol, while 7(1) were grown from ethyl 
acetate as a co-crystallization reaction between SR 7 and benzoic acid. We were interested in 
determining if the solvent i.e. ethanol or ethyl acetate or the benzoic acid additive produced one 
polymorph over another.  Thus crystals were grown from ethyl acetate, examined using powder 
XRD, and compared to simulated powder patterns of 7 and 7(1). The simulated powder patterns 
of 7 and 7(1) are displayed in Figure 3.16. 
(7) 

7(1)
Figure 3.16 Powder XRD patterns for 7 (simulated) and 7(1) (simulated). 
The powder pattern, of the sample grown from ethyl acetate, matched very closely to the 
simulated powder pattern of 7, Figure 3.17. Thus, the conclusion was made that crystal packing 
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in structure 7 occurs independent of solvent choice, however the benzoic acid additive must be 
contributing to the packing arrangement within 7(1). 
2 theta 
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Figure 3.17 Powder XRD pattern of SR 7 grown from ethyl acetate (experimental). 
3.4.2 Formation of 4-py-pym/carboxylic acid co-crystals and salts 
SR 7 was prepared in good yields (71 %) through the palladium catalyzed Suzuki-
Miyaura reaction, by cross-coupling 4-pyridylboronic acid and 2-amino-4-methyl-6-chloro 
pyrimidine under basic conditions.  Both SR’s 1 and 7 have similar molecular structures with the 
only difference being the placement of the pyridyl nitrogen atom.  However, this small structural 
variation in 7 made a significant difference in the outcome of the products produced.   
Each of the structures 7a-7f were obtained upon mixing SR 7 with various aromatic 
carboxylic acids in polar solvents. In every structure the primary intermolecular interaction is a 
pairwise O-H···N/N-H···O or N–H+···O-/N–H···O- motif between the carboxylic acid or 
carboxylate and the amino-pyrimidine or amino-pyrimidinium moieties, Figure 3.18. 
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Figure 3.18 Primary hydrogen bonding interactions between SR 7 and an incoming carboxylic 
acid molecule. 
In structures 7a-7c the connectivities support the results obtained from the AM1­
calculations, in which the Q-value of the amino-pyrimidine moiety (400 kJ/mol) significantly 
outweighs the 4-pyridyl/auxillary C-H site (341 kJ/mol) as the dominating primary hydrogen 
bonding site. Additionally, structures 7a-7c match those of Chapter 2, 1a-1d, 2a-2e, and 6a-6d, 
where 1:1 stoichiometric products were produced through carboxylic acid/amino-pyrimidine or 
carboxylate/amino-pyrimidinium synthons.   
Upon increasing the acid:ligand mixing ratio from 1:1 to 2:1, a 2:1 acid:ligand product 7d 
and 7e form. The 2:1 acid:ligand complexes are held together through the conventional 
hydrogen bonding pattern at the amino-pyrimidine site, while a second acid molecule hydrogen 
bonds to the 4-pyridyl nitrogen through O-H···N interactions, Figure 3.19. These two results are 
quite different from what was seen in Chapter 2, when the product was a 1:1 dimer, regardless of 
stoichiometric mixing ratios.        
H 
N O 
N 
N 
H 
O RHO H N 
R O 
Figure 3.19 Pictorial description of the hydrogen bonding synthons seen between SR 7 and a 
carboxylic acid upon mixing in a 2:1 acid/SR stoichiometric ratio. 
It is conceivable that only two of the three sites i.e. 1 and 2 on SR 7 are accessible for an 
approaching carboxylic acid, since site 3 is slightly sterically hindered by the neighboring 
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pyridyl ring, Figure 3.20. In fact, every example in which a carboxylic acid is hydrogen bound 
to a py-pym SR, the acid preferentially binds at site 1 and never at site 3.  
N 
NN 
NH2 
(1) 
(2) 
(3) 
(2) 
(1) 
(3) 
Figure 3.20 (left) Schematic and space-filling model of SR 7 displaying the three potential 
hydrogen bonding sites (1-3) for an incoming carboxylic acid. 
Clearly, both hydrogen bond acceptor sites i.e. amino-pyrimidine and 4-pyridyl are 
suitable supramolecular tools, capable of bringing together multiple carboxylic acids into a 
single crystalline lattice. Thus, SR 7 was used as a ‘supramolecular-hub’ in attempts to form 
ternary co-crystals with two different carboxylic acids.  One ternary complex 3f was produced 
however the overall connectivities of the species was unexpected. The stronger 
pentafluorobenzoic acid was expected to bind to the amino-pyrimidine site, the strongest base, 
while the weaker pentamethylbenzoic acid was expected to bind to pyridine.  The stronger 
pentafluorobenzoic acid molecule does indeed hydrogen bond with the strongest base, however, 
proton-transfer to a pyrimidine nitrogen atom occurs, resulting in charge assisted N–H+···O-/N– 
H···O- interactions. Thus a competition, between the pyridyl nitrogen and the carboxylate 
oxygen of the pentafluorobenzoate molecule occurs, for the remaining pentamethylcarboxylic 
acid. Possibly due to the carboxylate oxygen being the second best hydrogen bond acceptor, 
paired with strong π···π stacking between pentamethyl and pentafluoro rings (~3.5 Å), the 
carboxylic acid moiety prefers a charge-assisted O-H···O- hydrogen bond motif instead of the 
pyridyl nitrogen atom. 
3.4.3 Q-value determinations through AM1 calculations 
AM1 electrostatic potential surfaces were calculated in order to determine if the methyl-
substituent, on the amino-pyrimidine ring, plays a role in directing the supramolecular assembly.   
92 
        
        
                                                                            
Each molecule (1, 7, a, and b) has two separate Q-values, pyrimidine nitrogen atoms + amino-
protons ( ) and pyridine nitrogen atoms + auxiliary C-H protons ( ), Figure 3.21. 
NH2 NH2 NH2 NH2 
N N N N N N N N 
N NH N H N 
H H 
(1) (7) (a) (b) 
  kJ/mol  
  kJ/mol  
404 
339 
400 
341 
402 
350 
383 
330 
Figure 3.21 Calculated electrostatic potential surfaces for a variety of pyridine/amino­
pyrimidine SR’s.   
These calculations show that the methyl-group does not play a significant role in altering 
the electronics of the amino-pyrimidine or pyridine ring.  In fact, the Q-value of the amino-
pyrimidine moiety in b decreases upon removing the methyl group, correlating to a weaker 
hydrogen bonding site, compared to SR’s 1 and 7. The connectivity displayed in the 1:1 co­
crystal, Figure 3.1, fails to correlate with our calculated and structural data for similar systems. 
This clearly demonstrates the need for multiple crystal structures, within a particular study, if one 
is to draw strict conclusions on connectivity and stoichiometry  of the final products. 
3.4.4 Co-crystal or salt; is it predictable based on pKa values? 
Is it possible to determine if proton transfer is going to occur, upon mixing a carboxylic 
acid and N-containing base, before conducting the actual experiment?  Some guidelines based 
upon solid-state and solution infrared spectroscopy have been reported.4   The rule simply states, 
that if the ΔpKa is >3.75, the system is favorable for proton transfer.5   We decided to examine if 
our results could be explained against this background.   
Since a titration experiment of py-pym 7 would be difficult to carry out, we relied on 
theoretical calculations to generate the necessary pKa values.6  Relevant pKa values, for the 
carboxylic acids contained in this study were obtained from reported literature values.7  Our  
findings for this study are displayed in Table 3.2. 
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Table 3.2 Determination of ΔpKa for structures 3c-3h 
Co-crystal Salt Benzoic acid SR 7 (pKa) 
N / NH2 
Acid (pKa) ΔpKa 
7a ---- 4-hydroxybenzoic acid 1.83 4.58 2.75 
7b ---- 3-hydroxybenzoic acid 1.83 4.06 2.23 
---- 7c 3,5-dinitrobenzoic acid 1.83 2.82 0.99 
7e ---- 3-bromo-4-methylbenzoic acid 1.83 3.87 3.04 
---- 7f pentafluorobenzoic acid 1.83 1.73 0.10 
Interestingly, co-crystals 7a, 7b, and 7e produce the largest ΔpKa, while salts 7c and 7f 
display small ΔpKa difference although proton transfer has occurred.  No doubt, these guidelines 
will work for some hydrogen bond donor/acceptor pairs, however in our py-pym/carboxylic acid 
system, the ΔpKa results do not offer any reliable guidelines.  The drawbacks with this type of 
comparison are numerous, e.g. varying types of reaction conditions, instrumentation, and 
scientific advances, all of which could lead to misinterpreted data and conclusions.  
This study has displayed how subtle molecular modifications can have dramatic effects 
on the overall supramolecular assembly process.  The difference, in product outcome, was 
observed when SR 7 versus SR 1 was allowed to react with aromatic carboxylic acids.  From 
these results, SR 7 should provide an ideal environment for the construction of ternary 
supermolecules, between aromatic carboxylic acids of different strength and/or other hydrogen 
bond donor moieties i.e. oxime, hydroxy, or acetamide. This study also serves to underscore 
some of the similarities between the development of non-covalent and covalent synthetic 
methodologies.  In each case, the driving force is a specific goal.  Within supramolecular 
synthesis the goal is an assembly of molecules with predictable connectivities and 
stoichiometries, while successful covalent synthesis is based on the organization of individual 
atoms.  For instance, the supramolecular chemist might rely on the placement of individual 
atoms to direct the overall assembly, while the organic chemist might rely on the directing 
effects of substituents i.e. ortho, meta, and para, when carrying out an electrophilic aromatic 
substitution reaction on substituted benzenes. The efficiency of the supramolecular synthesis can 
be improved by systematically altering reaction conditions or by making deliberate changes to 
the supramolecular reagent. 
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CHAPTER 4 - Combining hydrogen and halogen bonding in the 
construction of polymeric supermolecules 
4.1 Introduction 
Heteromeric synthons such as carboxylic acid···pyridine1 and carboxylic acid···amide2 are 
well-established and dependable partners within crystal engineering, however synthons such as 
amino-pyrimidine···carboxylic acid3 and nitrogen···halogen (I or Br)4 have been utilized far less 
frequently, although they can form discrete and/or extended supramolecular architectures, Figure 
4.1 
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Figure 4.1 A variety of heteromeric synthons employed in crystal engineering. 
Designing and constructing supermolecular products from two individual entities, which 
contain only one complementary moiety each, is often predictable due to the limited number of 
synthons that could form between the reactants. However, predictability becomes inherently 
more difficult upon increasing the number of potentially interactive moieties on each reactant 
leading to an increase in possible synthons that might form.  In this chapter, we will be focus on 
the design and synthesis of supramolecular architectures formed through combinations of both 
hydrogen and halogen bonds in a systematic manner. 
There is one example in the literature of an assembly deliberately formed through 
combinations of both hydrogen and halogen bonds.5  In this example, 4-nitrobenzoic acid and 4­
iodopyridine assemble into 1-D tapes through acid···pyridine and nitro···iodo heteromeric 
synthons, Figure 4.2. 
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Figure 4.2 1-D strands formed through combinations of both hydrogen and halogen bonding. 
Within this system, two molecules containing a total of four different functional groups 
are allowed to react, in which (based on electrostatics) the acid/pyridine heterosynthon is the 
most favorable primary interaction (9.9 kcal/mol),6 while the iodo/nitro heterosynthon forms as a 
secondary interaction (2.5 kcal/mol).7  Calculations were also carried out for the acid/acid dimer 
and iodo/pyridine interaction which shows energy values lower (7.8 and 3.4 kcal/mol) than the 
primary acid/pyridine synthon. 
A suitable bifunctional ligand for selective hydrogen and halogen bonding would need to 
contain a robust chemical functionality capable of forming hydrogen bonds even in the presence 
of other potential disruptive moieties, coupled with a functional group that would prefer to 
interact with a halogen atom through N···X (X = I or Br) halogen bonds.    
Conventional halogen bonds are typically formed through a suitable halogen bond donor 
i.e. iodine or bromine and a halogen bond acceptor, a nitrogen containing heterocycle. 
Furthermore, the halogen bond donor can be strengthened upon fluorination of the molecule, 
which leads to a dramatic increase in the electron-acceptor ability of the iodine or bromine 
atoms.8 
In Chapter 2 we demonstrated how ditopic pyridine/amino-pyrimidine functionalized 
SR’s selectively interact and bind aromatic carboxylic acids utilizing a hierarchical approach 
through hydrogen bond strength and synthon complementarity.  In all cases (13/13), when the 3­
pyridyl functionalized SR’s were allowed to react with aromatic carboxylic acids, the result was 
a 1:1 co-crystal or salt assembled through an amino-pyrimidine/carboxylic acid or amino­
pyrimidinium/carboxylate heterosynthon, Figure 4.3. 
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Figure 4.3 Results obtained by mixing carboxylic acids with 3-pyridine/amino-pyrimidine SR’s. 
These results show that our py/pym based SR’s provide ideal molecular recognition sites 
for promoting both hydrogen and halogen bonding in a controllable and predictable manner. By 
introducing a halogen-bonding atom (Br or I) on an aromatic carboxylic acid, we can take 
advantage of the complementarity between the amino-pyrimidine and carboxylic acid moieties, 
while allowing the 1:1 dimer to assemble into an infinite network through pyridyl-iodine or ­
bromine halogen bonding, Figure 4.4. 
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Figure 4.4 A postulated network formed through a series of hydrogen and halogen bonds (X = I, 
Br). 
With these goals in mind, we decided to target three py/pym SR’s 1, 6, and 7 and three 
halogenated benzoic acids 8, 13, and 14, Figure. 4.5. 
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Figure 4.5 Three bifunctional SR’s 1, 6, and 7, possessing two distinctly different hydrogen-
bonding moieties i.e. pyridine and amino-pyrimidine and three halogenated aromatic carboxylic 
acids 8, 13, and 14. 
In order to study the limits and limitations of the hierarchical approach to supramolecular 
synthesis through hydrogen and halogen bonding, py-pym SR’s 1, 6, and 7 were allowed to react 
with either 4-iodobenzoic acid 8, 1-iodo-2,3,5,6-tetrafluorobenzoic acid 13, or 1-bromo-2,3,5,6­
tetrafluorobenzoic acid 14 in a 1:1 ratio. This chapter will attempt to address the following 
questions: 
•	 Can combinations of hydrogen and halogen bonds be utilized, in a hierarchical 
fashion to construct predictable assemblies? 
•	 Is iodine a better halogen bond donor than bromine? 
•	 Does the Lewis acidity of halogen nuclei increase upon fluorination of the aryl ring? 
4.2 Experimental 
4.2.1 Synthesis 
All chemicals, unless noted, were purchased from Aldrich and used without further 
purification. 1,2,4,5-tetrafluorobenzene was purchased from Apollo Scientific Inc.  Column 
chromatography was carried out on silica gel (150 Å pore size) from Analtech Inc. Melting 
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 points were determined on a Fisher-Johns melting point apparatus and are uncorrected.  1H and 
13C NMR spectra were recorded on a Varian Unity plus 400 MHz or 200 MHz spectrometer in 
CDCl3 or D6-DMSO. Compounds were prepared for infrared spectroscopic (IR) analysis as a 
mixture in KBr. Electrospray Ionization – Ion-Trap Mass Spectrometry (ESI-IT-MS) was carried 
out on a Bruker Daltonics Esquire 3000 plus.  MALDI-TOF / TOF-MS was carried out on a 
Bruker Daltonics Ultraflex TOF/TOF. 
4.2.1.1 Synthesis of 1,2,4,5-tetrafluoro-3-(1,3-dioxol-2-yl)benzene, 99 
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9 
Under a dinitrogen atmosphere, a single neck round-bottom flask containing dry THF (65 
mL) was cooled to –78 °C (dry ice/acetone).  Upon cooling, n-BuLi (1.6 M, 21.25 mL) was 
added to the stirred solution.  1,2,4,5-Tetrafluorobenzene (5 g, 0.033 mol) was added and 
allowed to stir at –78 ° for 1h.  After 1h ethyl formate (5.0 g, excess) was added in one portion 
and the reaction was allowed to reach room temperature.  The mixture was then diluted with 
saturated NaHCO3(aq) (45 mL), separated, dried over MgSO4 and the solvent removed on a 
rotary evaporator.  The mixture was then transferred to a round-bottom flask containing ethylene 
glycol (5.0 g, excess) and toluene (35 mL).  4-Toluenesulfonic acid (40 mg) was added and a 
dean-stark trap was attached and the mixture was refluxed for 2h.  After cooling to room 
temperature, the reaction mixture was washed with NaHCO3(aq) (45 mL), separated, dried over 
MgSO4 and the solvent removed on a rotary evaporator.  The residue was chromatographed on 
silica with hexanes as the eluant.  The product 9 was isolated as a colorless oil, which solidified 
upon standing, (5.4 g, 74 %). M.p. 38-40 ºC; 1H NMR (δH; 200 MHz, CDCl3): 7.17-7.00 (m, 
1H), 6.24 (s, 1H), 4.26-4.01 (m, 4H); IR (KBr pellet): υ 3078, 2914, 1511, 1403, 1260, 1178, 
1132, 989, 937, 851, 702, 615, 559 cm-1. 
4.2.1.2 Synthesis of 2-(2,3,5,6-tetrafluoro-4-iodo-phenyl)-[1,3]dioxolane, 1010 
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Under a dinitrogen atmosphere, a single neck round-bottom flask containing dry THF (22 
mL) and 1,2,4,5-Tetrafluoro-3-(1,3-dioxol-2-yl)benzene 9 (1.5 g, 6.73 mmol) was cooled to –78 
°C (dry ice/acetone bath).  Upon cooling, n-BuLi (1.6 M, 4.65 mL) was added dropwise to the 
stirred solution. After 1h, a solution of iodine (1.88 g, 7.41 mmol) in THF (6 mL) was added by 
syringe all at once. The reaction was allowed to reach room temperature, upon which THF (20 
mL) was added. The reaction mixture was washed with aqueous NaHCO3(aq) (5 mL), then 0.5 
M aqueous Na2S2O3, dried over MgSO4 and the solvent removed on a rotary evaporator.  The 
off-white solid residue was recrystallized from dissolving in boiling n-pentane and placed in the 
refrigerator affording colorless plate-shaped crystals of 10, (1.90 g, 81 %). M.p. 92-94 ºC; 1H 
NMR (δH; 200 MHz, CDCl3): 6.23 (s, 1H), 4.26-4.01 (m, 4H); IR (KBr pellet): υ 2981, 2904, 
1640, 1481, 1399, 1271, 1112, 994, 922, 758, 723, 630 cm-1. 
4.2.1.3 Synthesis of 1-iodo-2,3,5,6-tetrafluorobenzaldehyde, 1110 
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In a round-bottom flask, 2-(2,3,5,6-tetrafluoro-4-iodo-phenyl)-[1,3]dioxolane 10 (800 
mg, 2.29 mmol) and trifluoroacetic acid (2.5 mL) were allowed to stir.  To the solution, water (7 
mL) was added, followed by HCl (1.5 mL, 37 %), affording a white precipitate.  The reaction 
mixture was heated to 70 °C for 2h.  Upon cooling, the mixture was washed with chloroform (3 
x 25 mL) and the organic layer washed with water, separated, and dried over MgSO4. The 
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solvent was removed on a rotary evaporator and the residue dissolved in dichloromethane.  This 
solution was then poured into hexanes and cooled to 0 ºC.  The white precipitate 11 was filtered 
and dried, (610 mg, 88 %).  M.p. 108-110 ºC; 1H NMR (δH; 200 MHz, CDCl3): 10.31-10.30 (m, 
1H); IR (KBr pellet): υ 1696, 1629, 1470, 1414, 1373, 1265, 1030, 963, 769, 620 cm-1. 
4.2.1.4 Synthesis of 1-bromo-2,3,5,6-tetrafluorobenzaldehyde, 1211 
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Pentafluorbenzaldehyde (12.0 g, 61.22 mmol), anhydrous lithium bromide beads (6.0 g, 
69.0 mmol) and N-methylpyrrolidone (36 mL) were added to a round bottom flask and heated to 
160 ºC under a dinitrogen atmosphere for 2h.  Upon cooling the mixture was poured into water 
and the brown precipitate filtered and dried in a dessicator over phosphorus pentoxide.  The solid 
was subject to silica gel column chromatography with hexanes as the eluent, affording a white 
solid. This solid was further purified by recrystallization from hexanes, yielding 12 as colorless 
crystals, (6.6 g, 42 %). M.p. 93-95 ºC; 1H NMR (δH; 200 MHz, CDCl3): 10.31 (s, 1H); IR (KBr 
pellet): υ 1703, 1636, 1487, 1415, 1391, 1274, 1036, 971, 830, 777, 626 cm-1. 
4.2.1.5 Synthesis of 1-iodo-2,3,5,6-tetrafluorobenzoic acid, 13 
CHO COOH 
FF F	 KMnO4 
F 
Acetone F 
I I 
11 13 
A solution of 1-iodo-2,3,5,6-tetrafluoro benzaldehyde 11 (1.52 g, 5.0 mmol) in acetone 
(50 mL) was brought to reflux, when a saturated aqueous solution of KMnO4 (1.67 g, 10.57 
mmol) was added. The reaction was kept under reflux for 18h.  Upon completion the reaction 
mixture was filtered hot and the precipitate washed with acetone.  The filtrate and the acetone 
wash were combined and concentrated by rotary evaporator.  The residue was treated with dilute
F F	 F 
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HCl (5 %) and extracted into dichloromethane.  The organic layer was washed with water, dried 
over magnesium sulfate and evaporated on a rotary evaporator yielding a white solid 13, (1.29 g, 
81 %). Dec. 140 ºC; 1H NMR (δH; 200 MHz, CDCl3): 8.173 (br s); ESI-IT-MS m/z 318 ([13 ­
H]-); IR (KBr pellet): υ 2996, 1700, 1475, 979, 718 cm-1. 
4.2.1.6 Synthesis of 1-bromo-2,3,5,6-tetrafluorobenzoic acid, 14 
CHO COOH 
F FF FKMnO4 
Acetone FF F F 
Br Br 
12 14 
A solution of 1-bromo-2,3,5,6-tetrafluoro benzaldehyde 12 (1.54 g, 6.0 mmol) in acetone 
(60 mL) was brought to reflux, when a saturated aqueous solution of KMnO4 (2.01 g, 12.72 
mmol) was added. The reaction was kept under reflux for 18h.  Upon completion the reaction 
mixture was filtered hot and the precipitate washed with acetone.  The filtrate and the acetone 
wash were combined and concentrated by rotary evaporator.  The residue was treated with dilute 
HCl (5 %) and extracted into dichloromethane.  The organic layer was washed with water, dried 
over magnesium sulfate and evaporated on a rotary evaporator yielding a white solid 14, (1.32 g, 
81 %). M.p. 128 - 130 ºC; 1H NMR (δH; 200 MHz, CDCl3): 10.16 (br s); ESI-IT-MS m/z 270 
([14 - H]-); IR (KBr pellet): υ 2996, 1711, 1475, 979, 712 cm-1. 
4.2.2 Synthesis of co-crystals and salts 
4.2.2.1 Synthesis of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-iodobenzoic acid, 8a 
3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 4-iodobenzoic 
acid (13 mg, 0.05 mmol) were placed in a beaker containing an ethyl acetate/toluene (2:1) 
mixture and heated until a clear homogeneous solution was obtained.  After two days of slow 
evaporation, colorless rod-shaped crystals were obtained.  M.p. 152-154 °C; IR (KBr pellet) υ 
3329 and 3083 cm-1 (NH2, m), 2413 and 1921 cm-1 (O-H···N, br), 1685 cm-1 (C=O, m). 
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4.2.2.2 Synthesis of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:1-iodo-2,3,5,6­
tetrafluorobenzoic acid, 13a 
3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 1-iodo-2,3,5,6­
tetrafluorobenzoic acid (17 mg, 0.05 mmol) were placed in a beaker containing ethanol (6 mL) 
and heated until a clear homogeneous solution was obtained.  After two days of slow 
evaporation, colorless rod-shaped crystals were obtained. M.p. 196-198 °C; IR (KBr pellet) υ 
3334 and 3104 cm-1 (NH2, m), 2407 and 1972 cm-1 (O-H···N, br), 1680 cm-1 (C=O, m), 963 cm-1. 
4.2.2.3 Synthesis of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-iodobenzoic acid, 8b 
4-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 4-iodobenzoic 
acid (13 mg, 0.05 mmol) were placed in a vial containing acetonitrile (6 mL) and heated until a 
clear homogeneous solution was obtained.  After two days of slow evaporation, orange block-
shaped crystals were obtained. M.p. 181-183 °C; IR (KBr pellet) υ 3334 and 3176 cm-1 (NH2, 
m), 2428 and 1895 cm-1 (O-H···N, br), 1660 cm-1 (C=O, m). 
4.2.2.4 Synthesis of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:1-iodo-2,3,5,6­
tetrafluorobenzoate, 13b 
3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 1-iodo-2,3,5,6­
tetrafluorobenzoic acid (17 mg, 0.05 mmol) were placed in a vial containing ethanol/ethyl 
acetate (3:2) and heated until a clear homogeneous solution was obtained.  After one day of slow 
evaporation, colorless rod-shaped crystals were obtained.  Dec. 210 °C; IR (KBr pellet) υ 3350 
and 2996 cm-1 (NH2, m), 2387 and 1967 cm-1 (O-H···N, br), 1690 cm-1 (C=O, m) 
4.2.2.5 Synthesis of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:1-bromo-2,3,5,6­
tetrafluorobenzoate, 14a 
3-(2-Amino-4-methylpyrimidin-6-yl)pyridine (10 mg, 0.05 mmol) and 1-bromo-2,3,5,6­
tetrafluorobenzoic acid (17 mg, 0.05 mmol) were placed in a vial containing 
nitromethane/acetonitrile (5:1) and heated until a clear homogeneous solution was obtained. 
After one day of slow evaporation, colorless rod-shaped crystals were obtained.  M.p. 204-206 
°C; IR (KBr pellet) υ 3340 and 3044 cm-1 (NH2, m), 2361 and 1962 cm-1 (O-H···N, br), 1696 cm­
1 (C=O, m). 
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4.2.2.6 Synthesis of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne:4­
iodobenzoic acid, 8c 
1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne (10 mg, 0.04 
mmol) and 4-iodobenzoic acid (12 mg, 0.04 mmol) were placed in a vial containing a 
methanol/nitromethane solution (2:1) and heated until a clear homogeneous solution was 
obtained. After four days of slow evaporation, colorless rod-shaped crystals were obtained. 
M.p. 188-190 °C; IR (KBr pellet) υ 3257 and 3037 cm-1 (NH2, m), 2361 and 1957 cm-1 (O-H···N, 
br), 1690 cm-1 (C=O, m), 2218 cm-1 (-C≡C-, m). 
4.2.2.7 Synthesis of 1-(2-amino-4-methylpyrimidinium-6-yl)-2-(3-methoxypyridin-5­
yl)ethyne:1-bromo-2,3,5,6-tetrafluorobenzoate, 14b 
1-(2-Amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne (10 mg, 0.04 
mmol) and 1-bromo-2,3,5,6-tetrafluorobenzoic acid (12 mg, 0.04 mmol) were placed in a vial 
containing ethanol (6 mL) and heated until a clear homogeneous solution was obtained.  After 
four days of slow evaporation, colorless rod-shaped crystals were obtained. M.p. 188-190 °C; IR 
(KBr pellet) υ 3257 and 3037 cm-1 (NH2, m), 2361 and 1957 cm-1 (O-H···N, br), 1690 cm-1 
(C=O, m), 2218 cm-1 (-C≡C-, m). 
4.3 Results 
A summary of the crystallographic information for 14, 8a-8c, 13a-13b, and 14a-14b 
displayed in Tables B.3 and all hydrogen-bond geometries for  are listed in Table 4.1 
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Table 4.1 Hydrogen-Bond Geometries for 14, 8a-8c, 13a-13b, and 14a-14b 
Structure   D-H···H  d(D-H)/Å d(H···A)/Å d(D···A)/Å  <(DHA)/º  
14i	 O(1)-H(1)...O(2)#1 0.84    1.82  2.663(6)  175.4 
8aii	 O(31)-H(31)...N(11)    0.98(2)     1.59(3)  2.5607(19)  168(2) 
N(12)-H(12A)...O(32) 0.84(2) 2.21(2)    3.035(2) 168(2) 
N(12)-H(12B)...N(21)#1 0.83(2)     2.12(2)  2.951(2) 177(2) 
13aiii  O(31)-H(31)...N(11) 0.84    1.77 2.589(7)   165.0 
N(12)-H(12A)...O(32) 0.88 2.06       2.924(8)  168.6 
N(12)-H(12B)...O(32)#1    0.88 2.05 2.855(8) 150.9 
 8b	 N(11)-H(12A)...O(32) 0.88 1.95 2.818(4)  167.9 
  O(31)-H(31)...N(11) 0.84 1.84    2.675(3) 172.6 
13biv	 N(11)-H(11)...O(31)  0.85(6)   1.81(6)    2.646(5)     167(5) 
N(12)-H(12A)...O(32) 0.88     1.94     2.801(5)  164.7 
N(12)-H(12B)...O(32)#1 0.88 2.07       2.808(5)  141.4 
14av	 N(11)-H(11)...O(31)  0.82(2)  1.83(2)  2.6430(19)    173(2) 
N(12)-H(12A)...O(32) 0.84(2)     1.99(2)    2.823(2) 172(2) 
N(12)-H(12B)...O(32)#1 0.89(2)   2.07(2)   2.812(2)  140(2) 
8cvi	 O(31)-H(31)...N(11)   0.97(9)    1.71(9)    2.643(8)     162(7) 
  N(12)-H(12A)...O(32) 0.86   2.14    2.987(8)  169(3)
  N(12)-H(12B)...N(13)#1    0.86 2.28 3.108(8)  160.3 
14bvii	 N(11)-H(11)...O(31)      0.94(3)    1.68(3)    2.605(2)  169(2 )
  N(12)-H(12A)...O(32) 0.93(3)  1.90(3)    2.832(2)  173(2)
  N(12)-H(12B)...N(13)#1     0.74(3) 2.34(3) 3.073(2) 170(3) 
i) #1 -x,-y+1,-z+1  ii) #1 -x,-y+2,-z+1  iii)  #1 -x+2,-y+1,-z+2  iv) #1 -x+1,-y+1,-z+1  v) #1 -x+1,-y+2,­
z+2 vi) #1 -x,-y+1,-z vii) #1 -x+1,-y,-z+1 
4.3.1 Crystal structure of 1-bromo-2,3,5,6-tetrafluorobenzoic acid, 14 
Crystals of 1-bromo-2,3,5,6-tetrafluorobenzoic acid 14 were grown at room temperature 
by slow evaporation of a saturated dichloromethane solution.  As expected the acid moieties 
form head-to-head dimers through self-complementary O-H···O (O1 ···O2, 2.663(6)) hydrogen 
bonds, Figure 4.6. Bromine···bromine contacts were not observed. 
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                                                                    (a) (b) 
Figure 4.6 a) Thermal-ellipsoids plot (50% probability level) of 1-bromo-2,3,5,6­
tetrafluorobenzoic acid; b) acid···acid dimer produced from two molecules of 14. 
4.3.2 Crystal structure of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-iodobenzoic 
acid, 8a 
The primary motif in the crystal structure of 8a is composed of SR 1 and 4-iodobenzoic 
acid 8, assembled via a complementary hydrogen-bond interaction between the carboxylic acid 
and the amino-pyrimidine moieties, Figure 4.7.  The primary hydrogen bonds are O–H···N and 
N–H···O with O31···N11 and N12···O32 distances of 2.5607(19) Å and 3.035(2) Å, respectively. 
Secondary N-H···N hydrogen bonds, N12-N21, 2.951(2) Å, formed from the anti-amino and the 
pyridyl nitrogen atom extend the architecture into a four-component supermolecule, Figure 4.8. 
No halogen···nitrogen or halogen···halogen interactions are observed. 
Figure 4.7 Thermal-ellipsoids plot (50% probability level) of the 1:1 co-crystal 8a. 
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Figure 4.8 Four-component supermolecule of 8a comprised of N-H···O, O-H···N, and N-H···N 
hydrogen bonds.  The toluene solvent molecule has been omitted for clarity. 
4.3.3 Crystal structure of 3-(2-amino-4-methylpyrimidin-6-yl)pyridine:1-iodo-2,3,5,6­
tetrafluorobenzoic acid, 13a 
In the crystal structure of 13a the main motif consists of SR 1 and 1-iodo-2,3,5,6­
tetrafluorobenzoic acid 13, assembled via a complementary hydrogen-bond interaction between 
the carboxylic acid and the amino-pyrimidine moieties, Figure 4.9. The primary hydrogen bonds 
are O–H···N and N–H···O interactions with O31···N11 and N12···O32 distances of 2.589(7) Å 
and 2.924(8) Å, respectively. Halogen bonding formed through the iodine atom and the pyridyl 
nitrogen atom extend the architecture into one-dimensional chains with a N···I distance of 2.941 
Å. The 1-D chains are connected into a two-dimensional wave-like pattern through additional 
N–H···O interactions (N12···O32, 2.855(8) Å) from the anti-proton of the amino-functionality to 
the carbonyl oxygen of the halogenated benzoic acid, Figure 4.10. 
Figure 4.9 Thermal-ellipsoids plot (50% probability level) of the 1:1 binary co-crystal of 13a. 
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Figure 4.10 Extended motif of 13a, displaying the combinations of O–H···N and N–H···O 
hydrogen bonds as well as N···I halogen bonds. 
4.3.4 Crystal structure of 4-(2-amino-4-methylpyrimidin-6-yl)pyridine:4-iodobenzoic 
acid, 8b 
In the crystal structure of 8b the main motif consists of SR 7 and 4-iodobenzoic acid 8, 
assembled via a complementary hydrogen-bond interaction between the carboxylic acid and the 
amino-pyrimidine moieties, Figure 4.11. The primary hydrogen bonds are O–H···N and N–H···O 
interactions with O31···N11 and N12···O32 distances of 2.675(3) Å and 2.818(4) Å, respectively. 
Halogen bonding extends the architecture into 1-D chains with a N···I distance of 3.004 Å. 
Adjacent chains are connected through self-complementary N–H···N hydrogen bonds with 
N12···N13 distances of 2.250 Å, Figure 4.12. 
Figure 4.11 Thermal-ellipsoids plot (50% probability level) of the 1:1 binary co-crystal of 8b. 
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Figure 4.12 Extended motif of 8b, displaying combinations of O–H···N, N–H···O, and N–H···N 
hydrogen bonds as well as N···I halogen bonds. 
4.3.5 Crystal structure of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:1-iodo­
2,3,5,6-tetrafluorobenzoate, 13b 
In the crystal structure of 13b the main motif consists of a protonated SR 7 and one 1­
iodo-2,3,5,6-tetrafluorobenzoate ion, assembled via charge-assisted hydrogen-bond interactions 
between the carboxylate and the amino-pyrimidinium moieties, Figure 4.13. The primary 
hydrogen bonds are N–H+···O- and N-H···O- interactions with N+11···O-31 and N12···O-32 
distances of 2.675(3) Å and 2.818(4) Å, respectively.  Halogen bonding extends the architecture 
into 1-D chains with a N···I distance of 2.812 Å. The 1:1 ionic chains are linked into a ladder 
motif through secondary N-H···O- hydrogen bonds (N12···O32, 2.812(2)), from the anti-amino 
proton and the carboxylate oxygen atom, Figure 4.14. 
Figure 4.13 Thermal-ellipsoids plot (50% probability level) of the 1:1 ionic dimer of 13b. 
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Figure 4.14 1-D strands formed through a series of hydrogen bonds and halogen bonds. 
4.3.6 Crystal structure of 4-(2-amino-4-methylpyrimidinium-6-yl)pyridine:1-bromo­
2,3,5,6-tetrafluorobenzoate, 14a 
In the crystal structure of 14a the main motif consists of one protonated SR 7 and one 1­
bromo-2,3,5,6-tetrafluorobenzoate ion, assembled via charge-assisted hydrogen-bond 
interactions between the carboxylate and the amino-pyrimidinium moieties, Figure 4.15, with 
N+11···O-31 and N+12···O-32 distances of 2.6430(19) Å and 2.823(2) Å, respectively.  Halogen 
bonds extend the architecture into 1-D chains with an N···Br distance of 2.840 Å, while the anti­
proton of the amino group forms an N–H···O- hydrogen bond (N12···O-32, 2.812(2) Å) with a 
neighboring carboxylate oxygen atom generating a ladder motif, Figure 4.16. 
Figure 4.15 Thermal-ellipsoids plot (50% probability level) of the 1:1 dimer 14a. 
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Figure 4.16 1-D strands formed through a series of hydrogen bonds and halogen bonds. 
4.3.7 Crystal structure of 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5­
yl)ethyne:4-iodobenzoic acid, 8c 
The primary motif in the crystal structure of 8c consists of O–H···N and N–H···O 
interactions with O31···N11 and N12···O32 distances of 2.643(8) and 2.987(8) Å, respectively, 
Figure 4.17. The anti-proton of the amino group forms self-complementary N–H···N hydrogen 
bonds (N12···N13, 3.108(8) Å) with a pyrimidine nitrogen of a neighboring 1-D strand 
generating a tetrameric supermolecule, Figure 4.18.   
Figure 4.17 Thermal-ellipsoids plot (50% probability level) of the 1:1 binary co-crystal of 8c. 
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Figure 4.18 Tetrameric supermolecule 8c formed through a series of hydrogen bonds. 
4.3.8 Crystal structure of 1-(2-amino-4-methylpyrimidinium-6-yl)-2-(3­
methoxypyridin-5-yl)ethyne:1-bromo-2-3-5-6-tetrafluorobenzoate, 14b 
In the crystal structure of 14b the main motif comprises hydrogen-bonding interactions 
between the carboxylate and the amino-pyrimidinium moieties, with N+11···O-31 and N12···O-32 
distances of 2.605(2) Å and 2.832(2) Å, respectively.  Adjacent ions are connected through self-
complementary N–H···N hydrogen bonds with N12···N13 distances of 3.073(2) Å, producing a 
four-component supermolecule, Figure 4.20.  No short Br···N or Br···Br interactions were 
observed. 
Figure 4.19 Thermal-ellipsoids plot (50% probability level) of the 1:1 dimer 14b. 
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Figure 4.20 Four-component supermolecule 14b constructed through charge-assisted and neutral 
hydrogen bonds. 
4.4 Discussion 
4.4.1 Can a hierarchy through hydrogen and halogen bonds be established? 
Each of the four co-crystals obtained so far, possesses the robust and reliable amino-
pyrimidine···carboxylic acid heterosynthon.  Additionally, the same connectivities are observed 
in the three ionic salts, through pairwise N-H+···O- and N-H···O- charge-assisted hydrogen bonds 
between the amino-pyrimidinium and the carboxylate moieties.  Unfortunately, suitable crystals 
for single-crystal X-ray crystallography were not obtained for compounds 3-(2-amino-4­
methylpyrimidin-6-yl)pyridine:1-bromo-2,3,5,6-tetrafluorobenzoic acid and 1-(2-amino-4­
methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne:1-iodo-2-3-5-6-tetrafluorobenzoic acid. 
In four of the seven structures 13a-13b, 8b, and 14a halogen bonds i.e.  N···I or N···Br 
extend the acid/SR dimers into polymeric networks.  The halogen bonding patterns and distances 
for each crystal structure is displayed in Table 4.2. 
114 
Table 4.2 Halogen bonding patterns observed in crystal structures 8a-8c, 13a-13b, and 14a-14b 
SR Acid Structure # Halogen 
bonds 
Type of 
Halogen bond 
Halogen bond 
Distance (Å) 
1 I-BA 8a No ---- ---- 
1 I-F4BA 13a Yes N···I 2.941 
7 I-BA 8b Yes N···I 3.004 
7 I-F4BA 13b Yes N···I 2.812 
7 Br-F4BA 14a Yes N···Br 2.840 
6 I-BA 8c No ---- ----- 
6 Br-F4BA 14b No ---- ----- 
Note: I-BA = 4-iodobenzoic acid, I-F4BA = 1-iodo-2,3,5,6-tetrafluorobenzoic acid, and Br-F4BA 
= 1-bromo-2,3,5,6-tetrafluorobenzoic acid. 
4.4.2 Characterization of halogen bonding through IR  spectroscopy 
Attempts were made at detecting whether or not an actual N···I or N···Br halogen bond 
had formed through changes in the C-X (X = I or Br) stretch in the IR spectrum.  If halogen 
bonding takes place, then shifts to lower wavenumbers should occur for the C-X (X = I or Br) 
stretch. In “free” 1,4-diiodotetrafluorobenzene, the C-I stretch is observed around 945 cm-1, 
however upon complexation (with a N-heterocycle) the C-I stretch shifts to lower wavenumbers 
around 940 cm-1. 
We assigned the band at 979 cm-1 to the C-I stretch of “free” halogenated benzoic acid 13 
to 979 cm-1, however upon complexation, structures 13a and 13b, that band had shifted to around 
963 and 968 wavenumbers, respectively. Attempts to monitor the change in the C-I stretch of 
benzoic acid 8, i.e. uncomplexed vs. complexed were unsuccessful.  The uncomplexed C-I 
stretch occurs ~1010 cm-1, however we observed C-I stretches at lower wavenumbers, i.e. 1004, 
1009, and 1004 cm-1 for compounds 8a, 8b, and 8c, even though complexation did not take place 
(based upon crystallography). This may be explained based on attempting to track band shifts 
between relatively weak interactions, which would produce very small changes in the IR spectra. 
Additionally, we were unable to identify the C-Br stretching band for halogenated benzoic acid 
14, and thus characterization of whether or not complexation, based on IR data had occurred, 
was not possible. 
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4.4.3 Does the Lewis acidity of the halogen nuclei increase upon fluorination? 
As expected, comparing structures 13a and 8b, the halogen bond distance becomes 
shorter upon fluorination of the aryl ring.  Furthermore, structure 13a also displays a shorter 
halogen bond distance compared to that of the bromo analog, 14a, which is consistent with aryl 
iodides being stronger Lewis acid’s than aryl bromides. 
It is possible that SR’s 1 and 6 only formed the desired halogen bonding connectivities 1 
out of 4 times, due to the location of the pyridyl nitrogen atom i.e. 3- vs. 4-pyridyl. Although 
upon fluorination of the carboxylic acid, structure 13a displays the desired hydrogen and halogen 
bonding arrangement and connectivity, while 8a failed to produce halogen bonds. 
4.4.4. Effects of the halogen (I or Br) on the directed-assembly 
Due to the limited number of crystal structures, it is difficult to draw direct conclusions 
about the binding effects of iodine vs. bromine as a more suitable electron-pair acceptor atom 
within our py-pym SR/carboxylic acid systems.  However, upon observation of the halogen bond 
distances, Table 4.2, 13b displays a shorter N···I distance, 2.812 Å, compared to 14a, which has 
an N···Br distance of 2.840 Å, even though the size of iodine (1.32 Å) is larger than bromine 
(1.14 Å). Furthermore, a search through the CSD revealed only thirteen structures containing 
N···Br interactions, however fifty-three contained N···I contacts.   
This Chapter has described a strategy for designing and constructing supermolecules 
through combinations of hydrogen bonds and halogen bonds. In all seven structures the amino-
pyrimidine···carboxylic acid synthon was utilized to ‘lock’ two individual molecules into a 
correct orientation and arrangement, in which secondary N···I or N···Br halogen bonds, in four 
cases, extended the architecture.  We were also able to display how the electron-pair accepting 
ability of the 4-iodobenzoic acid molecule was increased upon fluorination in comparing 
structures 13a and 13b. 
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CHAPTER 5 - Directed supramolecular assembly of M(II)­
containing complexes (M = Co, Cu, Ni) into infinite 1-D chains using 
structurally bifunctional ligands 
5.1 Introduction 
The design and synthesis of inorganic:organic hybrid materials through supramolecular 
synthesis, is a rapidly emerging field within crystal engineering.1  The ability to translate the 
inherent dimensionality and geometry of any coordination complex into extended architectures 
with specific (and tunable) metrics is critical for producing materials with desired chemical and 
physical properties.2  The use of coordinate covalent bonds for the assembly of coordination 
polymers is well established,3 whereas synthetic strategies that utilize non-covalent (i.e. 
hydrogen bonds,4 π-π interactions,5 etc.) and metal-ligand interactions within the same network 
are far less developed.6  Composite hybrid materials are of crucial importance in natural systems7 
and they have also found numerous uses in synthetic high-tech applications.8  Since the physical 
properties of any solid are influenced by the communication and interactions between molecules 
or complex ions, it is important, from the point of view of tuning properties, to be able to alter 
specific metrics (e.g. distance between metal ions) without inducing dramatic changes to the 
overall crystal structure. Thus, the design of versatile bifunctional ligands that are capable of 
coordinating to a metal ion whilst providing the means for organizing such complex ions into 
extended networks in a predictable manner is an important aspect of current structural inorganic 
chemistry. 
We are specifically interested in developing reliable and versatile supramolecular routes 
for the directed assembly of metal ions and multi-functional organic ligands into infinite 1-D 
chains, which means that we need to (a) carefully control the geometry of the complex ion and, 
(b) eliminate the need for potentially disruptive counterions.  This is particularly important when 
targeting metal ions with diverse and unpredictable coordination modes such as Cu(II).  In order 
to reach this specific supramolecular goal it is essential that the synthetic process is designed 
such that the number of potentially structural interfering components present, or introduced, 
during the assembly process is kept to a minimum.  In essence, the reaction conditions need to be 
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optimized in the same way that reaction conditions for covalent synthesis are selected for 
maximum yield. 
With this in mind, a variety of structurally bifunctional organic ligands containing a 
metal-ion coordinating moiety and a hydrogen bonding functionality were synthesized with the 
specific supramolecular goal of organizing a variety of M(II)-based complex ions (M = Co, Cu, 
Ni) into infinite 1-D chains. Dinuclear Cu(II) complexes incorporating four carboxylate moieties 
(CuII2L4, where L = acetate or 2-fluorobenzoate) provides a reasonable starting point since the 
four monoanionic functional groups bridge two copper(II) centers thereby creating a neutral 
“paddlewheel” complex, Figure 5.1a.  Each copper ion is in an arrangement where four of the 
equatorial positions are coordinated by the anions, leaving a vacant axial position accessible for 
the supramolecular ligand.   
O 
M 
OO 
O 
R 
R 
R 
R 
O 
Cu 
O 
OO 
Cu 
O 
R 
O 
O O 
R 
R 
R 
IIII 
R = CH3 or 2-fluorobenzoate 	 R = CF3, Phenyl 
M = Co, Cu, N 
(a) (b) 
Figure 5.1 Substituted M(II) “paddlewheel” and “acac” complexes with arrows showing the two 
axial coordination sites. 
Additionally, copper(II) 1,1,1,5,5,5-hexafluoro-2,4-pentanedione [Cu(II) (hfacac)2], 
cobalt(II) 1,3-diphenyl-1,3-propanedione [Co(II)(DBM)2] and nickel(II) 1,3-diphenyl-1,3­
propanedione [Ni(II)(DBM)2] were also used in this study.9  Complexes of this type are 
attractive due to the fact that two dione anions occupy four equatorial sites around the M(II) ion 
thereby producing an overall neutral metal-containing building block.  The two remaining axial 
sites can be utilized for constructing extended linear supramolecular architectures with an 
appropriate bifunctional ligand, Figure 5.1b.   
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A structurally bifunctional ligand (a supramolecular linker) for this family of complex 
ions could combine a donor atom capable of effective metal-ion coordination with a functional 
group capable of forming self-complementary hydrogen bonds to a neighboring complex, thus 
extending the network. Four different ligands were designed and synthesized to fit these specific 
requirements, Figure 5.2.   
NH2 
NH2 NH2 N 
N 
N 
N 
MeO 
N	 N 
OMe 
N N	 N 
1 15 	 6 
N N 
NH2 
16 
Figure 5.2 A family of structurally bifunctional ligands; 3-(2-amino-4-methylpyrimidin-6­
yl)pyridine 1, 3-(2-amino-4-methoxypyrimidin-6-yl)pyridine 15, 1-(2-amino-4-methylpyrimidin­
6-yl)-2-(3-methoxypyridin-5-yl)ethyne 6, 1-(2-aminopyrid-5-yl)-2-(pyrid-3-yl)ethyne 16. 
Ligands 1 and 15 have slightly dissimilar hydrogen-bonding moieties due to the 
differences in electronic and steric influences provided by the methyl and methoxy substituents, 
respectively. In contrast, ligands 6 and 16 contain an ethynyl linker between the two 
heterocyclic rings, allowing for greater separation between the metal-ions within each chain, 
which provides a handle for tuning some potentially important metrics of the resulting 
architecture.  Ligand 16 contains an amino-pyridine fragment instead of an amino-pyrimidine 
unit but it is still capable of forming self-complementary hydrogen-bond interactions with 
ligands of neighboring complex ions.  
Herein we outline a specific and predetermined supramolecular design strategy for the 
construction of 1-D chains from suitable bifunctional organic ligands 1, 15, 6, and 16 and 
dinuclear copper(II) “paddlewheels” or M(II)(acac)2 (M = Co, Cu, Ni) complex ions.  We are 
particularly interested in: 
•	 Attempting to control the coordination geometry around the metal center upon 
introduction of the bifunctional ligand; 
121 
•	 The reliability of the self-complementary amino-pyrimidine/amino-pyrimidine hydrogen 
bonds to propagate the metal complexes into infinite 1-D chains;  
•	 Examining the effects on supramolecular assembly upon altering the steric influences (­
Me vs. -OMe) around the hydrogen bonding moiety as well as length (-C-C- vs. -C-C≡C­
C-) between the two functional groups; and   
•	 Investigating functional group tolerance upon supramolecular assembly, by examining 
the effects of changing the hydrogen bonding moiety from an amino-pyrimidine to 
amino-pyridine.   
The reliability of the overall assembly process is evaluated by an examination of thirteen 
crystal structures in the context of the desired supramolecular target and the primary 
intermolecular interactions. 
5.2 Experimental 
5.2.1 Synthesis 
All chemicals, unless otherwise noted, were purchased from Aldrich and used without 
further purification. The catalyst, bis(triphenylphosphine)palladium(II) dichloride, was 
purchased from Strem chemicals. 3-Pyridylboronic acid was synthesized according to previous 
literature.10 Metal salts, copper(II) 1,1,1,5,5,5-hexafluoro-2,4-pentanedione, cobalt(II) 1,3­
diphenyl-1,3-propanedione, nickel(II) 1,3-diphenyl-1,3-propanedione, and copper(II) 2­
fluorobenzoate, were prepared according to the literature.11 The synthesis of 3-(2-amino-4­
methylpyrimidin-6-yl)pyridine 1 and 1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin­
5-yl)ethyne 6 are described in Chapter 2. Column chromatography was carried out on silica gel 
(150 Å pore size) from Analtech Inc. Melting points were determined on a Fisher-Johns melting 
point apparatus and are uncorrected. 1H and 13C NMR spectra were recorded on a Varian Unity 
plus 400 MHz or 200 MHz spectrometer in CDCl3. Compounds were prepared for infrared 
spectroscopic (IR) analysis as a mixture in KBr. Electrospray Ionization – Ion-Trap Mass 
Spectrometry (ESI-IT-MS) was carried out on a Bruker Daltonics Esquire 3000 Plus.  MALDI­
TOF / TOF-MS was carried out on a Bruker Daltonics Ultraflex TOF/TOF. 
5.2.1.1 Synthesis of 3-(2-amino-4-methoxypyrimidin-6-yl)pyridine, 15 
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NH2 
NH2 N N 
B(OH)2 
PdCl2(PPh3)2 / Na2CO3N N OMe+ 
Cl OMe N 
MeCN / H2O 
N 
A mixture of 2-amino-4-chloro-6-methoxypyrimidine (1.50 g, 9.38 mmol), 3­
pyridylboronic acid (1.58 g, 10.33 mmol), sodium carbonate (0.700 g, 6.6 mmol) 
bis(triphenylphosphine)palladium(II) dichloride (180 mg, 0.256 mmol, 2.7 mol %) was added to 
a round bottom flask.  Acetonitrile (35 mL) and water (35 mL) were added and dinitrogen 
bubbled through the resultant mixture for 10 minutes.  A condenser was attached and the mixture 
heated at 75 ˚C under a dinitrogen atmosphere. The reaction was monitored by TLC and allowed 
to cool to room temperature on completion (12 hours).  The solution was then diluted with ethyl 
acetate (150 mL), washed with water (3 x 100 mL) then washed with saturated aqueous sodium 
chloride (2 x 100 mL).  The organic layer was separated and dried over magnesium sulfate.  The 
solvent was removed on a rotary evaporator and the residue chromatographed on silica with a 
hexanes/ethyl acetate mixture (1:1) as the eluant.  The product was isolated as a white solid.  The 
product 15 was then recrystallized from ethanol (200 proof) as colorless hair-shaped crystals, 
(1.44 g, 76 %). M.p. 138-140 ºC; 1H NMR (δH; 400 MHz, CDCl3): 9.15 (d, J = 2.4Hz, 1H), 8.68 
(dd, J = 4Hz, J = 1Hz, 1H), 8.25 (dt, J = 8.8Hz, J = 2.4Hz, 1H), 7.38 (dd, J = 8Hz, J = 4.8Hz, 
1H), 6.52 (s, 1H), 5.09 (s, 2H), 3.95 (s, 3H); 13C NMR (δC; 400 MHz, CDCl3): 171.61, 163.34, 
163.21, 150.87, 148.38, 134.28, 133.15, 123.37, 94.387, 53.51; IR (KBr pellet): υ 3451, 3354, 
1582, 1362 cm-1, MALDI-TOF / TOF-MS m/z 187 ([15 + H]+). 
5.2.1.2 Synthesis of 1-(2-aminopyrid-5-yl)-2-(pyrid-3-yl)ethyne, 16 
NH2 
BrN 
PdCl2(PPh3)2 / CuI / PPh3+ NH2 
THF / NEt3 NN N 
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A mixture of 2-amino-5-ethynylpyridine (1.00 g, 8.70 mmol), 3-bromopyridine (1.60 g, 
10.12 mmol), copper(I) iodide (0.050 g, 0.262 mmol), triphenylphosphine (0.220 g, 0.840 
mmol), bis(triphenylphosphine)palladium(II) dichloride (0.220 g, 0.314 mmol) were added to a 
round bottom flask.  Tetrahydrofuran (30 mL) and triethylamine (30 mL) were added and 
dinitrogen bubbled through the resultant mixture for 10 minutes.  A condenser was attached and 
the mixture heated at 70 ˚C under a dinitrogen atmosphere. The reaction was monitored by TLC 
and allowed to cool to room temperature upon completion (36 hours).  The solution was then 
diluted with ethyl acetate (100 mL), washed with water (3 x 100 mL) then washed with saturated 
aqueous sodium chloride (1 x 100 mL).  The organic layer was separated and dried over 
magnesium sulfate.  The solvent was removed on a rotary evaporator and the residue 
chromatographed on silica with a hexane/ethyl acetate mixture (1:1) as the eluant.  The product 
16 was isolated as a light brown solid and recrystallized from chloroform producing orange 
block-shaped crystals, (1.20 g, 79 %). M.p. 131-133 ºC; 1H NMR (δH; 200 MHz, CDCl3): 8.73 
(d, J = 2.6Hz, 1H), 8.52 (dd, J = 4.9Hz, J = 1.7Hz, 1H), 8.28 (d, J = 2Hz, 1H), 7.77 (dt, J=8Hz, 
J=2Hz, 1H), 7.56 (dd, J=8.6Hz, J=2.4Hz, 1H), 7.27 (m, 1H), 6.49 (dd, J=8.4Hz, J=0.8Hz, 1H), 
4.77 (s, 1H); 13C NMR (δC; 200 MHz, CDCl3): 157.79, 152.02, 151.50, 148.29, 140.39, 138.09, 
122.96, 120.60, 109.08, 107.96, 90.37, 86.53; IR (KBr pellet): υ 3318, 3140, 2213, 1602, 1508, 
1398 cm-1, ESI-IT-MS m/z 197 ([16 + H]+). 
5.2.2 Synthesis of coordination complexes  
5.2.2.1 Synthesis of {tetrakis(μ-acetato-O,O’)-bis(3-(2-amino-4-methylpyrimidin-6-yl)pyridine-
N) dicopper(II)}, 1e 
 A mixture of 1 (9 mg, 0.05 mmol) and copper(II) acetate (10 mg, 0.05 mmol) were added 
to a screw cap vial along with a methanol/acetonitrile mixture (2:1 mL).  The mixture was heated 
gently until a clear homogeneous solution resulted.  Without solvent evaporation, green block-
shaped crystals were collected after one day. M.p. 210 - 212 °C. Anal. Calcd. for 
C28H32N8O8Cu2: C, 45.77; H, 4.39; N, 15.26. Found: C, 45.72; H, 4.46; N, 15.09. 
5.2.2.2 Synthesis of {tetrakis(μ-2-fluorobenzoato-O,O’)-bis(3-(2-amino-4-methylpyrimidin-6­
yl)pyridine-N) dicopper(II)}, 1f 
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 A mixture of 1 (9 mg, 0.05 mmol) and copper(II)2-fluorobenzoate (16 mg, 0.02 mmol) 
were added to a screw cap vial along with a mixture of methanol/acetonitrile mixture (1:5 mL). 
The mixture was heated gently until a clear homogeneous solution resulted.  Without solvent 
evaporation, green plate-shaped crystals were collected after one day. M.p. 224 - 226 °C. Anal. 
Calcd. for C48H36N8O8F4Cu2 · H2O: C, 53.75; H, 3.57; N, 10.45. Found: C, 53.69; H, 3.30; N, 
10.45. 
5.2.2.3 Synthesis of {tetrakis(μ-acetato-O,O’)-bis(3-(2-amino-4-methoxylpyrimidin-6­
yl)pyridine-N) dicopper(II)}, 15a 
 A mixture of 15 (10 mg, 0.05 mmol) and copper(II) acetate (10 mg, 0.05 mmol) were 
added to a screw cap vial along with a methanol/acetonitrile mixture (2:1 mL).  The mixture was 
heated gently until a clear homogeneous solution resulted.  Without solvent evaporation, green 
block-shaped crystals were harvested after one day. Dec. 212 °C.  Anal. Calcd. for 
C28H32N8O10Cu2: C, 43.86; H, 4.21; N, 14.62. Found: C, 43.62; H, 4.19; N, 14.57. 
5.2.2.4 Synthesis of {tetrakis(μ-2-fluorobenzoato-O,O’)-bis(3-(2-amino-4-methoxypyrimidin-6­
yl)pyridine-N) dicopper(II)}, 15b 
A mixture of 15 (9 mg, 0.05 mmol) and copper(II)2-fluorobenzoate (17 mg, 0.03 mmol) 
were added to a screw cap vial along with a mixture of methanol/acetonitrile mixture (1:5 mL). 
The mixture was heated gently until a clear homogeneous solution resulted.  Without solvent 
evaporation, green plate-shaped crystals were collected after one day. M.p. 224 - 226 °C. Anal. 
Calcd. for C48H36N8O10F4Cu2: C, 53.03; H, 3.34; N, 10.31. Found: C, 52.92; H, 3.14; N, 10.22. 
5.2.2.5 Synthesis of {tetrakis(μ-acetato-O,O’)-bis(1-(2-amino-4-methylpyrimidin-6-yl)-2-(3­
methoxypyridin-5-yl-N)ethyne) dicopper(II)}, 6e 
A mixture of 6 (10 mg, 0.04 mmol) and copper(II)acetate (17 mg, 0.08 mmol) were 
added to a screw cap vial along with a 1:1:1 mixture of ethanol/acetonitrile/nitromethane. The 
mixture was heated gently until a clear homogeneous solution resulted.  Without solvent 
evaporation, green block-shaped crystals were collected after two days. Dec. 160 °C. Anal. 
Calcd. for C34H36N8O10Cu2: C, 48.45; H, 4.31; N, 13.30. Found: C, 48.11; H, 4.28; N, 13.28. 
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5.2.2.6 Synthesis of {tetrakis(μ-2-fluorobenzoato-O,O’)-bis((2-aminopyrid-5-yl)-2-(pyrid-3-yl-
N)ethyne) dicopper(II)}, 16a 
 A mixture of 16 (11 mg, 0.06 mmol) and copper(II)2-fluorobenzoate (19 mg, 0.03 mmol) 
were added to a screw cap vial along with a mixture of methanol/acetonitrile mixture (3:5 mL). 
The mixture was heated gently until a clear homogeneous solution resulted.  Without solvent 
evaporation, green plate-shaped crystals were collected after one day. Dec. 255 °C. Anal. Calcd. 
for C40H25N3O8F4Cu2: C, 54.73; H, 2.87; N, 4.79. Found: C, 54.65; H, 2.89; N, 4.96. 
5.2.2.7 Synthesis of {tetrakis(μ-acetato-O,O’)-bis((1-(2-aminopyrid-5-yl)-2-(pyrid-3-yl-
N)ethyne) copper(II)}, 16b 
A mixture of 16 (13 mg, 0.07 mmol) and copper(II)acetate (26 mg, 0.13 mmol) were 
added to a screw cap vial along with a mixture of methanol/acetonitrile mixture (3:5 mL).  The 
mixture was heated gently until a clear homogeneous solution resulted.  Without solvent 
evaporation, green block-shaped crystals were collected after one day. Dec. 210 °C. Anal. Calcd. 
for C20H21N3O8Cu2: C, 43.09; H, 3.80; N, 7.54. Found: C, 42.92; H, 3.77; N, 7.54. 
5.2.2.8 Synthesis of {bis(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O’)-trans-bis(3-(2­
amino-4-methoxypyrimidin-6-yl)pyridine-N) copper(II)}-chloroform, 15c 
A mixture of 15 (13 mg, 0.060 mmol) and copper(II)-1,1,1,5,5,5-hexafluoro-2,4­
pentanedione (17 mg, 0.040 mmol) were added to a screw cap vial along with chloroform (3 
mL). The mixture was heated gently until a clear homogeneous solution resulted.  Green prism-
shaped crystals were harvested after three days (13 mg, 46%).  M.p. 143-145 °C. 
5.2.2.9 Synthesis of {bis(1,3-diphenyl-1,3-propanedionato-O,O’)-trans-bis(3-(2-amino-4­
methoxypyrimidin-6-yl)pyridine-N) cobalt(II)}, 15d    
 A mixture of 15 (12 mg, 0.060 mmol) and cobalt(II)-1,3-diphenyl-1,3-propanedione (16 
mg, 0.030 mmol) were added to a screw cap vial along with a mixture of 1,2­
dichloroethane/chloroform (7:3 mL).  The mixture was heated gently until a clear homogeneous 
solution resulted.  Orange prism-shaped crystals formed after one day (19 mg, 70%). Dec. 219 
°C. 
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5.2.2.10 Synthesis of {bis(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O’)-trans-bis(3-(2­
amino-4-methylpyrimidin-6-yl)pyridine-N) copper(II)}-1,2-dichloroethane, 1g 
 A mixture 1 (14 mg, 0.080 mmol) and copper(II)-1,1,1,5,5,5-hexafluoro-2,4-pentanedione 
(18 mg, 0.040 mmol) were added to a screw cap vial along with 1,2-dichloroethane (4 mL).  The 
mixture was heated gently until a clear homogeneous solution resulted.  Green block-shaped 
crystals were collected after two days (18 mg, 56%).  M.p. 156-158 °C. 
5.2.2.11 Synthesis of {bis(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O’)-(1-(2-amino-4­
methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl-N)ethyne) copper(II)}, 6f 
A mixture of 6 (9.0 mg, 0.040 mmol) and copper(II)-1,1,1,5,5,5-hexafluoro-2,4­
pentanedione (10 mg, 0.020 mmol) were added to a screw cap vial along with chloroform (2 
mL). Green block-shaped crystals were collected after one day (14 mg, 52%).  M.p. 164-166 °C. 
5.2.2.12 Synthesis of {bis(1,3-diphenyl-1,3-propanedionato-O,O’)-trans-bis(1-(2-amino-4­
methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl-N)ethyne) cobalt(II)}, 6g 
 A mixture of 6 (10 mg, 0.040 mmol) and cobalt(II)-1,3-diphenyl-1,3-propanedione (11 mg, 
0.020 mmol) were added to a screw cap vial along with chloroform (2 mL).  Orange block-
shaped crystals were grown over a period of one day. (13 mg, 65 %). Dec. 215 °C.   
5.2.2.13 Synthesis of {bis(1,3-diphenyl-1,3-propanedionato-O,O’)-trans-bis(1-(2-amino-4­
methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl-N)ethyne) nickel(II)}, 6h 
 A mixture of 6 (10 mg, 0.04 mmol) and nickel(II)-1,3-diphenyl-1,3-propanedione (11 mg, 
0.02 mmol) were added to a screw cap vial along with a mixture of 
nitromethane/dichloromethane (2:2 mL).  Green plate-shaped crystals were grown over a period 
of two days. (12 mg, 36 %) Dec. 205 °C.   
5.3 Results 
A summary of the crystallographic information for 1e-1g, 15a-15d, 6e-6h, and 16a-16b 
is displayed in Tables B.4. Bond distances and angles for these compounds are given in Table 
5.1 and hydrogen-bond geometries for 1e-1g, 15a-15d, 6e-6h, and 16a-16b are listed in Table 
5.2. 
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Table 5.1 Selected bond distances and angles for 1e-1g, 15a-15d, 6e-6h, and 16a-16b 
Compound M(II)–N (Å) < N–M(II)–N (°) < N–M(II)–M(II) (°) 
1e Cu1–N21, 2.1743(11) ----- 177.68(3) 
1f Cu1–N11, 2.145(3) 
Cu2-N51, 2.149(2) 
----- 
----- 
173.73(8) 
178.71(8) 
15a Cu1–N21, 2.169(2) ----- 174.68(5) 
15b Cu1–N11, 2.149(3) ----- 176.24(8) 
6e Cu1–N21, 2.1813(18) ----- 176.17(5) 
16a Cu1–N11, 2.162(3) ----- 176.37(10) 
16b Cu1–N11, 2.1981(14) ----- 177.49(4) 
15c Cu1–N11, 2.0227(16) 179.998(1) ----- 
15d Co1–N41, 2.1514(14) 
Co1–N41, 2.1515(14) 
180.0 
180.0 
----- 
----- 
1g Cu1–N31, 2.0044(12) 180.00(11) ----- 
6f Cu1–N21, 2.2751(18) ----- ----- 
6g Co1–N21, 2.2083(11) 
Co1-N21, 2.2083(11) 
180.0 
180.0 
----- 
----- 
6h Ni1–N11, 2.142(2) 
Ni1-N11, 2.142(2) 
180.0 
180.0 
----- 
----- 
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Table 5.2 Hydrogen-bond geometries for 16, 1e-1g, 15a-15d, 6e-6h, and 16a-16b 
Compound D-H…A D-H/ Å H…A/Å D…A/Å <(DHA)/° Generator for A 
16 N12-H12A…N21 
N12-H12B…N11 
0.872(9) 
0.88(10) 
2.25(10) 
2.17(10) 
3.1183(9) 
3.0522(9) 
175.8(8) 
178.0(8) 
x+1,-y+1/2,z+3/2 
-x+2,-y+1,-z+3 
1e N12-H12…N11 
N12-H12…O42 
0.87(2) 
0.89(2) 
2.17(2) 
0.89(2) 
3.043(17) 
2.975(16) 
175.2(2) 
170.5(19) 
-x,-y+1,-z+1 
-x+1, y-1/2,-z+1/2 
1f N22-H22…N63 
N22-H22…O78 
N62-H62…N21 
N62-H62…O48 
0.93(4) 
0.95(4) 
0.73(4) 
0.83(4) 
2.31(4) 
2.26(4) 
2.27(4) 
2.27(4) 
3.241(4) 
3.206(4) 
3.001(4) 
3.055(4) 
174(3) 
173(3) 
171(4) 
159(3) 
-x+1,-y+1,-z+1 
-x+1,-y+1,-z+1 
x-1,y,z 
-----
15a N12-H12…N11 
N12-H12…O41 
0.95(3) 
0.91(3) 
2.24(3) 
2.29(3) 
3.177(3) 
3.185(3) 
171(2) 
170(3) 
-x+1,-y,-z+1 
-x+1,-y,-z+1 
15b N22-H22…N23 0.88 2.52 3.253(5) 141.2 -x+1,-y+1,-z 
6e N12-H12…N23 
N12-H12…O42 
0.82(4) 
0.72(3) 
2.22(4) 
2.34(4) 
2.982(3) 
3.061(3) 
155(3) 
173(3) 
x,y-1,z+1 
-x,-y,-z+2 
16a N12-H12…O38 0.88 2.43 3.295(8) 168.3 x+1,y,z 
16b N16-H16…O31 0.88 2.32 3.078(3) 144.5 -x+1,-y+1,-z+1 
15c N27-H27…O34 
N57-H57…O62 
0.88 
0.88 
2.25 
2.19 
3.112(2) 
3.040(2) 
165.5 
162.7 
x,y-1,z 
x,y+1,z 
15d N52-H52…N51#2 
N52-H52…O13#3 
0.86(2) 
0.88(2) 
2.37(2) 
2.16(2) 
3.203 
3.033(18) 
164(2) 
171(2) 
-x+1,-y,-z 
x,y,z-1 
1g N22-H22…N21#3 0.80(3) 2.28(3) 3.085(19) 174(2) -x+2,-y+1,-z+1 
6f N12-H12…N11#1 
N12-H12…O42#2 
0.88 
0.88 
2.12 
2.27 
3.002(3) 
3.044(2) 
175.0 
147.5 
-x+1,-y,-z+2 
-x+1,-y+1,-z+1 
6g N12-H12…O31#2 
N12-H12…N11#3 
0.87(2) 
0.81(2) 
2.18(2) 
2.26(2) 
3.036(16) 
3.065(17) 
169.1(18) 
173.1(18) 
-x+1,-y+2,-z+1 
-x,-y+3,-z 
6h N22-H22…O31#2 
N22-H22…N21#3 
0.78(3) 
0.82(3) 
2.29(3) 
2.24(3) 
3.058(3) 
3.058(3) 
168(3) 
173(3) 
-----
2-x,-y,-z 
5.3.1 Crystal structure of 1-(2-aminopyrid-5-yl)-2-(pyrid-3-yl)ethyne, 16 
The crystal structure of 16 displays one molecule within the asymmetric unit, orientated 
in a relatively planar fashion, Figure 5.3. 
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Figure 5.3 Thermal-ellipsoids plot (50% probability level) of ligand 16. 
Extension of the architecture shows individual ligands forming a 2-D sheet through 
multiple N-H···N hydrogen bonds. The amino-pyridine moiety forms self-complementary N­
H···N hydrogen bonds with a neighboring ligand producing a dimeric unit, which is further 
extended by secondary N-H···N hydrogen bonds from the anti-amino proton to the pyridyl 
nitrogen atom, Figure 5.4. 
Figure 5.4 Extended 2-D architecture formed through multiple N-H···N hydrogen bonds. 
5.3.2 Crystal structure of {tetrakis(μ-acetato-O,O’)-bis(3-(2-amino-4-methylpyrimidin­
6-yl)pyridine-N) dicopper(II)}, 1e 
The complex-ion in the crystal structure of 1e is composed of two ligands 1 bound at the 
axial positions of the dicopper tetraacetate complex, Figure 5.5.  The symmetry-related Cu(II) 
ion displays a square-pyramidal coordination geometry and is assembled into infinite chains 
through self-complementary N-H···N hydrogen bonds, between the syn-amino proton and a 
pyrimidine nitrogen atom.  Neighboring chains are organized into a 2-D sheet via N-H···O 
hydrogen bonds between the anti-amino proton and an acetate oxygen atom from an adjacent 
strand, Figure 5.6 (a) and (b). 
130 
Figure 5.5 Labeled thermal ellipsoids of 1e (50% probability level). 
Figure 5.6 (a) One-dimensional strand in 1e formed  by self-complementary N-H···N 
hydrogen bonds (top); (b) Two-dimensional sheet produced in 1e from a combination of N-H···N 
and N-H···O hydrogen bonds (bottom). 
5.3.3 Crystal structure of {tetrakis(μ-2-fluorobenzoato-O,O’)-bis(3-(2-amino-4­
methylpyrimidin-6-yl)pyridine-N) dicopper(II)}, 1f 
The crystal structure of 1f contains two crystallographically unique Cu(II)-complexes, 
Figure 5.7. Within each complex the copper atoms are arranged in the familiar “paddle-wheel” 
motif in which two copper atoms are bridged by four acetate groups, thus leaving two axial sites 
for further coordination. The two ligands 1 are coordinated axially through the nitrogen atom of 
the pyridyl moiety to the Cu(II) ions, each with a square-pyramidal geometry.  The two unique 
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complexes are connected in a zig-zag manner through self-complementary N-H···N hydrogen 
bonds, produced from the syn-amino proton and a pyrimidine nitrogen atom, Figure 5.8   
Figure 5.7 Labeled thermal ellipsoids of 1f (50% probability level). 
Figure 5.8 1-D zig-zag chain in 1f produced through self-complementary N-H···N hydrogen 
bonds. 
The 1-D zig-zag rows are then extended into a 2-D sheet through N-H···O hydrogen 
bonds from the anti-amino proton to an adjacent acetate oxygen atom from an adjacent strand, 
Figure 5.9 
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Figure 5.9 Extended network of 1f through a series of N-H···N and N-H···O hydrogen bonds (the 
fluoro-phenyl rings have been omitted for clarity).   
5.3.4 Crystal structure of {tetrakis(μ-acetato-O,O’)-bis(3-(2-amino-4­
methoxylpyrimidin-6-yl)pyridine-N) dicopper(II)}, 15a 
The complex-ion in the crystal structure of 15a contains two ligands 15 bound axially 
through their pyridyl nitrogen atoms to the dicopper tetraacetate dimer affording a five-
coordinate square-pyramidal geometry around each Cu(II) ion, Figure 5.10. Discrete 1-D chains 
are formed from self-complementary N-H···N hydrogen bonds between the syn-amino proton and 
a pyrimidine nitrogen atom, whilst the anti-amino proton hydrogen bonds with a neighboring 
acetate oxygen atom through N-H···O interactions, Figure 5.11.  The second nitrogen atom of the 
pyrimidine ring is blocked by the adjacent methoxy substituent and does not act as a hydrogen-
bond acceptor. 
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Figure 5.10 Labeled thermal ellipsoids of 15a (50% probability level). 
Figure 5.11 Infinite chain in 15a formed from Cu(II)-py coordination bonds and self-
complementary N-H···N and heteromeric N-H···O hydrogen bonds. 
5.3.5 Crystal structure of {tetrakis(μ-2-fluorobenzoato-O,O’)-bis(3-(2-amino-4­
methoxypyrimidin-6-yl)pyridine-N) dicopper(II)}, 15b 
The complex ion in the structure of 15b contains two ligands 15 bound axially via the 
pyridyl nitrogen atoms to the “paddle-wheel” copper dimer unit, furnishing each Cu(II) ion with 
a square-pyramidal coordination geometry, Figure 5.12.  Similar to structure 15a, 1-D chains are 
produced from self-complementary N-H···N hydrogen bonds from the syn-amino proton to a 
pyrimidine nitrogen atom, and N-H···O interactions from the anti-amino proton to an acetate 
oxygen atom of a neighboring strand, Figure 5.13.  Additional stabilization is provided by π–π 
stacking between the fluoro-substituted phenyl rings and the amino-pyrimidine rings with a 
centroid-centroid distance of 3.28 Å, which is consistent (< 3.5 Å) with reported values when 
molecules are π-stacked in a slip-stacked fashion.12 
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Figure 5.12 Labeled thermal ellipsoids of 15b (50% probability level). 
Figure 5.13 1-D stair-step architecture stabilized by a combination of hydrogen bonds and π-π­
stacking in 15b. 
5.3.6 Crystal structure of {tetrakis(μ-acetato-O,O’)-bis(1-(2-amino-4-methylpyrimidin­
6-yl)-2-(3-methoxypyridin-5-yl-N)ethyne) dicopper(II)}, 6e 
The crystal structure of 6e contains two ligands 6 bound in the axial positions of the two 
Cu(II) ions contained within the tetraacetate “paddlewheel” unit, creating a square-pyramidal 
coordination geometry around each copper ion, Figure 5.14.  Infinite 1-D chains are produced 
from self-complementary N-H···N hydrogen bonds between the syn-amino proton and a 
pyrimidine nitrogen atom, Figure 5.15. Neighboring chains are subsequently organized into a 2­
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D sheet via N-H···O hydrogen bonds between the anti-amino proton and an acetate oxygen atom 
from an adjacent strand, similar to what was observed in the structure of 1e. 
Figure 5.14 Labeled thermal ellipsoids of 6e (50% probability level). 
Figure 5.15 1-D strand in 6e formed through self-complementary amino-pyrimidine N-H···N 
hydrogen bonds. 
5.3.7 Crystal structures of {tetrakis(μ-2-fluorobenzoato-O,O’)-bis((2-aminopyrid-5-yl)­
2-(pyrid-3-yl-N)ethyne) dicopper(II)}, 16a 
In the crystal structures of 16a there are two ligands 16 bound axially, through the pyridyl 
nitrogen atoms to the “paddle-wheel” copper dimer unit, creating a square-pyramidal 
coordination geometry.  The ligand 16 is essentially located on an inversion center, with–NH2 
and –H randomly disordered with 50% occupancy.  Thus, the complex ions are shown with both 
ends of the ligand containing an amino group, Figure 5.16. Although the ligand contains a 
potential self-complementary N-H···N hydrogen bonding moiety, no hydrogen bonds are formed 
between adjacent ligands. Instead, both pyridyl moieties coordinate to two different “paddle­
wheel” units which, in effect, creates 1-D coordination polymers within the lattice of 16a. 
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Figure 5.16 Labeled thermal ellipsoids of 16a at 50% probability level. 
5.3.8 Crystal structure of {tetrakis(μ-acetato-O,O’)-bis((1-(2-aminopyrid-5-yl)-2-(pyrid­
3-yl-N)ethyne) copper(II)}, 16b 
In the crystal structures of 16b there are two ligands 16 bound axially, through the 
pyridyl nitrogen atoms to the “paddle-wheel” copper dimer unit, creating a square-pyramidal 
coordination geometry.  The ligand 16 is essentially located on an inversion center, with–NH2 
and –H randomly disordered with 50% occupancy.  Thus, the complex ions are shown with both 
ends of the ligand containing an amino group, Figure 5.17. Although the ligand contains a 
potential self-complementary N-H···N hydrogen bonding moiety, no hydrogen bonds are formed 
between adjacent ligands.  Instead, both pyridyl moieties coordinate to two different “paddle­
wheel” units which, in effect, creates 1-D coordination polymers within the lattice of 16b. 
Figure 5.17 Labeled thermal ellipsoids of 16b (right) at 50% probability level. 
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5.3.9 Crystal structure of {bis(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O’)-trans­
bis(3-(2-amino-4-methoxypyrimidin-6-yl)pyridine-N) copper(II)}-chloroform, 15c 
The crystal structure of 15c contains two crystallographically unique complexes (A & B), 
Figure 5.18. The two ligands 15 reside perpendicular to the [(hfac)2Cu(II)] complex resulting in 
an octahedral coordination geometry around the copper center.  The ligands are coordinated 
through the pyridyl nitrogen atoms and due to the close similarities of the supramolecular 
assembly of A and B, only one will described in detail.  Neighboring complex ions are held 
together in a head-to-tail motif where the syn-amino proton forms a N-H···O hydrogen bond with 
an oxygen atom from an adjacent acac complex, producing an infinite ribbon, Figure 5.19.  The 
anti-amino proton and the pyrimidine nitrogen atoms are participating in extending the networks.  
In addition, two molecules of chloroform are incorporated into the crystal lattice. 
A B 
Figure 5.18 Labeled thermal ellipsoids (50 % probability level) of the two asymmetric complex 
ions in the crystal structure of 15c. Two molecules of chloroform are omitted for clarity.   
Figure 5.19 Adjacent complex ions in 15c organized into an extended chain held together by 
head-to-tail N-H···O hydrogen bonds. Two molecules of chloroform are omitted for clarity. 
138 
 5.3.10 Crystal structure of {bis(1,3-diphenyl-1,3-propanedionato-O,O’)-trans-bis(3-(2­
amino-4-methoxypyrimidin-6-yl)pyridine-N) cobalt(II)}, 15d  
The metal-complex in the crystal structure of 15d is composed of two ligands 15 bound 
at the axial positions of the [(DBM)2Co(II)] complex, Figure 5.20. The Co(II) ion displays an 
octahedral coordination geometry and the extended network exhibits a connectivity in which 
head-to-tail N-H···O hydrogen bonds are formed between the anti-amino proton and an oxygen 
atom from a neighboring acac complex.  Additionally there are self-complementary N-H···N 
hydrogen bonds, between the syn-amino proton and a pyrimidine nitrogen atom, Figure 5.21.    
Figure 5.20 Labeled thermal ellipsoids in the crystal structure of 15d drawn at 50% probability 
level (hydrogen atoms, apart from –NH2, omitted for clarity). 
Figure 5.21 Infinite chain in the crystal structure of 15d produced from N-H···O and N-H···N 
hydrogen bonds.  Acac phenyl rings have been omitted for clarity. 
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5.3.11 Crystal structure of {bis(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O’)-trans­
bis(3-(2-amino-4-methylpyrimidin-6-yl)pyridine-N) copper(II)}-1,2-dichloroethane, 1g 
The metal-complex in 1g is composed of two ligands 1 bound to a [(hfac)2Cu(II)] 
complex.  The orientation and arrangement of the ligands 1 with respect to the [(hfac)2Cu(II)] 
complex is similar to that shown in the structure of 15c, where coordination to the axial positions 
of the metal ion takes place via the pyridyl moieties thus creating an octahedral metal 
environment, Figure 5.22. Within this arrangement the amino-pyrimidine functionality is suitable 
for self-complementary hydrogen bonds with neighboring complexes.  Thus the syn-amino 
protons form N-H···N hydrogen bonds with pyrimidine nitrogen atoms resulting in a 1-D infinite 
ribbon, Figure 5.23. The extended structures of 15c and 15d are possibly different due to a subtle 
change of the substituents on the organic counterpart.  Ligand 15 has a methoxy substituent 
ortho- to the pyrimidine nitrogen atom sterically congesting that binding site, thus blocking the 
interactions to the neighboring amino- protons.  The second pyrimidine nitrogen atom and anti-
amino proton are not involved in extending the network.  Furthermore a solvent molecule of 1,2­
dichloroethane is incorporated in the crystal lattice, without disrupting any self-complementary 
hydrogen bonds. 
Figure 5.22 Numbered thermal ellipsoids in the crystal structure of 1g drawn at 50% probability 
level. One molecule of 1,2-dichloroethane and the hydrogen atoms (apart from –NH2) have been 
omitted for clarity).   
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Figure 5.23 Infinite ribbon held together by self-complementary N-H···N amino-pyrimidine 
interactions in the crystal structure of 1g. 
5.3.12 Crystal structure of {bis(1,1,1,5,5,5-hexafluoro-2,4-pentanedionato-O,O’)-(1-(2­
amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl-N)ethyne) copper(II)}, 6f 
The crystal structure of 6f includes only one ligand 6 coordinated to a [(hfac)2Cu(II)] 
complex in the axial position, Figure 5.24.  Coordination occurs through the pyridyl nitrogen 
atom of the ligand to the copper center resulting in a square pyramidal metal coordination 
geometry. The ligand:metal complexes form head-to-tail N-H···O hydrogen bonded dimers 
through the anti-amino proton to the oxygen atom of an adjacent metal acac complex. Further 
extension of the network is fashioned by N-H···N hydrogen bonds from the syn-amino proton to 
a nitrogen atom of the pyrimidine ring, Figure 5.25.  The second pyrimidine nitrogen atom is 
aligned to coordinate at the axial position of a neighboring acac complex, although the Cu-N 
distance is approximately 2.70 Å.  
Figure 5.24 Labeled thermal ellipsoids (drawn at 50% probability level) of crystal structure 6f 
with the hydrogen atoms (apart from –NH2) omitted for clarity.  
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Figure 5.25 Extended network in the crystal structure of 6f showing the N-H···N and N-H···O 
hydrogen bonds. 
5.3.13 Crystal structure of {bis(1,3-diphenyl-1,3-propanedionato-O,O’)-trans-bis(1-(2­
amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl-N)ethyne) cobalt(II)}, 6g 
The metal complex in 6g contains two symmetry related ligands 6 bound axially to a 
[(DBM)2Co(II)] complex creating an octahedral cobalt coordination geometry, Figure 5.26.  The 
network forms an infinite sheet by self-complementary N-H···N hydrogen bonds from the syn­
amino protons to a nitrogen atom of the pyrimidine ring and by N-H···O hydrogen bonds from 
the anti-amino protons to an oxygen atom of the adjacent acac complex, Figure 5.27   
Figure 5.26 Labeled thermal ellipsoids of structure 6g with the hydrogen atoms (apart from – 
NH2) omitted  for clarity drawn at 50% probability level.   
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Figure 5.27 Extended network in the crystal structure of 6g with the phenyl rings omitted from 
the metal acac complex for clarity.  
5.3.14 Crystal structure of {bis(1,3-diphenyl-1,3-propanedionato-O,O’)-trans-bis(1-(2­
amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl-N)ethyne) nickel(II)}, 6h 
The crystal structure of 6h is isostructural with the crystal structure of 6g. Two ligands 6 
are coordinate axially to the [(DBM)2Ni(II)] complex with creating an octahedral coordination 
geometry around the nickel center, Figure 5.28. The overall structure is extended through self-
complementary N-H···N hydrogen bonds from the syn-amino protons to a nitrogen atom of the 
pyrimidine ring and by N-H···O hydrogen bonds from the anti-amino protons to an oxygen atom 
of an adjacent acac complex, Figure 5.29. 
Figure 5.28 Labeled thermal ellipsoids for the crystal structure of 6h with the hydrogen atoms 
(apart from –NH2) omitted for clarity drawn at 50% probability level.   
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Figure 5.29 Extended network in the crystal structure of 6h with the phenyl rings omitted from 
the metal acac complex for clarity.   
5.4 Discussion 
5.4.1 Controlling the M(II) coordination geometry  
In twelve of the thirteen crystal structures obtained in this effort, the desired coordination 
environment around each M(II) ion was achieved resulting in rigid neutral metal-containing acac 
complexes or dicopper(II) tetracarboxylate complexes, while structure 6f displays a five-
coordinate square-pyramidal coordination geometry around the copper ion. A search through the 
CSD resulted in 109 hits when the search criteria consisted of Cu(II)(hfacac)2 and an N-donor 
ligand.13  Of the 109 structures, 88 posses an octahedral six-coordinate geometry, while 21 have 
a five-coordinate geometry.  Although the majority of the structures favor an octahedral 
environment (~81 %), five-coordinate structures do exist (~19 %), with 6f being the first five-
coordinate pyridine/amino-pyrimidine-containing Cu(II)(hfacac)2 complex reported.6f  The next 
phase in the supramolecular synthesis requires some means for aligning and connecting these 
complex ions in such a way that the inherent geometry of the metal complex is propagated into 
extended metal-containing networks. We therefore examined the ability of four different 
bifunctional ligands 1, 6, 15, and 16 to act as supramolecular reagents for the construction of 1-D 
motifs. In all seven structures containing dicopper(II) tetracarboxylate complexes 1e-1f, 6e, 15a­
15b, and 16a-16b and five out of six structures containing M(II)-acac complexes 1g, 6g-6h, 15c­
15d the pyridyl moiety provides a robust and reliable binding site for attaching the 
supramolecular bifunctional ligand to the open, axial coordination sites on the M(II) ion, Figure 
5.30. 
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Figure 5.30 Pictoral representation of the desired coordination chemistry around the M(II) 
centers after SR binding. SR 1, is only used in this example, however the other SR’s also display 
the observed coordination chemistry. 
5.4.2 Attempts at controlling the supramolecular assembly 
With a remarkable success rate, each time a bifunctional ligand with a pyrimidine 
component was employed (10/11 structures, 91 %) neighboring ligands were connected via a 
dimeric N-H···N motif.  The desired supramolecular chemistry failed in 15c, and the assembly is 
generated through an N-H···O hydrogen bond, from the syn-amino proton to an oxygen atom 
from an adjacent acac complex. The exact directional and structural consequence of this 
interaction is, however, complicated by the fact that the 2-aminopyrimidine moieties, employed 
in this study, are asymmetric about the C1-C4 vector, Figure 5.31.  Consequently, each 
bifunctional ligand, 1, 6, and 15 has two different ways of producing a self-complementary N­
H···N/N···H-N motif.  If the hydrogen bonds between adjacent 2-aminopyrimidine moieties serve 
to maximize the through-space separation between metal ions, Figure 5.31a, the result is a 
diverging assembly, whereas if the N-H···N/N···H-N synthon brings the complex ions closer 
together, Figure 5.31b, the assembly is converging.  
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Figure 5.31 Pictorial description of converging or diverging structural motifs. 
Another variable that needs to be taken into consideration is the fact that the pyridyl 
moiety and the 2-amino substituent can be arranged either cis- or trans with respect to each 
other, Figure 5.32. 
HH HH
NN 
N NNN 
RRN 
N 
 Cis Trans 
Figure 5.32 Possible cis- or trans isomers based on the arrangement of the pyridine nitrogen 
atom and the 2-amino substituent. 
Steric considerations dictate that only one of the two arrangements is possible in any 
given structure but, from a supramolecular synthetic viewpoint, it would be of interest to 
establish whether or not a suitable molecular substitution can provide a tool for guiding this 
particular assembly process in a rational manner.   
5.4.2.1 Effects of sterics and SR length on supramolecular assembly 
The five crystal structures 1e, 1g, 6e, 6g, and 6h posses diverging motifs, Figure 5.31a, 
and in all cases the 2-amino moiety is trans to the pyridyl nitrogen.  The methyl substituent 
present on the pyrimidine ring does not seem large enough to control the relative interplanar 
orientation in the bifunctional ligands and it is not clear if a specific interaction is responsible for 
the observed orientation. 
However, the three crystal structures 15a, 15b, and 15d display converging motifs, 
Figure 5.31b, and in all cases a cis arrangement exists.  The converging motif is due to the fact 
that the –OMe substituent blocks the adjacent cyclic nitrogen atom, and thus prevents it from 
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participating as an acceptor in a self-complementary N-H···N/N···H-N motif.  In fact, a search of 
the CSD showed that a methoxy-substituent ortho- to a pyridine nitrogen atom is very likely to 
reside co-planar with the ring and face the adjacent nitrogen atom, which does limit its 
availability as a potential hydrogen-bond acceptor.14  Furthermore, relevant literature shows 
when a –OMe substituent is ortho- to the amino-pyrimidine nitrogen atoms, N-H···N/N···H-N 
interactions are possible, but occurring only 43 % of the time (3 out of 7).15 
The crystal structure of 1f provides a good example of the difficulties that can be 
encountered when trying to establish clear structural patterns and/or intermolecular preferences. 
In this structure there are two crystallographically unique metal-containing building blocks: one 
with a cis and one with a trans orientation of the 2-amino functionality with respect to the 
pyridyl moiety.  The former ligand gives rise to a converging assembly, whereas the latter 
produces a divergent motif. 
As stated earlier, another way of minimizing steric crowding (that could prevent or 
disrupt intended supramolecular assembly) would be to increase the separation between the two 
different binding sites on the bifunctional ligand.  Consequently, an ethynyl bridge was 
incorporated into ligand 6 in an attempt to facilitate access to the hydrogen-bonding site and this 
strategy worked very well as exemplified by the crystal structure determinations of 6e and 6f-6h. 
Despite the fact that the coordination chemistry is different, square-pyramidal vs. octahedral, 
respectively, each contains the trans arrangement as well as self-complementary N-H···N/N···H­
N hydrogen bonds between adjacent amino-pyrimidine sites that act as the principle driving 
forces for the supramolecular assembly. 
5.4.3 Amino-pyrimidine or amino-pyridine; does it matter? 
For the extension of the metal:ligand complex, three of the ligands utilize an amino-
pyrimidine moiety, whereas one ligand, 16, relies on the amino-pyridine functionality.  For the 
two structures, 16a and 16b, were the latter ligand was employed, the desired intermolecular 
interactions failed to materialize.  Surprisingly, the disordered bipyridine-type ligands acted as 
ditopic linkers between adjacent Cu(II)-ions resulting in 1-D coordination polymers.  The reason 
for the failure of 16 to act in the desired manner is not obvious, but it is possible that the pyridyl 
moiety, which is an integral part of the hydrogen-bonding functionality, is simply too good of a 
ligand to give up a Cu(II) ion in exchange for acting as an acceptor in an N-H···N hydrogen 
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bond. This interpretation is supported by the fact that when a pyridyl moiety is replaced with a 
less effective ligand, a pyrimidine heterocycle, a dimeric hydrogen-bond motif is favored over a 
pyrimidine-Cu, ligand-metal, interaction. 
The principle supramolecular target for this study, M(II)-containing 1-D assemblies was 
realized in a reasonable supramolecular yield (10/13, 77 %) using a combination of new 
bifunctional ligands and the well-known μ-O,O’coordinating mode of the carboxylate 
functionality or vacant axial sites of the M(II)-acac complex. In 12 out of 13 cases, we 
successfully controlled the coordination geometry around the often M(II) ion.  The exact nature 
of the assembly, convergent or divergent, is determined by the relative orientation of the two 
aromatic components of our bifunctional ligands, which, in turn, can be represented by the rather 
soft potential energy curve typically associated with aryl-aryl torsion angles. 
In a sense, our supramolecular success mirrors quite closely the relative strengths of the 
interactions that are responsible for the different recognition and binding events that take place in 
the course of these reactions: metal-ligand 13/13 (100%) and N-H…N hydrogen-bonds 10/13 (77 
%). 
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CHAPTER 6 - Formation of hydrogen-bonded heterodimeric 
cavitand-based molecular capsules 
6.1 Introduction 
Molecular recognition, a central concept within supramolecular chemistry, is the result of 
a fine-balance between shape, size, and functional complementarity, which allows for the 
assembly of individual entities into multi-component aggregates.1 These reversible 
intermolecular forces are the synthetic tools for the supramolecular chemist, just as the making 
and breaking of covalent bonds provide the tools for the synthetic organic chemist.   
Utilizing directed-assembly to bring together two concave bowl-shaped supramolecular 
hosts into discrete nano-sized capsules is of considerable importance.  Upon formation, the 
interior of the capsule offers a nano-sized reaction chamber where a range of important chemical 
transformations can be carried out with an unprecedented degree of control.  Due to the restricted 
and isolated nature of the inner-cavity, properties differ (within the capsule) drastically compared 
to those of the bulk phase environment.  This leads to potential practical applications including, 
molecular sensing,2 stabilization of reactive intermediates,3 increased chemical reaction rates,4 
molecular catalysis,5 and detection of various isomers.6 Furthermore, individual molecules 
coming together to form larger aggregates, which contain enforced cavities, play vital roles in 
many biological molecular recognition processes such as a concave receptor or enzyme site 
recognizing and binding to a convex substrate surface.7  More specifically, the protein shell or 
coat of a virus is made up of hundreds of subunits that self-assemble into a cage arrangement, 
surrounding, then transporting, viral nucleic acids.  Many efforts have been made to mimick the 
function of various cage-like protein coats, which provide great promise for the pharmaceutical 
industry in hopes of advancing drug delivery systems.8 
The construction of molecular capsules has been primarily achieved through 
complementary ionic9 or non-covalent interactions (i.e., hydrogen bonds10 with the formation of 
either homodimeric- or heterodimeric-based assemblies).  Incorporation of two or more different 
guests within a cavity of a homodimeric/symmetric capsule is unusual and only achievable if the 
guests preferentially engage in heteromeric interactions, independent of the host, before entering 
the cavity.11 However, within a heterodimeric-based assembly, if both halves of the capsule are 
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 different and capable of incorporating its own guest selectively, then upon capsule formation two 
different reactive guests could reside within the same cavity, Figure 6.1   
Homomeric Heteromeric → ←interactions interactions
Figure 6.1 A cartoon representation of a homodimeric capsule encapsulating two of the same 
guests (left) and a heterodimeric capsule incorporating two different guests (right). 
Cavitands were originally defined by D. J. Cram, as “synthetic organic compounds with 
enforced cavities large enough to complex complementary organic compounds or ions.”12 
Through the years, two types of bowl-shaped hosts, resorcin[4]arene-based and 
cyclotriveratrylenes (CTV’s), have received particular attention, Figure 6.2. Both of these cavity-
bearing frameworks are constructed from multiple aromatic rings tethered together by methylene 
bridges, constricting the overall arrangement to a rigid bowl-shaped curvature.  This Chapter 
will discuss resorcin[4]arene-based cavitands in greater detail, while Chapter 7 will focus solely 
on the CTV’s. 
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Figure 6.2 Two types of cavitands; resorcin[4]arene-based (left) and cyclotriveratrylene (right). 
Resorcin[4]arene-based cavitands are attractive molecules due the large variation of 
covalent modifications that can be achieved in three general positions, without compromising the 
overall structural integrity of the cavity-bearing framework, Figure 6.3.   
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Figure 6.3 A resorcin[4]arene-based cavitand outlining the location of its functionalizable parts. 
Although modifications to the ‘feet’,13 usually to improve solubility, have been reported, 
most alterations occur at the ‘upper-rim’14 or ‘bridging groups’15 producing a multitude of 
functionalized products. Our efforts will focus on covalent modifications to the upper-rim 
(labeled X) of resorcin[4]arene-based cavitands, while the bridging groups (-CH2-) and feet (­
pentyl) will not be altered, Figure 6.4. 
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Figure 6.4 Double-rimmed resorcinarene-based cavitands; top-view (left) and side-view (right).   
In order to rationally design and build heterodimeric hydrogen-bonded cavitand-based 
capsules, it is necessary to have access to a wide range of cavitands that posess functional groups 
that complement each other such that heteromeric hydrogen-bonds are favored over homomeric 
intermolecular interactions.16  Based upon extensive results from recent efforts in design and 
synthesis of co-crystals,17 it is clear that the pyridine moiety is an effective hydrogen-bond 
acceptor that can form intermolecular interactions of sufficient strength to drive the formation of 
binary and ternary co-crystals.  Consequently, a pyridyl functionalized cavitand can, in principle, 
act as one half of numerous hydrogen-bonded capsules where the complementary cavitand is 
decorated with hydrogen-bond donors such as –OH, -COOH, –NH2, or –C(R)=NOH moieties. 
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Herein we present our recent efforts in resorcin[4]arene-based cavitand design and 
synthesis, with the construction of various hydrogen-bond donor and acceptor appended 
cavitands. These functionalized cavitands will be utilized in the directed-assembly of 
heterodimeric capsules.   
6.2 Experimental 
6.2.1 Synthesis 
All chemicals were purchased from Aldrich and used without further purification. 
Melting points were determined on a Fisher-Johns melting point apparatus and are uncorrected. 
1H and 13C NMR spectra were recorded on a Varian Unity plus 400 MHz or 200 MHz 
spectrometer in CDCl3 or D6-DMSO. Compounds were prepared for infrared spectroscopic (IR) 
analysis as a mixture in KBr. Elemental Analysis was carried out by Atlantic Microlab Inc. 
Electrospray Ionization – Ion-Trap Mass Spectrometry (ESI-IT-MS) was carried out on a Bruker 
Daltonics Esquire 3000 Plus. MALDI-TOF / TOF-MS was carried out on a Bruker Daltonics 
Ultraflex TOF/TOF. 
6.2.1.1 Synthesis of C-pentylcalix[4]resorcinarene, 1718 
H H 
H H 
R = (CH2)4CH3
 17 
To a solution of resorcinol (10.0 g, 0.09 mol) and hexanal (9.10 g, 0.09 mol) in ethanol 
(90 mL) was added conc. HCl (14.5 mL) at 0 ºC under a dinitrogen atmosphere.  A condenser 
was attached and the mixture heated to 70 ˚C for 10 hours. The reaction was monitored by TLC 
and allowed to cool to room temperature upon completion, then diluted with water.  A white 
precipitate formed which was filtered and dried, (15.1 g, 86 %). M.p. >280 ˚C; 1H NMR (δH; 400 
MHz, D6-DMSO): 8.86 (s, 8H), 7.15 (s, 4H), 6.14 (s, 4H), 4.21 (t, J = 7.6Hz, 4H), 2.00 – 2.02 
OH OH 
H 
O 
OH OH
OH 
OH 
OHOH 
OH
OH
R 
R 
R 
R 
+ 
conc. HCl 
MeOH 
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2-butanone 
N-bromosuccinamide 
(m, 8H), 1.16 – 1.25 (m, 24H), 0.83 (t, J = 6.4Hz, 12H); 13C NMR (δH; 200 MHz, D6-DMSO): 
151.68, 124.92, 123.08, 102.37, 33.99, 33.07, 31.51, 27.49, 22.27, 13.99; IR (KBr pellet): ν 
3276, 2955, 2859, 1617, 1502, 1457, 1293, 1170, 1084, 841 cm-1; MALDI-TOF / TOF-MS m/z 
791 ([17 + Na]+). 
6.2.1.2 Synthesis of C-pentyltetrabromocalix[4]resorcinarene, 1819 
R = (CH2)4CH3 R = (CH2)4CH3 
17 18 
A mixture of C-pentylcalix[4]resorcinarene 17 (10.0 g, 0.013 mol) and N­
bromosuccinamide (13.8 g, 0.078 mol) were added to a round bottom flask.  2-Butanone (75 mL) 
was added and stirred at room temperature for 12 hours.  The precipitate from the reaction was 
filtered and washed with cold 2-butanone (50 mL) then cold water (3 x 100 mL).  Product 18 
was dried in the oven overnight producing a pure white solid, (10.2 g, 72 %). M.p. >280 ˚C; 1H 
NMR (δH; 400 MHz, D6-DMSO): 9.10 (s, 8H), 7.35 (s, 4H), 4.35 (t, J = 7.6Hz, 4H), 2.15 – 2.17 
(m, 8H), 1.18 – 1.32 (m, 24H), 0.84 (t, J = 7Hz, 12H); 13C NMR (δH; 200 MHz, D6-DMSO): 
148.60, 125.48, 123.64, 101.29, 35.46, 33.48, 31.35, 27.38, 22.25, 13.94; IR (KBr pellet): ν 
3397, 2929, 2853, 1614, 1472, 1306, 1168, 1081, 768 cm-1; MALDI-TOF / TOF-MS m/z 1107 
([18 + Na]+). 
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6.2.1.3 Synthesis of C-pentyltetrabromocavitand, 1919 
OH HO 
Br 
HO OH K2CO3 O 
HO OH 
+ BrClCH2 
Dry DMF 
R R 
OH HO R = (CH2)4CH3 
R = (CH2)4CH3 
18 19 
A mixture of C-pentyltetrabromocalix[4]resorcinarene 18 (1.0 g, 1.30 mmol), potassium 
carbonate (3.8 g, 27.7 mmol) and bromochloromethane (1.2 mL, 9.3 mmol) were added to a 
round bottom flask. Dry DMF (27 mL) was added and dinitrogen bubbled through the resultant 
mixture for 10 minutes.  A condenser was attached and the mixture heated to 65 ˚C under a 
dinitrogen atmosphere for 4 days. Every 24 hours, more bromochloromethane (0.3 mL, 2.3 
mmol) was added. The DMF was removed under vacuo to give a dark brown solid.  Chloroform 
(20 mL) was added to the reaction mixture along with 2M HCl (30 mL).  The aqueous phase was 
separated and extracted with more chloroform (3 x 50 mL).  The organic separations were 
combined then washed with water (3 x 100 mL) then washed with saturated aqueous sodium 
chloride (1 x 100 mL) and dried over magnesium sulfate.  The solvent was removed on a rotary 
evaporator and the residue chromatographed on silica with a hexane/dichloromethane (1/2) 
mixture as the eluant.  Product 19 was isolated as a white solid, (720 mg, 49 %). M.p. >280 ˚C; 
1H NMR (δH; 400 MHz, CDCl3): 7.04 (s, 4H), 5.97 (d, J = 7.2Hz, 4H), 4.86 (t, J = 8.2Hz, 4H), 
4.40 (d, J = 7.2Hz, 4H), 2.18 – 2.24 (m, 8H), 1.32 – 1.43 (m, 24H), 0.87 – 0.94 (m, 12H); 13C 
NMR (δH; 400 MHz, CDCl3): 152.04, 139.26, 119.01, 113.50, 98.45, 37.66, 31.84, 29.80, 27.39, 
22.60, 14.03; IR (KBr pellet): ν 2919, 2858, 1460, 1404, 1296, 1086, 1015, 948, 789 cm-1; ESI­
IT-MS m/z 1167 ([19 + Cl]-). 
6.2.1.4 Synthesis of C-pentyltetra(3-pyridyl)cavitand, 20 
BrBr 
Br Br 
R 
R 
R 
R 
OO OO 
O O O 
RR 
H HH H 
Br 
Br 
Br
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O 
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Pd(PPh3)4 / Na2CO3+ 
B(OH)2 Toluene / EtOH
R R 
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R = (CH2)4CH3 
19 
R = (CH2)4CH3 
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A mixture of C-pentyltetrabromocavitand 19 (2.0 g, 1.77 mmol) and tetrakis­
triphenylphosphine palladium (II)  (420 mg, 0.362 mmol) were added to a round bottom flask 
under a stream of dinitrogen.  Toluene (30 mL), ethanol (20 mL) and aqueous sodium 
bicarbonate (100 mg, 5 mL) were all purged with dinitrogen, then added to the round bottom 
flask along with 3-pyridylboronic acid (2.8 g, 22.76 mmol).  The reaction mixture was refluxed 
for 72 hours under a dinitrogen atmosphere.  Upon completion the reaction was cooled to room 
temperature and diluted with water (100 mL).  The aqueous phase was washed with 
dichloromethane (3 x 100 mL) and dried with magnesium sulfate. The solvent was removed on a 
rotary evaporator and the residue purified by column chromatography using an ethanol/ethyl 
acetate (1:2) mixture as the eluant.  The product 20 was isolated as a white crystalline solid, 
(1.72 g, 87 %). M.p. >280 ˚C; 1H NMR (δH; 400 MHz, CDCl3): 8.35 (br s, 4H), 8.21 (br s, 4H), 
7.39 (br s, 4H), 7.33 (br s, 4H), 7.12 (s, 4H), 5.18 (s, 4H), 4.86 (t, J = 8Hz, 4H), 4.20 (s, 4H), 
2.39 – 2.34 (m, 8H), 1.50 – 1.38 (m, 24H), 0.95 (t, J = 7Hz, 12 H); 13C NMR (δH; 200 MHz, 
CDCl3): 152.61, 150.16, 148.24, 138.58, 137.56, 129.52, 125.90, 122.70, 120.60, 100.21, 37.13, 
31.99, 30.32, 17.61, 22.66, 14.09; IR (KBr pellet): ν 2929, 2859, 1583, 1450, 1408, 1160, 1084, 
975, 716 cm-1; ESI-IT-MS m/z 1125 ([20 + H]+); Anal. Calcd. for C72H76N4O8 · H2O: C, 75.66; 
H, 6.83; N, 4.90. Found: C, 75.50; H, 6.78; N, 4.89. 
6.2.1.5 Synthesis of C-pentyltetra(4-carboxyphenyl)cavitand, 21 
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O O O 
RR 
H HH H 
Br 
Br 
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R R 
R = (CH2)4CH3 R = (CH2)4CH3 
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A mixture of C-pentyltetrabromocavitand 19 (1.00 g, 0.883 mmol), 4­
carboxyphenylboronic acid (1.47 g, 8.86 mmol), and tetrakis-triphenylphosphine palladium (II) 
(210 mg, 0.181 mmol) were added to a round bottom flask under a stream of dinitrogen. 
Toluene (20 mL), ethanol (15 mL) and aqueous sodium bicarbonate (1.0 g, in 5 mL H2O) were 
all purged with dinitrogen, then added to the round bottom flask.  The reaction mixture was 
refluxed for 72 hours under a dinitrogen atmosphere.  Upon completion the reaction was cooled 
to room temperature and diluted with water (100 mL).  The aqueous phase was washed with 
chloroform (3 x 100 mL) then precipitated with concentrated hydrochloric acid.  Upon 
acidification a white precipitate formed, which was filtered and dried.  The product 21 was 
isolated as a white crystalline solid, (900 mg, 79 %). M.p. >280 ˚C; 1H NMR (δH; 200 MHz, 
CDCl3): 8.35 (s, 4H), 8.21 (s, 4H), 7.39 (s, 4H), 7.33 (s, 4H), 7.12 (s, 4H), 5.18 (s, 4H), 4.86 (t, J 
= 8Hz, 4H), 4.20 (s, 4H), 2.39 – 2.34 (m, 8H), 1.50 – 1.38 (m, 24H), 0.95 (t, J = 7Hz, 12 H). 
6.2.1.6 Synthesis of C-pentyltetraboronic acid pinacolyl ester cavitand, 22 
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R = (CH2)4CH3 R = (CH2)4CH3
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C-Pentyltetrabromocavitand 19 (1.00g, 0.883 mmol) was dissolved in dry tetrahydrofuran 
(10 mL), and the solution was then evaporated and dried at 130 °C (0.1 mmHg) for 2 h under an 
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argon atmosphere.  This procedure was repeated until all the water and residual solvents were 
removed from the sample.  The resulting cavitand was dissolved in dry tetrahydrofuran (70 mL) 
and cooled to –78 °C (dry ice/acetone bath), under a dinitrogen atmosphere.  N-butyllithium (1.6 
M in hexanes, 2.54 mL, 4.06 mmol) was added dropwise over 10 minutes and stirred for an 
additional 0.5h. Trimethoxyborane (0.60 mL, 5.3 mmol) was added dropwise over 10 minutes 
and the resulting solution was stirred at –78 °C for 0.5h, at which time the dry ice/acetone bath 
was removed and the reaction mixture was allowed to reach room temperature. Upon reaching 
room temperature, the reaction mixture was quenched with a 1M hydrochloric acid solution (100 
mL) and stirred for 0.5h. The mixture was extracted with dichloromethane (3 x 100 mL), the 
organic portions collected and dried over magnesium sulfate.  The solvent was removed via 
rotary evaporator and the resulting residue dissolved in dichloromethane (100 mL).  Excess 
pinacol (750 mg, 6.30 mmol) and magnesium sulfate (2.25 g) were added to the mixture, which 
was stirred for 12 h and then filtered and brought to dryness via a rotary evaporator.  The residue 
was dissolved in dichloromethane and added to a beaker of acetone, in which a white precipitate 
formed and was filtered resulting in pure product 22, (800 mg, 70 %). M.p. >280 ˚C; 1H NMR 
(δH; 400 MHz, CDCl3): 7.10 (s, 4H), 5.59 (d, J = 6.8Hz, 4H), 4.75 (t, J = 7.2Hz, 4H), 4.54 (d, J = 
7.6Hz, 4H), 2.17-2.15 (m, 8H), 1.40-1.29 (m, 72H), 0.90-0.88 (m, 12H); 13C NMR (δH; 200 
MHz, CDCl3); 157.72, 137.77, 122.37, 99.42, 83.53, 36.11, 31.91, 30.89, 29.88, 27.54, 24.70, 
22.65, 14.02; IR (KBr pellet): ν 2977, 2931, 1705, 1592, 1442, 1358, 1316, 1145, 978, 851, 582 
cm-1; MALDI-TOF / TOF-MS m/z 1344 ([22 + H + (Na)23]+); Anal. Calcd. for C76H108O16B4: C, 
69.09; H, 8.18. Found: C, 69.24; H, 8.44. 
6.2.1.7 Synthesis of C-pentyltetraiodocavitand, 23 
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C-pentyltetrabromocavitand 19 (2.0 g, 1.77 mmol) was added to a round-bottomed 
flask containing dry, freshly distilled THF (40 mL).  The solution was cooled to –78 °C (dry 
ice/acetone bath temperature) and n-butyllithium (6.0 equiv., 6.63 mL, ca. 1.6 M solution in 
hexanes) was rapidly added.  After stirring for 1h, iodine (3.6 g, 14.2 mmol, solution in THF 
(5 mL)) was added and the cooling bath removed allowing the reaction mixture to warm to 
room temperature. After 2 hours the reaction mixture was cooled to 0 ºC and quenched with 
a saturated aqueous sodium thiosulfate solution.  The aqueous phase was extracted with ethyl 
acetate (3 x 75 mL), the portions washed with brine and dried with magnesium sulfate. The 
solvent was removed on a rotary evaporator and the residue purified by column 
chromatography using a hexanes/dichloromethane (4:1) mixture as the eluent. The product 
was further purified by reprecipitation (dichloromethane:hexanes) yielding a white powder 
23, (1.46 g, 63 %). M.p. >280 ˚C; 1H NMR (δH; 200 MHz, CDCl3): 7.07 (s, 4H), 5.98 (d, J = 
7.4Hz, 4H), 4.86 (t, J = 8Hz, 4H), 4.33 (d, 7.8Hz, 4H), 2.20 – 2.19 (m, 8H), 1.39 (m, 24H), 
0.92 (t, J = 7Hz, 12 H); 13C NMR (δH; 200 MHz, CDCl3): 154.86, 138.69, 120.65, 98.70, 
93.02, 37.94, 31.84, 30.04, 27.40, 22.61, 14.03. 
6.2.1.8 Synthesis of C-pentyltetra(3-ethynylpyridine)cavitand, 24 
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A mixture of C-pentyltetraiodocavitand 23 (400 mg, 0.303 mmol), 3-ethynylpyridine 
(480 mg, 4.29 mmol), bis(triphenylphosphine)palladium (II) dichloride (50 mg, 0.07 mmol), 
triphenylphosphine (20 mg, 0.08 mmol), and copper(I) iodide (12 mg, 0.06 mmol) was added 
to a round bottom flask.  Tetrahydrofuran (25 mL) and triethylamine (25 mL) were added 
and dinitrogen bubbled through the resultant mixture for 10 minutes.  A condenser was 
attached and the mixture heated at 65 ºC under a dinitrogen atmosphere.  The reaction was 
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monitored by TLC and allowed to cool to room temperature upon completion (72 hours). 
The solution was diluted with chloroform (100 mL), washed with water (3 x 100 mL), and 
washed with brine (2 x 100 mL).  The organic layer was separated and dried over magnesium 
sulfate. The solvent was removed on a rotary evaporator and the residue chromatographed 
on silica with an ethyl acetate/ethanol mixture (2:1) containing 1% triethylamine as the 
eluant. The product was isolated as an off-white solid.  The product 24 was then 
recrystallized from chloroform and hexanes, (250 mg, 67 %). M.p. >280 ˚C; 1H NMR (δH; 
400 MHz, CDCl3): 8.69 (m, 4H), 8.55 (dd, J = 4.8Hz, J = 1.6Hz, 4H), 7.71 (dt, J = 8Hz, J = 
1.6Hz, 4 H), 7.29 (m, 4H), 6.03 (d, J = 7.2Hz, 4H) 4.88 (t, J = 8Hz, 4H), 4.62 (d, 6.8Hz, 4H), 
2.28 – 2.45 (m, 8H), 1.46 – 1.35 (m, 24H), 0.96 – 0.92 (m, 12 H); 13C NMR (δH; 200 MHz, 
CDCl3): 155.40, 152.23, 148.93, 138.52, 138.39, 123.11, 120.65, 120.03, 112.60, 98.36, 
94.07, 84.25, 36.50, 31.81, 29.46, 27.38, 22.63, 14.03. 
6.2.1.9 Synthesis of C-pentyltetra(2-amino-5-ethynylpyridine)cavitand, 25 
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A mixture of C-pentyltetraiodocavitand 23 (250 mg, 0.189 mmol), 2-amino-5­
ethynylpyridine (217 mg, 1.89 mmol), bis(triphenylphosphine)palladium (II) dichloride (30 mg, 
0.04 mmol), triphenylphosphine (10 mg, 0.04 mmol), and copper(I) iodide (7 mg, 0.04 mmol) 
were added to a round bottom flask.  Tetrahydrofuran (15 mL) and triethylamine (15 mL) were 
added and dinitrogen bubbled through the resultant mixture of 10 minutes.  A condenser was 
attached and the mixture heated at 50 ºC under a dinitrogen atmosphere.  The reaction was 
monitored by TLC and allowed to cool to room temperature upon completion (72 hours).  The 
solution was diluted with chloroform (100 mL), washed with water (3 x 100 mL), and washed 
with brine (2 x 100 mL).  The organic layer was separated and dried over magnesium sulfate. 
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 The solvent was removed on a rotary evaporator and the residue chromatographed on silica with 
an ethyl acetate/ethanol mixture (2:1) containing 1% triethylamine as the eluant.  The product 
was isolated as a yellow solid. The product 25 was then reprecipitated, as a white solid, from 
dissolving in chloroform and adding to hexanes, (178 mg, 74 %). M.p. >285 ˚C; 1H NMR (δH; 
400 MHz, CDCl3): 8.16 (d, J = 2Hz, 4H), 7.47 (dd, J = 8.4Hz, J = 2Hz, 4H), 7.06 (s, 4 H), 6.45 
(d, J = 8.8Hz, 4H), 5.98 (d, J = 7.2Hz, 4H), 4.84 (t, J = 8Hz, 4H), 4.75 (s, 8H), 4.59 (d, 7.2 Hz, 
4H), 2.28 – 2.21 (m, 8H), 1.44 – 1.36 (m, 24H), 0.98 – 0.90 (m, 12 H); 13C NMR (δH; 200 MHz, 
CDCl3): 157.64, 155.08, 151.53, 140.36, 138.38, 119.77, 113.32, 109.64, 107.94, 98.41, 95.32, 
81.62, 36.52, 31.85, 29.52, 27.43, 22.67, 14.07; IR (KBr pellet): ν 3380, 3196, 2930, 2853, 2203, 
1608, 1445, 1086, 1020, 974, 697 cm-1. 
6.2.1.10 Synthesis of C-pentyltetra(4-formyl)cavitand, 26 
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A mixture of C-pentyltetrabromocavitand 19 (1.0 g, 0.883 mmol) and tetrakis­
triphenylphosphine palladium (II)  (210 mg, 0.181 mmol) were added to a round bottom flask 
under a stream of dinitrogen.  Toluene (20 mL), ethanol (15 mL), and aqueous sodium 
bicarbonate (1.00 g) were all purged with dinitrogen, then added to the round bottom flask along 
with 4-formylphenyl boronic acid (1.32 g, 8.80 mmol).  The reaction mixture was refluxed for 72 
hours under a dinitrogen atmosphere.  Upon completion the reaction was cooled to room 
temperature and diluted with water (100 mL).  The aqueous phase was extracted with chloroform 
(3 x 100 mL) and dried with magnesium sulfate.  The solvent was removed on a rotary 
evaporator and the residue purified by column chromatography using a hexanes/ethyl acetate 
(1:1) mixture as the eluant. The product was further purified by reprecipitation 
(chloroform:hexanes). The product 26 was isolated as a white crystalline solid, (900 mg, 83 %). 
M.p. >270 ˚C; 1H NMR (δH; 400 MHz, CDCl3): 10.00 (s, 4H), 7.85 (d, J = 8.4Hz, 8H), 7.38 (s, 
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 4H), 7.20 (d, J = 8.4Hz, 8H), 5.16 (d, J = 6.8Hz, 4H), 4.86 (t, J = 8Hz, 4H), 4.23 (d, 6.8 Hz, 4H), 
2.39 – 2.34 (m, 8H), 1.50 – 1.38 (m, 24H), 0.95 (t, J = 7Hz, 12 H); 13C NMR (δH; 200 MHz, 
CDCl3): 191.68, 152.37, 140.44, 138.55, 135.22, 130.58, 129.26, 128.44, 120.62, 100.43, 37.08, 
32.02, 30.31, 27.63, 22.69, 14.12. 
6.2.1.11 Synthesis of C-pentyltetra(3-methoxy-5-ethynylpyridine)cavitand, 27 
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A mixture of C-pentyltetraiodocavitand 23 (250 mg, 0.189 mmol), 3-methoxy-5­
ethynylpyridine (310 mg, 2.30 mmol), bis(triphenylphosphine)palladium (II) dichloride (25 mg, 
0.04 mmol), triphenylphosphine (10 mg, 0.04 mmol), and copper(I) iodide (7 mg, 0.04 mmol) 
were added to a round bottom flask.  Tetrahydrofuran (15 mL) and triethylamine (15 mL) were 
added and dinitrogen bubbled through the resultant mixture of 10 minutes.  A condenser was 
attached and the mixture heated at 50 ºC under a dinitrogen atmosphere.  The reaction was 
monitored by TLC and allowed to cool to room temperature upon completion (72 hours).  The 
solution was diluted with chloroform (100 mL), washed with water (3 x 100 mL), and washed 
with brine (2 x 100 mL).  The organic layer was separated and dried over magnesium sulfate. 
The solvent was removed on a rotary evaporator and the residue chromatographed on silica with 
an ethyl acetate/ethanol mixture (2:1) containing 1% triethylamine as the eluant.  The product 
was isolated as an off-white solid. The product 27 was then recrystallized, as colorless rods, 
from  chloroform and then addition of hexanes, (105 mg, 41 %). M.p. 240-242 ˚C; 1H NMR (δH; 
200 MHz, CDCl3): 8.28 (d, J = 1.6Hz, 4H), 8.25 (d, J = 3Hz, 4H), 7.23 (dd, J = 1.6Hz, J = 2.8Hz, 
4 H), 7.14 (s, 4H), 6.03 (d, J = 7.4Hz, 4H), 4.88 (t, J = 8Hz, 4H), 4.62 (d, 7.4Hz, 4H), 2.28 – 2.35 
(m, 8H), 1.43 – 1.36 (m, 24H), 0.98 – 0.91 (m, 12 H); 13C NMR (δH; 200 MHz, CDCl3): 155.46, 
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155.05, 144.59, 138.54, 137.48, 122.44, 120.69, 120.13, 112.63, 98.43, 94.09, 84.00, 55.67, 
36.53, 31.84, 29.50, 27.42, 22.66, 14.07. 
6.2.2 Synthetic challenges 
An optimum yield was achieved in the synthesis of 23, when precursor 19 was totally 
free of solvent or moisture.  Accordingly, precursor 19 was kept under high vacuum for 24 hours 
while being heated ~125 °C, to remove excess moisture, before it was added to the reaction 
mixture.  Additionally, new sure-seal bottles of n-butyl lithium and molecular iodine where used 
immediately upon opening.   
6.2.3 Crystallizations 
6.2.3.1 C-pentyltetrabromocavitand, 19; C-pentyltetrabromocavitand 19(1); C-pentyltetra(3­
pyridyl)cavitand, 20; C-pentyltetra(3-pyridyl)cavitand, 20(1) 
Crystals suitable for single-crystal X-ray crystallography, of 19 were grown by slow 
evaporation of an acetonitrile solution at room temperature over one day. Crystals suitable for 
single-crystal X-ray crystallography, of 19(1) were grown by slow evaporation of a 
dichloromethane solution at room temperature over one day.  Crystals suitable for single-crystal 
X-ray crystallography, of 20 were grown by slow evaporation of an acetonitrile solution at room 
temperature over one day. Crystals suitable for single-crystal X-ray crystallography, of 20(1) 
were grown by slow evaporation of a methanol solution at room temperature over two days. 
6.2.3.2 C-pentyltetra(3-pyridyl)cavitand:4-cyanobenzoic acid, 20a 
C-pentyltetra(3-pyridyl)cavitand (10 mg, 0.05 mmol) and 4-cyanobenzoic acid (63 mg, 
0.30 mmol) were placed in a beaker containing ethanol (10 mL) and heated until a clear 
homogeneous solution was obtained. After one day of slow evaporation, yellowish/orange prism-
shaped crystals were obtained. M.p. 155-157 °C; IR (KBr pellet) υ 3331 and 3198 cm-1 (NH2, 
m), 2442 and 1912 cm-1 (O-H···N, br), 1635 cm-1 (C=O, m). 
6.2.3.3 C-pentyltetra(3-pyridyl)cavitand:C-pentyltetra(4-carboxyphenyl)cavitand:1,4­
diiodobenzene, 20b 
C-pentyltetra(3-pyridyl)cavitand (10 mg, 0.01 mmol), C-pentyltetra(4­
carboxyphenyl)cavitand (15 mg, 0.01 mmol), and 1,4-diiodobenzene (40 mg, 0.12 mmol) 
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were placed in a beaker containing ethanol and heated until a clear homogeneous solution was 
obtained. After five days of slow evaporation, colorless block-shaped crystals were obtained. 
M.p. > 285 °C; IR (KBr pellet) υ 2925, 2853, 2510, 1931, 1696, 1465, 1408, 1276, 1081, 973. 
Anal. Calcd. for C152H156N4O24I2: C, 68.21; H, 5.83; N, 2.09. Found: C, 69.18; H, 5.99; N, 2.2 
6.2.3.4 C-pentyltetra(4-carboxyphenyl)cavitand, 21; C-pentyltetraboronic acid pinacolyl 
ester cavitand, 22; C-pentyltetraiodocavitand, 23; C-pentyltetra(3-ethynylpyridine)cavitand, 
24 
Crystals suitable for single-crystal X-ray crystallography, of 21 were grown by slow 
evaporation of an ethanol solution at room temperature over one day.  Crystals suitable for 
single-crystal X-ray crystallography, of 22 were grown by slow evaporation of a 
hexanes/dichloromethane solution at room temperature over one day.  Crystals suitable for 
single-crystal X-ray crystallography, of 23 were grown by slow evaporation of an acetronitrile 
solution at room temperature over one day. Crystals suitable for single-crystal X-ray 
crystallography, of 24 were grown by slow evaporation of an acetonitrile solution at room 
temperature over one day. 
6.2.3.5 C-pentyltetra(2-amino-5-ethynylpyridine)cavitand:3,5-dinitrobenzoic acid, 25a 
C-pentyltetra(2-amino-5-ethynylpyridine)cavitand (10 mg, 0.05 mmol) and 3,5­
dinitrobenzoic acid (21 mg, 0.10 mmol) were placed in a beaker containing a solution of 
acetonitrile, ethanol, p-xylenes and nitrobenzene (5:10:1:1 mL) and heated until a clear yellow 
homogeneous solution was obtained.  After one day of slow evaporation, yellowish/orange 
prism-shaped crystals were obtained. M.p. 155-157 °C; IR (KBr pellet) υ 3331 and 3198 cm-1 
(NH2, m), 2442 and 1912 cm-1 (O-H···N, br), 1635 cm-1 (C=O, m). 
6.2.3.6 C-pentyltetra(2-amino-5-ethynylpyridine)cavitand:glutaric acid, 25b 
C-pentyltetra(2-amino-5-ethynylpyridine)cavitand (10 mg, 0.05 mmol) and glutaric acid 
(21 mg, 0.10 mmol) were placed in a beaker containing a solution of  ethanol, p-xylenes and 
nitrobenzene (10:1:1 mL) and heated until a clear yellow homogeneous solution was obtained. 
After one day of slow evaporation, yellowish/orange prism-shaped crystals were obtained.  M.p. 
155-157 °C; IR (KBr pellet) υ 3331 and 3198 cm-1 (NH2, m), 2442 and 1912 cm-1 (O-H···N, br), 
1635 cm-1 (C=O, m). 
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6.3 Results and Discussion 
6.3.1 Cross-coupling reaction precursors and their tetra-functionalized products 
Crystallographic information for 19, 19(1), 20, 20(1), 20a-20b, 21-24, 25a-25b is 
displayed in Tables B.5. 
The synthesis of cavitand precursor 19 was achieved in good yields following three well-
established steps beginning with the acid-catalyzed cyclocondensation of resorcinol and hexanal 
generating the calix[4]resorcinarene molecule.18 This compound is then brominated with N­
bromosuccinamide, forming the tetrabrominated calix[4]resorcinarene.19 The tetrabrominated 
calix[4]resorcinarene is then deepened and rigidified by 4-fold cyclizations with treatments of 
bromochloromethane, producing the final bromo-functionalized cavitand precursor 19.18 
The structure determination of 19, Figure 6.5, shows that one guest molecule of 
acetonitrile is positioned at the lower-rim of the cavitand, surrounded by the pentyl-feet. 
    R = (CH2)4CH3 
OO O 
OO 
O O O 
R RR R 
Br Br 
BrBr 
Figure 6.5 Molecular structure and thermal ellipsoids (50% probility level) of the tetrabromo 
cavitand in the crystal structure of 19. 
The cavitands are organized into 1-dimensional strands as a result of the interaction 
between one of the pentyl-feet and the upper-rim of a neighboring cavitand, Figure 6.6a, 
furthermore, cavitands in neighboring strands are arranged in anti-parallel dimers organized via a 
pair of very short and symmetry related Br···Br interactions, 3.470 Å, Figure 6.6b. 
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                                                              (a) (b) 
Figure 6.6 (a) Packing of cavitand 19; (b) Neighboring cavitands linked through short Br···Br 
interactions in cavitand 19. The hydrogen atoms have been removed, except on the acetonitrile 
solvent molecules, for clarity. 
If 19 is recrystallized from dichloromethane instead of acetonitrile however, a cavitate 
19(1) is formed where the guest molecule resides outside the host-cavitand framework. 
However, regardless of the location of the guest, neighboring hosts are arranged into 1­
dimensional strands where one of the pentyl-feet is dipping into the upper-rim of a neighboring 
cavitand, Figure 6.7a. One of the “feet“ of the cavitand in 19(1) does display a gauche 
conformation, but although unusal, such configurations are not rare,20 and it is difficult to point 
directly at what may cause this geometry.  The crystallographic screw axis is essentially 
perpendicular to the two 1-D strands shown in Figure 6.7, which means that the cavitands are not 
all pointing in the same direction. Furthermore, two symmetry-related pairs of Br···Br 
interactions, 3.349 Å and 3.676 Å, respectively, also play an important role in positioning 
adjacent cavitands into an extended up-and-down arrangement (running parallel with a), Figure 
6.7b. 
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                                                                     (a) (b) 
Figure 6.7 (a) Packing of cavitand 19(1); (b) Adjacent hosts in cavitand 19(1) linked via 
multiple Br···Br interactions.  The hydrogen atoms have been omitted, except from the 
dichloromethane solvent molecules, for clarity. 
Within the last five years, the palladium-catalyzed Suzuki-Miyaura cross-coupling 
reaction, has been utilized multiple times in the synthesis of functionalized resorcinarene-based 
cavitand receptor molecules.16a, 21  In all reports, except one, the cavitand was tetrahalogenated (I 
or Br) and cross-coupled with a substituted (e.g. pyridyl, benzonitrile, or methoxyphenyl) aryl 
boronic acid or ester. In the one exception, the tetraboronic acid cavitand was formed and cross-
coupled with 3-bromopyridine.  
With the tetra-bromo cavitand precursor 19 synthesized and fully characterized, multiple 
Suzuki-Miyaura cross-coupling reactions were carried out.22 The desired pyridyl-functionalized 
cavitand was synthesized by cross-coupling cavitand 19 and excess 3-pyridyl boronic acid under 
a basic media, Figure 6.8.   
169 
Br Br 
Br 
OO OO O O
RR 
OO O
OO 
O O O
R RRR
N 
N N 
N 
O 
Br 
O N Pd(PPh3)4 / Na2CO3 
B(OH)2 Tol / EtOH / H2O

R R

R = (CH2)4CH3 R = (CH2)4CH3 
Figure 6.8 Synthesis of C-pentyltetra(3-pyridyl)cavitand 20. 
It should be noted that cavitands similar to 20, C-heptyltetra(3-pyidyl) and C­
phenylethyltetra(3-pyridyl)cavitands, have been reported in the literature16a however, overall 
yields of these cavitands were 23% and 20%, respectively.  In those cases, the synthesis was 
achieved by converting a tetra-bromo cavitand to the desired tetraboronic acid followed by 
reaction with 3-bromopyridine.   
The structure determination of 20, Figure 6.9, shows one py-cavitand and three 
acetonitrile molecules, although the asymmetric unit contains only one-half of a cavitand and 
three-half solvent molecules. 
Figure 6.9 Thermal ellipsoid plot (50% probability level) of py-cavitand 20. The blue spheres 
represent nitrogen atoms, while the red spheres are oxygen atoms.  The hydrogen atoms have 
been removed for clarity. 
Suitable crystals were also obtained when cavitand 20 was recrystallized from methanol 
instead of acetonitrile. The asymmetric unit 20(1) contains two py-cavitands and seven methanol 
solvent molecules, Figure 6.10. 
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Figure 6.10 Asymmetric unit of 20(1) with the hydrogen atoms removed, except on the 
methanol solvent molecules, for clarity.  The pyridyl nitrogen atoms are represented as light-blue 
spheres. 
To complement the existing tetra-pyridyl functionalized cavitand, a tetra-substituted 
carboxyphenyl-derivatized cavitand was generated, following similar reaction conditions, Figure 
6.11. 
COOH COOH 
COOH 
Br 
OO OO O O
RR 
Br Br 
Br 
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Pd(PPh3)4 / Na2CO3 
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R R B(OH)2 
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R = (CH2)4CH3 
R = (CH2)4CH3 
Figure 6.11 Synthesis of C-pentyltetra(4-carboxyphenyl)cavitand 21. 
The structure determination of 21, Figure 6.12, displays the tetra-carboxyphenyl 
functionalized cavitand. Due to poor quality diffraction data and heavy disorder around the 
ethanol solvent molecules, exact location of the carboxylic acid protons and solvent molecules 
cannot be determined.  
OO O 
OO 
O O O 
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Figure 6.12 Tetra-carboxyphenyl functionalized cavitand 21 with the alkyl and aromatic 
hydrogens omitted for clarity. 
Extension of the architecture, reveals the multiple acid···acid homomeric dimers (O···O 
distance, 2.610 Å) produced from each carboxylic acid moiety, which links the neighboring 
cavitands in a 2-dimensional sheet through an up-down-up-down repeating pattern, Figure 6.13. 
Figure 6.13 Linking of neighboring cavitands through acid···acid dimers to produce a 2-D wave­

like sheet.

The formation of polymeric capsules arises, upon stacking two sheets on top of one another. 

One sheet has the cavitands arranged in an up-down-up fashion, while the second sheet stacks in 

a down-up-down arrangement, Figure 6.14.  
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Figure 6.14 Side-view of the polymeric network (left) and a top-view of the two independent 
sheets forming the polymeric capsules (right). 
So far we have described the synthesis and characterization of tetrahalogenated cavitands 
and examined their ability to act as palladium catalyzed cross-coupling reactants with aryl 
boronic acids. We believe the limited number of functional groups appended to various 
cavitands, can be attributed to the relatively small number of inexpensive boronic acids and 
esters commercially available. However, if the cavitand was appended with the corresponding 
boronic acid or ester moiety, then a wider range of functionalized halogenated species are 
available for cross-coupling. 
The synthesis of cavitand 22 was achieved in good yields ~70%, following a modified 
procedure.23  It should be noted, in that case, the goal was to only convert two of the four 
bromine atoms into the pinacolyl borornate derivatives.  In our case, C-pentyltetrabromo 
cavitand was allowed to react with 4.6 eq. of n-butyllithium at –78 °C for 0.5h resulting in a tetra 
lithium-halogen exchange.  To this reaction 6 eq. of trimethoxyborane was added and the 
reaction was allowed to reach room temperature after 0.5h. The mixture was acidified with 
hydrochloric acid, producing the tetraboronic acid cavitand, which was converted to the desired 
tetraboronic pinacolyl ester cavitand 22, by addition of excess pinacol and magnesium sulfate, 
Figure 6.15. Purification was carried out by dissolving the reaction mixture in dichloromethane 
and adding excess acetone, in which a white precipitate formed and was isolated. 
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Figure 6.15 Synthesis of tetraboronic pinacolyl ester cavitand 22. 
The structure determination of 22, shows one tetraboronic pinacolyl ester cavitand and 
two hexanes molecules.  The disorder around one boronic pinacolyl ester and both hexanes 
molecules has been omitted for clarity.  One hexanes solvent molecule resides within the ‘upper­
cavity’, while the second solvent molecule resides outside the cavitand, filling space within the 
crystalline lattice.  Additionally, each of the pinacolyl ester fragments resides almost 
perpendicularly to the periphery of the upper-rim, due to electron-electron repulsion from the 
bridging oxygens of the cavitand, Figure 6.16a-b. 
Figure 6.16 (a) Side view of the asymmetric unit of 22; (b) Top view displaying one hexane 
solvent molecule residing in the cavity of cavitand 22, while one resides outside.  Both pictures 
are with the hydrogen atoms removed, except on the hexane solvent molecules, for clarity. The 
boron atoms are represented as light-pink spheres. 
Multiple palladium catalyzed cross-coupling reactions were carried out between 
tetraboronic pinacolyl ester cavitand, 22 and halogenated heterocyles, however, at this time, 
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successful coupling has not been achieved and further investigation into the reaction conditions 
i.e. catalyst, solvent, temperature, duration is needed. 
In order to advance the synthesis of other functionalized cavitands, through palladium-
catalyzed cross-coupling reactions, some additional covalent modifications needed to be carried 
out. We found no success in cross-coupling C-pentyltetrabromocavitand 19 and mono­
ethynylated species under the Sonogashira reaction conditions, however improved coupling was 
achieved upon exchange of the bromine atoms for iodine atoms.  Furthermore, the tetraiodo 
cavitand 23, was synthesised by treating its tetrabromo analog with n-BuLi followed by addition 
of iodine.24 Purificiation was carried out by silica-gel column chromatography and 
recrystallization from acetonitrile. 
The crystal structure determination of 23, Figure 6.17, reveals that one molecule of 
acetonitrile is located between the ‘feet’ of the host, with the nitrile end pointing up towards the 
equator of the host. 
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Figure 6.17 Molecular structure and labeled thermal ellipsoids (50% probability level) of 
tetraiodo cavitand in the crystal structure of 23. 
The extended architecture of 23, displays a ‘foot-in-mouth’ type of arrangement, where 
one of the pentyl-feet is resting in the upper-rim of an adjacent molecule, Figure 6.18.   
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Figure 6.18 Packing of molecule 23. The hydrogen atoms have been removed, except on the 
acetonitrile solvent molecules, for clarity.  The iodine atoms are represented as purple spheres. 
To date, there are only six reported crystal structures,25 of similar neutral host molecules 
where the upper-rim is tetra-substituted with halogen atoms and a lower-rim comprising of alkyl 
chains. However, none of these, except our previous examples, pack in a fashion where a ‘foot’ 
of one cavitand resides in the ‘mouth’ of a neighboring cavitand molecule.  A search through the 
CSD reveled twenty-three hits when including cavitands with any type of tetra-substituted upper 
rim in combination with an alkyl-substituted lower-rim.  However, none of these display the 
‘foot-in-mouth’ arrangement observed in the crystal structures 19, 19(1), and 23. In one case, 
however, the upper-rim substituents interact with the ‘mouth’ of an adjacent cavitand molecule.26 
With the complete synthesis and full characterization of the tetraiodo cavitand 23, several 
palladium-catalyzed Sonogashira cross-coupling reactions were carried out.  The desired pyridyl­
functionalized cavitand 24 was synthesized under conventional palladium-catalyzed Sonogashira 
reaction conditions between 23 and 3-ethynylpyridine under basic media. Purification was 
achieved by silica-gel column chromatography.  Recrystallization from a mixture of chloroform 
and hexanes yielded 67% of pure cavitand 24. 
The structure determination of 24, shows the presence of one disordered molecule of 
acetonitrile (located within cavity), and two water molecules, which engage in multiple hydrogen 
bonds with the pyridyl-nitrogen atoms on the upper rim of the host, Figure 6.19. 
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Figure 6.19 Labeled molecular structure and molecular structure 24 displaying the disordered 
acetonitrile molecule in the center of the host and the two water molecules forming O-H···N 
hydrogen bonds to the pyridyl rings (blue spheres). 
One of the water molecules in the crystal structure of 24 is responsible for linking the 
cavitands into one-dimensional rows, via symmetry related O-H···N hydrogen bonds, (O···N 
2.8644(15) Å), Figure 6.20a. The second water molecule provides a bridge between the 1-D 
strands through symmetry-related O-H···N hydrogen bonds (O···N 2.912(2) Å), resulting in a 
two-dimensional “wavy” network, Figure 6.20b.  
(a) 
177 
         (b) 
(b) 
Figure 6.20 (a) One-dimensional strands of 24 formed through O-H···N hydrogen bonds from 
bridging water molecules. (b) Side-on view of the extended architecture. Both pictures are 
displayed with the solvent and hydrogen atoms omitted for clarity, except on the water 
molecules. 
Another potentially useful and versatile building block for the construction of a wide 
range of heterodimeric hydrogen-bond based capsules, is C-pentyltetra(2-amino-5­
ethynylpyridine)cavitand. Once again, under palladium-catalyzed Sonogashira cross-coupling 
conditions, 5-ethynyl-2-aminopyridine and C-pentyltetraiodo cavitand 23 coupled smoothly to 
generate 25 in moderate to good yields ~ 74%, Figure 6.21. 
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Figure 6.21 C-pentyltetra(2-amino-5-ethynylpyridine)cavitand 25 synthesized through 
conventional Sonogashira reaction conditions.   
Unfortunately, single-crystals of cavitand 25 were not obtained, however the amino-
pyridine substituted cavitand will be used in the assembly process to form heteromeric-driven 
supermolecules with suitably functionalized counterparts.   
6.3.2 Heteromeric-synthon driven multi-component cavitand-based supermolecules 
In order to design heteromeric multi-component hosts where hydrogen bonds are 
employed as the synthetic avenues for organizing individual building blocks into the appropriate 
configurations, we allowed our functionalized cavitands to self-assemble with the corresponding 
hydrogen-bond counterparts. We were initially interested in the versatility and strength of the 
pyridyl-functionalized cavitands to form heteromeric hydrogen bonds with mono-carboxylic 
acids through each of the pyridyl moieties.  Thus, we allowed excess 4-cyanobenzoic acid to 
react with the pyridyl-functionalized cavitand 20. Crystals of 20a suitable for X-ray single-
crystal diffraction were grown by slow evaporation from a saturated solution of ethanol at room 
temperature.  Surprisingly, only one 4-cyanobenzoic acid molecule forms hydrogen bonds 
(O···O, 2.546 Å), through acid···pyridine interactions, to a pyridyl moiety of the tetrapyridyl 
cavitand, Figure 6.22a. Due to low quality of the data, from solvent disorder and crystal size, 
exact hydrogen atom location on the carboxylic acid cannot be determined.  The extended 
network is comprised of 1-D columns, with the cyano-benzyl fragment resting in the feet region 
of the above cavitand, Figure 6.22b. 
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(a) (b) 
Figure 6.22 (a) Two-component supermolcule formed through a carboxylic acid/pyridine 
heteromeric synthon (hydrogen atoms on the cavitand have been omitted for clarity); (b) 
Molecular packing of neighboring 1:1 pyridyl-cavitand/acid complexes. 
Although the overall result was not exactly as expected, we realized that the introduction 
of a moiety, in which strong complementary interactions could proceed, might be necessary in 
order to bring multiple components into a single crystalline lattice.    
Thus, to explore the versatility and hydrogen-bonding capabilities of the four 2­
aminopyridine moieties appended to 25, an excess of 3,5-dintrobenzoic acid was presented to the 
cavitand in order to ensure that all four binding sites were simultaneously engaged by a 
complementary chemical functionality.  Suitable single crystals were grown by slow evaporation 
from a mixture of solvents including acetonitrile, ethanol, nitrobenzene, and p-xylene (5:10:1:1). 
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The crystal lattice of 25a contains four 3,5-dinitrobenzoic acid molecules and three molecules of 
acetonitrile for every cavitand 25. Each 2-aminopyridine moiety participates in a pair of O­
H···N/N-H···O hydrogen-bonds with a neighboring carboxylic acid, Figure 6.23.  The O-H···N 
and N-H···O hydrogen bonding distances are 2.558 (8) Å, 2.582 (10) Å, 2.703 (8) Å, 2.579 (9) Å 
and 2.765 (9) Å, 2.863 (12) Å, 2.724 (9) Å, 2.878 (9) Å, respectively.   
Figure 6.23 A pentameric supermolecule in 25a produced by four 3,5-dinitrobenzoic acid 
molecules forming O-H···N and N-H···O hydrogen bonds with each cavitand 25 (three 
acetonitrile molecules are also shown).  Blue spheres indicate the pyridyl-nitrogen atoms. 
This result displayed the versatility and strength of the amino-pyridine functionality in its 
ability to attract and bond multiple carboxylic acid moieties, compared to the pyridine moiety.   
Table 6.1 Hydrogen bonds for 25a [Å and °]. 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O411-H411...N211 0.84 1.74 2.558(8) 164.2 
O412-H412...N212 0.84 1.75 2.582(10) 170.6 
O413-H413...N213 0.84 1.88 2.703(8) 168.0 
O414-H414...N214 0.84 1.76 2.579(9) 163.5 
N221-H22A1...O421 0.88 1.89 2.765(9) 176.8 
N222-H22A2...O422 0.88 2.06 2.863(12) 151.7 
N223-H22A3...O423 0.88 1.85 2.724(9) 169.7 
N224-H22A4...O424 0.88 2.01 2.878(9) 171.1 
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It seemed reasonable, due to the increased hydrogen-bonding strength and directionality 
between the amino-pyridine and carboxylic acid moieties, that upon mixing cavitand 25 with a 
dicarboxylic acid, a molecular capsule composed of two cavitands (top and bottom) and four 
dicarboxylic acids (equatorial-belt) could assemble through multiple heteromeric N-H···O/O­
H···N hydrogen bonds. Some elegant examples exist of molecular capsules, in which two 
individual cavity bearing hosts and four linking units, are brought together into discrete entities 
through hydrogen bonding. One such effort employed two carboxylic acid functionalized 
cavitands and four 2-aminopyrimidine molecules through sixteen complementary O-H···N/N­
H···O hydrogen bonds27, while another utilized O-H···N hydrogen bonds in order to assemble C­
methylcalix[4]resorcinarene and 4,4’-bipyridine into a molecular capsule28, Figure 6.24. 
(a) (b) 
Figure 6.24 (a) Molecular capsule assembled through multiple hydrogen bonds between two 
carboxylic acid cavitands and four 2-aminopyrimidine molecules; (b) Multi-component system 
composed of a resorcinarene derivative and 4,4’-bipyridine.29 
Our design strategy consists of linking two cavitand 25 molecules and four alkyl 
dicarboxylic acids through eight complementary heteromeric O-H···N/N-H···O hydrogen bonds. 
Thus cavitand 25 was allowed to self-assemble with a variety of alkyl dicarboxylic acids, in 
which one sample containing glutaric acid produced suitable crystals 25b for X-ray diffraction. 
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The crystal structure determination of 25b shows that the product contains two glutaric 
acid molecules and several solvent molecules (p-xylene and acetonitrile) for each cavitand 25. 
Each ethynyl 2-aminopyridine arm is engaged in a heteromeric O-H···N/N-H···O motif with an 
adjacent carboxylic acid moiety, Figure 6.25a. The acid···pyridine hydrogen bonds do not 
produce a discrete hexameric assembly, instead a polymeric network is formed through multiple 
carboxylic acid···amino-pyridine hydrogen bonds, Figure 6.25b. 
(a) (b) 
Figure 6.25 (a) Each binding site on 25b forms a heteromeric interaction with a carboxylic acid 
moiety. Picture shows both p-xylenes solvent molecules; (b) Side-on view of the polymeric 
network of 25b. Solvent molecules (p-xylene and acetonitrile) have been omitted for clarity.   
One-dimensional strands, Figure 6.25b, are linked to neighboring strands via N-H···O 
hydrogen bonds (2.847 (4) Å), from the anti-amino proton to the carbonyl oxygen of the acid to 
form a two-dimensional wave-like sheet, Figure 6.26a. The two-dimensional sheets stack on top 
of one another, with one p-xylene molecule and the pentyl-feet of a neighboring cavitand 
residing in the upper-cavity of the cavitand beneath it, Figure 6.26b.  
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(a) (b) 
Figure 6.26 (a) Molecular packing diagram of 25b, displaying the extensive hydrogen bonding 
between 1-D rows. Solvent molecules and hydrogen atoms have been removed for clarity; (b) 
Molecular packing of the cavitands in structure 25b. The hydrogen atoms have been removed 
for clarity and the blue spheres represent the pyridyl nitrogen atoms.   
Table 6.2 Hydrogen bonds for 25b [Å and °] 
D-H...A d(D-H) d(D-H) d(D...A) <(DHA) 
O(1)-H(1)...N(61) 0.84 1.82 2.652(4) 169.0 
O(5)-H(5)...N(71)#2 0.84 1.84 2.664(4) 165.7 
N(62)-H(62A)...O(2) 0.88 1.94 2.815(4) 173.4 
N(62)-H(62B)...O(6)#3 0.88 2.15 2.847(4) 136.1 
N(72)-H(72A)...O(6)#2 0.88 2.01 2.878(4) 168.6 
#2) -x+3,-y+1,-z+1 #3 x-1/2,y,-z+1/2 
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The question as to whether these assemblies 25a and 25b are held together, to some 
extent, by charge assisted, N-H+···-OOC hydrogen bonds in the solid state is not possible to 
answer unambiguously. For the strucure of 25b, it seems that all participating species are neutral 
as indicated by the C-N-C angle30 of the two unique pyridyl rings (118.5 (3) and 118.0 (3) and by 
the C-O bond distances of the carboxylic acids (C1-O1, 1.303 (4) Å; C1-O2, 1.213 (5) Å and C5­
O5, 1.304 (4) Å; C5-O6, 1.209 (4) Å). The large difference in C-O bond lengths ~ 0.09-0.095 Å 
and a smaller bond angle (< 120) supports the existence of a carboxylic acid moiety rather than a 
carboxylate.31  Structure 25a, is not as clear since the C-N-C angles of the pyridyl rings range 
from 116 to 120° and the difference betweeen the two C-O bond distances span 0.012 to 0.09 Å. 
A search of relevant structures in the CSD32 show that when an amino-pyridine moiety is 
engaged in a heteromeric hydrogen-bond interaction with a carboxylic acid, protonation occurs 
(8/10) times.31 
Surprisingly, only a handful of examples exist, in the literature, of hydrogen-bonded 
heterodimeric capsules composed of resorcinarene-based cavitands,16a, 33 while only one has been 
characterized through single-crystal diffraction.16a 
To expand upon previously reported data, we dissolved a 1:1 mixture of C-pentyltetra(3­
pyridyl)cavitand and C-pentyltetra(4-carboxyphenyl)cavitand, with an excess of 1,4­
diiodobenzene (10x) to aid as a template, in ethanol.  After five days of slow evaporation 
crystals suitable for single-crystal X-ray diffraction 20b were obtained. The crystalline 
product was intially characterized by melting point, elemental analysis and infrared 
spectroscopy, all confirming a 1:1 hydrogen bonded heterodimeric species.  X-ray diffraction 
proved that the two components had indeed formed a 1:1 heteromeric molecular capsule, 
Figure 6.28. 
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Figure 6.27 Heterodimeric molecular capsule 20b formed through O-H···N carboxylic 
acid/pyridine hydrogen bonds. The hydrogen atoms and solvent molecules have been removed 
for clarity. 
Unfortunately, due to solvent disorder and the diiodobenzene residing on a 
crystallographic inversion center, refinement of the structure is not well-behaved.  Furthermore, 
exact location of the carboxylic acid protons can not be established exactly, however short O···N 
contacts are observed for three of the four carboxylic acid/pyridine hydrogen bonds (027­
4···N21-8, 2.921 Å; 027-2···N21-6, 2.476 Å; 027-3···N21-7, 2.545 Å). The diiodobenzene 
actually resides outside of the inner-cavity of the resorcinarene-based capsule. Attempts were 
carried out to grow crystalline materials without introducing the guest, however all were 
unsuccessful. 
6.4 Conclusions 
The study provides a basis for new reliable methods for the assembly of discrete 
molecular capsules. A variety of functionalized resorcinarene-based cavitands have been 
synthesized, in good yields, through either the palladium-catalyzed Suzuki-Miyaura or 
Sonogashira cross-coupling reaction. 
The readily available pyridine and amino-pyridine decorated cavitands 21, 24, 25, and 27 
offer many opportunities for preparing asymmetric dimeric capsules using complementary 
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hydrogen-bond functionalities on different host molecules.  Furthermore, the ethynyl moieties 
linking the rim to the pyridyl-substituents, produce increased size and depth as well as a more 
electron rich interior that can be utilized for selectively capturing electron poor.   
The amino-pyridine appended cavitand demonstrated its usefulness and versatility in 
forming hydrogen bonds to either mono- or di-carboxylic acids.  Cavitand 25 represents a very 
useful and versatile building block for the construction of a wide range of heterodimeric capsules 
and by combining 25 with a suitably functionalized counterpart, a series of heterodimeric 
capsules capable of capturing and and organizing two different guests within their interior, may 
be constructed. 
Finally, upon mixing a pyridyl-functionalized cavitand along with a phenyl-carboxylic 
acid-coupled cavitand a 1:1 heterodimeric capsule is produced through complementary O-H···N 
hydrogen bonds. This example clearly demonstrates that heterotopic assembly can be achieved 
under suitable reaction conditions. 
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CHAPTER 7 - Cyclotriveratrylene-based molecular building blocks 

for hydrogen-bonded capsules 
7.1 Introduction 
Cyclotriveratrylene’s (CTV’s) belond to a class of cyclic oligomers, which form through 
condensation of the veratryl cation, under acidic conditions, in good yields, Figure 7.1. 
Numerous functionalized CTV’s have been synthesized and characterized,1 however our focus 
will be on the conventional tri-methoxy (R=Me) / tri-hydroxy (R’=H) molecular scaffold.2 
R'O OR 
RO OR'OR' RO 
CH2 
R'O 
RO 
H
+ 
+ 
Figure 7.1 General schematic displaying the cyclo-condensation of the veratryl cation. 
CTV’s possess a saucer-shape configuration, in which three aromatic rings are tethered 
together through methylene bridges.  Although considerably shallower than their resorcinarene­
based counterpart, CTV’s can bind or encapsulate large organic molecules i.e. fullerenes,3 o­
carborane,4 and organometallic complexes5 within their cavity bearing framework.  Extending 
the walls of the CTV through covalent synthesis has been explored, although only a small 
number of examples exist to date.1,6  Furthermore, there has only been one report on hydrogen-
bonded dimeric CTV capsules, where a carboxylate functionalized CTV was allowed to react 
with an ammonium functionalized CTV through charge-assisted interactions.7  Herein we present 
our initial synthetic endeavors for generating a library of neutral hydrogen bond donor/acceptor 
appended CTV’s, with the long-term goal of producing heterodimeric capsules through hydrogen 
bonds. However, we display some preliminary results in producing deep-walled CTV’s through 
heteromeric acid···pyridine hydrogen bonds. 
7.2 Experimental 
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7.2.1 Synthesis 
All chemicals, unless otherwise noted, were purchased from Aldrich and used without 
further purification.  Column chromatography was carried out on silica gel (150 Å pore size) 
from Analtech Inc. Melting points were determined on a Fisher-Johns melting point apparatus 
and are uncorrected. 1H and 13C NMR spectra were recorded on a Varian Unity plus 400 MHz 
or 200 MHz spectrometer in CDCl3 or D6-DMSO. Compounds were prepared for infrared 
spectroscopic (IR) analysis as a mixture in KBr. Electrospray Ionization – Ion-Trap Mass 
Spectrometry (ESI-IT-MS) was carried out on a Bruker Daltonics Esquire 3000 Plus.  MALDI­
TOF / TOF-MS was carried out on a Bruker Daltonics Ultraflex TOF/TOF. 
7.2.1.1 Synthesis of 3-methoxy-4-(2-propenyloxy)benzene, 282a 
CH2OH 
O 
MeO CH2OH 
OH
MeO 
+ Br 
K2CO3 
Acetone
 28 
A mixture of vanillyl alcohol (50.0 g, 0.32 mol), allyl bromide (31.5 ml, 0.36 mol) and 
potassium carbonate (45.0 g, 0.32 mol) were added to a round bottom flask.  Acetone (75 mL) 
was added and dinitrogen was bubbled through the resultant mixture for 10 minutes.  A 
condenser was attached and the mixture was heated to reflux under a dinitrogen atmosphere. 
The reaction was monitored by TLC and allowed to cool to room temperature on completion, 4 
h. The solution was then diluted with dichloromethane (150 mL), washed with water (3 x 100 
mL) and dried over magnesium sulfate.  The solvent was removed on a rotary evaporator 
producing a yellow oil. The product 28 was recrystallized from diethyl ether yielding a pure 
white solid, (44.6 g, 71 %). M.p. 66-68 ˚C; 1H NMR (δH; 400 MHz, CDCl3): 6.89 (s, 1H), 6.82 
(s, 2H), 6.01 – 6.10 (m, 1H), 5.25 – 5.40 (m, 2H), 4.56 (s + m, 4H), 3.84 (s, 3H), 2.31 (s, 1H). 
7.2.1.2 Synthesis of tris-methoxy-(2-propenyloxy) cyclotriveratrylene, 292a 
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CH2OHMeO 65 % perchloric acid 
MeO 
O O OMe MeO O MeOH O 
28 29 
A suspension of 28 (20.6 g, 0.11 mol) in methanol (125 mL) was cooled to 0 ˚C in an ice 
bath with magnetic stirring. Perchloric acid 65 % (60 mL) was added dropwise to the mixture, 
and then stirred under a dinitrogen atmosphere for 18 h at room temperature.  Upon completion, 
the solution was diluted with dichloromethane (100 mL), washed with water (3 x 150 mL) and 
dried over magnesium sulfate.  The solvent was removed on a rotary evaporator, which produced 
a white solid, that was further purified by recrystallization from diethyl ether (200 mL).  Product 
29 was isolated as a white powder, (8.3 g, 44 %).  M.p. 176-178 ˚C; 1H NMR (δH; 200 MHz, 
CDCl3): 6.86 (s, 3H), 6.81 (s, 3H), 5.98 – 6.14 (m, 3H), 5.22 – 5.43 (m, 6H), 4.75 (d, J = 14Hz, 
3H), 4.58 – 4.61 (m, 6H), 3.84 (s, 9H), 3.52 (d, J = 14Hz, 3H). 
7.2.1.3 Synthesis of tris-methoxy-(2-hydroxy) cyclotriveratrylene, 302b 
10% palladium on carbon
65 % perchloric acid 
dioxane / MeOH 
MeO 
O O OMe MeO O MeO 
OH OMe OHHO MeO 
29 30 
In a round-bottom flask 29 (3.00 g, 5.68 mmol) was dissolved in hot dioxane (15 mL). 
To this solution was added ethanol (27 mL), 10% palladium on carbon (600 mg), and dropwise 
65% perchloric acid (0.60 mL).  A condenser was attached and the mixture was heated to 55 – 60 
˚C, in an oil bath, for 20 h. Upon completion, the reaction was allowed to cool to room 
temperature and the catalyst filtered off and washed with dioxane (10 mL) and then 
dichloromethane (50 mL).  The organic layer was washed with water (3 x 100 mL) and dried 
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over magnesium sulfate.  The solution was concentrated to 25 mL and allowed to crystallize 
overnight. The product 30 was collected by suction filtration as a white solid, (1.75 g, 72 %). 
M.p. >280 ˚C; 1H NMR (δH; 200 MHz, CDCl3): 6.89 (s, 3H), 6.80 (s, 3H), 5.41 (s, 3H), 4.72 (d, 
J = 14Hz, 3H), 3.86 (s, 9H), 3.51 (d, J = 14Hz, 3H). 
7.2.1.4 Synthesis of tris(3-pyridylmethyl) cyclotriveratrylene, 31 
OH OMe 
MeO OHMeO OH 
N 
Cl 
N 
MeO 
MeO O 
O 
NN 
OMeO 
HCl 
+ K2CO3 
Acetone 
30 31 
A mixture of 30 (410 mg, 1.00 mmol) and potassium carbonate (1.39 g, 10.1 mmol) were 
refluxed under a dinitrogen atmosphere in acetone (60 mL) for 0.5 h. 3-picolylchloride 
hydrochloride (574 mg, 3.50 mmol) was added and the reaction refluxed for 96 h.  Upon cooling, 
the acetone was removed by rotary evaporator, water (100 mL) added and extracted with 
dichloromethane (3 x 100 mL).  The organic layer was dried over magnesium sulfate and the 
solvent removed on a rotary evaporator, producing a brown oil.  The residue was 
chromatographed on silica using ethyl acetate/ethanol (10:1) as the eluant.  The product 31 was 
further purified by trituration with methanol producing a white solid, (410 mg, 60 %).  M.p. 120­
122 °C; 1H NMR (δH; 200 MHz, CDCl3): 8.68 (d, J = 1.6Hz, 3H), 8.57 (dd, J = 4.8Hz, J = 1.8Hz, 
3H), 7.76 (dt, J = 8Hz, 1.8Hz, 3H), 7.33 – 7.26 (m, 3H), 6.87 (s, 3H), 6.74 (s, 3H), 5.10 (s, 6H), 
4.72 (d, J = 13.8Hz, 3H), 3.77 (s, 9 H), 3.50 (d, J = 14Hz, 3H); 13C NMR (δH; 400 MHz, CDCl3): 
149.3, 148.9, 148.8, 146.8, 135.1, 133.4, 133.0, 131.8, 123.5, 117.2, 114.1, 69.6, 56.2, 36.4; IR 
(KBr): 2925, 1608, 1577, 1510, 1261, 1087; ESI-IT-MS m/z 681 ([31 + H]+). 
7.2.1.5 Synthesis of tris(3-methoxycarbonylbenzyloxy) cyclotriveratrylene, 32 
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Br K2CO3 MeO OO O OMe MeO + 
MeCNMeO 
OH HO OMe MeO OH COOMe 
COOMe MeOOC 
MeOOC 
30 32 
A mixture of 30 (300 mg, 0.732 mmol) and potassium carbonate (625 mg, 4.54 mmol) 
were refluxed under a dinitrogen atmosphere in acetonitrile (25 mL) for 0.5 h. Methyl-3­
(bromomethyl)benzoate (1.0 g, 4.37 mmol) was added and the reaction refluxed for 96 h.  Upon 
cooling, acetonitrile was removed by rotary evaporator, water (100 mL) added and extracted 
with dichloromethane (3 x 100 mL).  The organic layer was dried over magnesium sulfate and 
the solvent removed on a rotary evaporator, producing a yellow oil.  The residue was 
chromatographed on silica using hexanes/ethyl acetate (3:1) as the eluant, affording 32 as a 
yellow oil, (410 mg, 66 %).  1H NMR (δH; 200 MHz, CDCl3): 8.10 (s, 1H), 8.57 (dt, J = 4.8Hz, J 
= 1.8Hz, 3H), 7.76 (dt, J = 8Hz, 1.8 Hz, 3H), 7.33 – 7.26 (m, 3H), 6.87 (s, 3H), 6.74 (s, 3H), 5.10 
(s, 6H), 4.72 (d, J = 13.8Hz, 3H), 3.77 (s, 9 H), 3.50 (d, J = 14Hz, 3H); 13C NMR (δH; 200 MHz, 
CDCl3): 166.81, 148.51, 146.86, 137.98, 132.87, 131.64, 131.55, 130.39, 129.00, 128.73, 
128.04, 116.35, 113.73, 71.21, 56.11, 52.13, 36.42. 
7.2.1.6 Synthesis of tris(3-phenylcarboxymethyl)cyclotriveratrylene, 33 
K2CO3 / MeOH 
MeO MeO O OO O OMe MeO 5 M HCl O O OMe MeO 
MeOOC HOOC COOMe COOH 
MeOOC HOOC 
32 33 
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A mixture of 30 (400 mg, 0.450 mmol) and potassium carbonate (625 mg, 4.06 mmol) 
was refluxed in an aqueous methanol solution (MeOH/H2O = 7:1, acetone, 60 mL) for 24 h. 
Upon cooling the solvent was removed on a rotary evaporator, water (30 mL) added along with 5 
M HCl (10 mL).  The suspension was stirred overnight and filtered, yielding an off-white 
precipitate, 33, (380 mg, 80 %). Dec. 150 °C; 1H NMR (δH; 200 MHz, DMSO-d6): 8.01 (s, 3H), 
7.88 (d, J = 7.4Hz, 3H), 7.64 (d, J = 7.6Hz, 3H), 7.49 (t, J = 7.6Hz, 3H), 7.18 (s, 3H), 7.02 (s, 
3H), 5.11 (q, J = 12.6Hz, J = 16.8Hz, 6H), 4.70 (d, J = 13.8Hz, 3H), 3.66 (s, 9 H), 3.49 (d, J = 
14.2Hz, 3H); IR (KBr pellet): 2930, 1696, 1609, 1511, 1445, 1265, 1184, 1081, 743; ESI-IT-MS 
m/z 811 (33 + H]+). 
7.2.2 Infrared spectroscopy 
7.2.2.1 Synthesis of tris(3-pyridylmethyl) cyclotriveratrylene:4-cyanobenzoic acid 
A mixture of 31 (10 mg, 0.015 mmol) and 4-cyanobenzoic acid (7 mg, 0.05 mmol) were 
placed on a watch glass.  The watch glass was heated until a homogeneous mixture was formed. 
IR (KBr pellet) υ 2551 and 1936 cm-1 (O-H···N, br), 1706 cm-1 (C=O, m). 
7.2.2.2 Synthesis of tris(3-pyridylmethyl) cyclotriveratrylene:4-nitrobenzoic acid 
A mixture of 31 (10 mg, 0.015 mmol) and 4-nitrobenzoic acid (8 mg, 0.05 mmol) were 
placed on a watch glass.  The watch glass was heated until a homogeneous mixture was formed. 
IR (KBr pellet) υ 2551 and 1957 cm-1 (O-H···N, br), 1696 cm-1 (C=O, m). 
7.2.2.3 Synthesis of tris(3-pyridylmethyl) cyclotriveratrylene:3,5-dinitrobenzoic acid 
A mixture of 31 (10 mg, 0.015 mmol) and 3,5-dinitrobenzoic acid (10 mg, 0.05 mmol) 
were placed on a watch glass.  The watch glass was heated until a homogeneous mixture was 
formed.  IR (KBr pellet) υ 2525 and 1921 cm-1 (O-H···N, br), 1706 cm-1 (C=O, m). 
7.2.2.4 Synthesis of tris(3-pyridylmethyl) cyclotriveratrylene:pentamethylbenzoic acid 
A mixture of 31 (10 mg, 0.015 mmol) and pentamethylbenzoic acid (9 mg, 0.05 mmol) 
were placed on a watch glass.  The watch glass was heated until a homogeneous mixture was 
formed.  IR (KBr pellet) υ 2561 and 1931 cm-1 (O-H···N, br), 1701 cm-1 (C=O, m). 
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 7.2.2.5 Synthesis of tris(3-pyridylmethyl) cyclotriveratrylene:3-N,N-dimethylaminobenzoic 
acid 
A mixture of 31 (10 mg, 0.015 mmol) and 3-N,N-dimethylaminobenzoic acid (8 mg, 0.05 
mmol) were placed on a watch glass.  The watch glass was heated until a homogeneous mixture 
was formed.  IR (KBr pellet) υ 2535 and 1926 cm-1 (O-H···N, br), 1675 cm-1 (C=O, m). 
7.3 Results and discussion 
7.3.1 Characterization of tris-substituted CTV’s 
Functionalized CTV’s 31 and 32 were prepared in good yields ~ 60 % under basic 
conditions with the appropriate electrophile.  For both molecules, purification proceeded 
smoothly through silica-gel column chromatography.  Conversion of the three ester-groups of 32, 
to carboxylic acids was achieved in good yields, i.e. 80%, under acidic conditions. Crystals 
suitable for single-crystal X-ray crystallography of 31 were grown by slow evaporation of a 
saturated toluene solution at room temperature over 36 h, Figure 7.2.   
Figure 7.2 (left) Top-view of CTV 31 along with one toluene solvent molecule. (right) Side-
view of CTV 31, displaying the shallow cavity. The hydrogen atoms and the toluene molecule 
have been omitted for clarity. 
The crystal structure determination confirms that CTV 31 has undergone a three-fold 
substitution with methylene extended pyridyl rings, in which each of the  pyridyl nitrogen atoms 
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 are facing upwards. The packing diagram of 31 shows the toluene solvate residing outside the 
cavity (Figure 7.2), while adjacent molecules stack in a cup-like fashion, Figure 7.3. 
Figure 7.3 Packing arrangement of adjacent CTV molecules within the solid state structure of 
31. 
Unfortunately, crystals suitable for X-ray diffraction were not obtained for compounds 32 
or 33, however combinations of 1H NMR, 13C NMR and mass spectrometry confirm the resulting 
tri-substituted product. 
As previously outlined in Chapter 6, the idea is to utilize self-complementary hydrogen 
bonding moieties to direct and align multiple components into discrete heteromeric complexes or 
capsules.  Suitable single crystals of asymmetric complexes and capsules could not be obtained 
however the desired hydrogen bond interactions were detected using infrared spectroscopy.   
7.3.2 Characterization through IR  spectroscopy 
To determine if CTV 31 and aromatic acids form O-H···N hydrogen bonds, melt 
experiments were conducted, in which stoichiometric amounts of each component is mixed and 
heated until melting occurs.  Melt experiments were carried out with CTV 31 and five different 
aromatic mono-carboxylic acids.8   Each sample was analyzed by IR and O-H···N stretches were 
observed in all 5 cases, proving that hydrogen bonds are forming between the pyridyl rings of  
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CTV 31 and the carboxylic acid moieties.  These very distinct, relatively broad stretches occur in 
the regions of 2500 and 1900 cm-1, Table 7.1. 
Table 7.1 O-H···N stretches formed between CTV 31 and five benzoic acids 
Benzoic acids 4-cyano 4-nitro 3,5-dinitro pentamethyl 4-N,N-dimethylamino 
O-H···N (cm-1) 1936 
2551 
1957 
2551 
1921 
2525 
1931 
2561 
1926 
2535 
Displayed in Figure 7.4 are IR spectra of CTV 31 and the product obtained between 
CTV 31 and 4-cyanobenzoic acid. Spectrum (b) reveals distinct O-H···N stretches at 2550 and 
1938 cm-1, while these stretches are absent in spectrum (a).   
(a) 
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 (b) 
Figure 7.4 (a) IR spectrum of CTV 31, and (b) IR spectrum of CTV 31:4-cyanobenzoic acid 
after the melt experiment.  
Even though it is impossible to determine how many benzoic acid molecules bind to the 
pyridyl-fucntionalized CTV the IR data does show that the two components form heteromeric O­
H···N hydrogen bonds. Continuing in our quest of detecting O-H···N hydrogen bonds through 
IR, a melt experiment with two individual CTV’s i.e. 31 and 33 containing self-complementary 
moieties was conducted. Displayed in Figure 7.5 are IR spectra of CTV 33 and the product 
formed between 31 and 33 after the melt experiment was conducted.  Unfortunately, the spectra 
of compounds 31 and 33; (a) and (c) contain stretches in the regions where O-H···N interactions 
appear, furthermore spectra (c) and (d) display similar bands, making it difficult to determine if 
both CTV’s are interacting through O-H···N hydrogen bonds or not.
 (c) 
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(d) 
Figure 7.5 (c) IR spectrum of CTV 33, and (d) IR spectrum of CTV 31:CTV 36 after the melt 
experiment.   
We have demonstrated that CTV’s containing either hydrogen bond donor or acceptor 
moieties can be easily prepared in good yields from the trimethoxy/trihydroxy molecular 
scaffold. Although single crystals were not obtained between reactions of CTV 31 and various 
benzoic acids, hydrogen bonds were detected using IR spectrometry. This project is still in the 
preliminary stages, however a foundation has been set for a variety of new functionalized CTV’s 
to be produced alongwith initial studies in detecting and characterizing hydrogen bonding 
interactions between multiple components.   
Future work will be centered around growing the number of CTV’s with suitable 
hydrogen-bond moieties appended to the scaffold for the construction of homomeric and 
heterodimeric capsules, Figure 7.6.     
N NH2 N 
N 
NH2 N NHCOMe 
CONH2 OH CCN=NOH 
Figure 7.6 Hydrogen bond donor/acceptor moieties to be substituted onto the CTV scaffold.   
Attempts will be made to obtain suitable crystals, for single crystal X-ray 
crystallography, of the individual hydrogen bond appended CTV’s (especially ones in which 
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self-complementry hydrogen bonds would exist) as well as combining suitable CTV’s for the 
construction of heterodimeric capsules.   
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CHAPTER 8 - Summary 
Supramolecular chemists have at their disposal a variety of reliable complementary 
intermolecular interactions e.g. hydrogen bonds, halogen···donor (N or O), and π-π interactions 
through which to synthesize supermolecules. Within supramolecular synthesis, desired product 
formation and isolation must be achieved from a single reaction, due to the freely reversible 
nature of non-covalent intermolecular interactions that hold the individual components together. 
This differs substantially from organic synthesis in which much stronger covalent bonds are 
broken and formed, allowing for reaction intermediates to be isolated, purified, and subjected to 
additional chemical transformations.  However, the ability to carry out sequential supramolecular 
synthesis, to form higher-ordered products with predictable connectivities and stiochiometries, is 
achievable (although rare!) within one reaction pot by relying on an established hierarchy of 
reliable intermolecular interactions.   
We designed and synthesized three supramolecular reactants (SR’s) containing two 
distinct hydrogen bonding donor/acceptor sites (pyridine/amino-pyrimidine) to establish 
competitive intermolecular interactions during co-crystal assembly.  These SR’s were allowed to 
react with various aromatic carboxylic acids producing nine 1:1 molecular co-crystals and four 
1:1 ionic salts through heteromeric O-H···N/N-H···O or charge-assisted N-H+···O-/N-H···O­
hydrogen bonds with the amino-pyrimidine binding site, Figure 8.1. 
N 
NN 
N 
H H 
O 
O 
H 
R 
MeO 
N 
NN 
N 
H H 
O 
O 
R 
H 
MeO 
Figure 8.1 Summary of primary hydrogen bonding motifs between 3-pyridine/amino-pyrimidine 
SR’s and aromatic carboxylic acids.  
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Attempts to quantify the strengths of both hydrogen bond acceptor sites i.e. pyridine or 
amino-pyrimidine were carried out using semi-emperical AM1 electrostatic potential surfaces. 
By simply subtracting the negative potential of the hydrogen-bond acceptor from the positive 
potential of the hydrogen-bond donor in each binding site, a numerical value, Q, which 
represents the overall hydrogen-bond capability is obtained, Figure 8.2. 
Pyridine ~ 346 kJ/mol 
Amino-pyrimidine ~ 408 
N N 
N 
H H 
N 
H 
Figure 8.2 Calculated Q-values for pyridine and amino-pyrimidine. 
A comparison of the two binding sites indicated that the amino-pyrimidine moiety was a 
superior hydrogen-bond acceptor for an incoming carboxylic acid.  This ranking in binding sites 
was also supported in the crystal structures that we obtained in which all thirteen structures 
(100% supramolecular yield) based upon SR’s 1, 2, and 6 display the carboxylic acid/amino­
pyrimidine synthon.   
We allowed the same family of pyridine/amino-pyrimidine SR’s to react with 
halogenated benzoic acids in which the amino-pyrimidine/carboxylic acid synthon formed 7/7 
times (100% supramolecular yield) and halogen bonds (N···I or N···Br) extended the SR/acid 
dimers into polymeric networks 4/7 times (57% supramolecular yield), Figure 8.3. 
N N 
N 
N 
H 
H 
O 
O 
H 
X N N 
N 
N 
H 
H 
O 
O 
H 
X 
Figure 8.3 A postulated network formed through a series of hydrogen and halogen bonds (X = I, 

Br). 

These results were rationalized through a hierarchical view of intermolecular interactions 

consisting of both hydrogen and halogen bonds. 

The construction of M(II)-containing (M = Cu, Co and Ni) supramolecular chains was 
achieved by combining suitable anionic ligands (for controlling the coordination geometry and 
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for creating a neutral building block) with three bifunctional ligands i.e. 3-pyridine/amino­
pyrimidine SR’s containing a metal-coordinating pyridyl site and a self-complementary 
hydrogen-bonding pyrimidine moiety.  Eleven crystal structures are presented and in each case, 
the metal complex displays a neutral overall charge, with anionic ligands occupying the 
equatorial sites leaving room for the bifunctional ligand to coordinate in the axial positions 10/11 
times (91% coordinate-covalent yield), Figure 8.4. 
Figure 8.4 The desired coordination chemistry around the metal center; (left) octahedral and 
(right) square-based pyramidal.  The supramolecular chemistry, which organizes the 
coordination-complexes into the desired infinite 1-D chains, was driven by a combination of N­
H···N amino-pyrimdine···amino-pyrimidine hydrogen bonds 10/13 times (77 % supramolecular 
yield), Figure 8.5. 
Figure 8.5 Extension of the ligand:metal complex through self-complementary N-H…N 
hydrogen bonds 
Finally, we utilized hydrogen-bonding interactions to organize and construct larger 
supermolecules.  Accordingly, we synthesized and characterized a series of tetra-halogenated 
and tetra-substituted hydrogen bond donor and acceptor functionalized, i.e. pyridyl, amino-
pyridine, carboxylic acid, resorcinarene-based cavitands, Figure 8.6. 
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                                                                                             (a) (b) (c) 
Figure 8.6 (a) Tetra-bromo; (b) Tetra-iodo; (c) Tetra-ethynylpryidyl functionalized cavitands. 
Our efforts produced deep-walled cavitands through amino-pyridine···carboxylic acid 
heteromeric synthons and a heterodimeric molecular capsule through pyridyl···carboxylic acid 
hydrogen bonds, Figure 8.7. The heterodimeric capsule is only one of three, of its type, 
characterized crystallographically. 
Figure 8.7 A pentameric supermolecule produced by four 3,5-dinitrobenzoic acid molecules 
forming O-H···N and H-H···O hydrogen bonds with each cavitand (left);  A 1:1 heterodimeric 
molecular capsule constructed through multiple pyridine···carboxylic acid hydrogen bonds (right) 
Due to the restricted and isolated nature of the inner-cavity, properties differ (within the 
capsule) drastically compared to those of the bulk phase environment.  This phenomenon leads 
to potential practical applications including, but not limited to, molecular sensing, stabilization of 
reactive intermediates, increase chemical reaction rates, molecular catalysis, drug delivery 
systems, and detection of various isomers.    
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Appendix A - Crystallographic Experimental Data 

209 
Chapter 2 
Datasets for  1,  2, 6, 1c-1d, 2a-2e, and 6b-6d were collected on a SMART APEX. Data 
for 1a-1b and 6a were collected on a SMART 1000. All datasets were collected using Mo-Kα 
radiation and were uncorrected for absorption. 
Data were collected using SMART.1  Initial cell constants were found by small widely 
separated “matrix” runs.  An entire hemisphere of reciprocal space was collected. Scan speed and 
scan width were chosen based on scattering power and peak rocking curves.        
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,2 using 
this improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT 
from the final merged dataset. Lorenz and polarization corrections were applied, and data were 
corrected for absorption 
Data were reduced with SHELXTL.3 All structures were solved by direct methods.  In 
general, hydrogen atoms were assigned to idealized positions and were allowed to ride.  Where 
possible, the coordinates of hydrogen-bonding hydrogens were allowed to refine. Where 
appropriate, weighting schemes were optimized based on the recommendations from SHELXL. 
Heavy atoms were refined with anisotropic thermal parameters. For all structures except 6a, 
positional coordinates for carboxylic acid hydrogens (labelled H31 except for 2c, where it is 
labelled H41) and amine hydrogens (H12A and H12B for all structures) were allowed to refine. 
Coordinates for the phenolic hydrogen atom H34 of 1c were allowed to refine. 
Chapter 3 
All datasets were collected on a SMART APEX at -120 °C using MoKα radiation. Data 
were collected using SMART.1  Initial cell constants were found by small widely separated 
“matrix” runs.  An entire hemisphere of reciprocal space was collected. Scan speed and scan 
width were chosen based on scattering power and peak rocking curves. 
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,2 using 
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this improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT 
from the final merged dataset. Lorenz and polarization corrections were applied. Absorption 
corrections were not applied. 
Data were reduced with SHELXTL.3 The structures were solved in all cases by direct 
methods without incident.  Unless otherwise noted, hydrogen atoms were assigned to idealized 
positions and were allowed to ride. All non-hydrogen atoms were given anisotropic thermal 
parameters. 
7 The compound crystallized in the noncentrosymmetric orthorhombic space group 
P212121. Friedel opposites were merged; no attempt was made to determine handedness of the 
lattice. Coordinates for the -NH2 protons (H12A&B) were allowed to refine. 
7(1) The compound crystallized in the monoclinic crystal system and exhibited pseudo­
merohedral twinning emulating the orthorhombic lattice; β=90.246, refined batch scale factor 
0.157(1). The –NH2 protons (H12A&B) were placed in calculated positions and were allowed to 
ride. 
7a Coordinates for the –NH2 protons (H12A&B), and carboxylic acid and phenol protons 
(H31 and H34, respectively) were allowed to refine. 
7b Coordinates for the –NH2 protons (H12A&B), and carboxylic acid and phenol protons 
(H31 and H33, respectively) were allowed to refine. 
7c Proton transfer from acid to pyrimidine was observed. All protons, including 
pyrimdinium and amine protons, were placed in calculated positions and were allowed to ride. 
The compound crystallized in the centrosymmetric space group P212121. Friedel opposites were 
merged and absolute stereochemistry was indeterminate. 
7d All protons, including carboxylic acid and amine protons, were placed in calculated 
positions and were allowed to ride. The molecule crystallized in the polar space group P2(1) and 
was refined as a racemic twin. 
7e Proton transfer from acid to pyrimidine was observed. Coordinates for the 
pyrimidinium proton H11, the –NH2 protons (H12A&B), and the protonated carboxylic acid 
proton H31 were allowed to refine. 
7f Proton transfer from acid to pyrimidine was observed. Coordinates for the 
pyrimidinium proton H11, the –NH2 protons (H12A&B), and the protonated carboxylic acid 
proton H51 were allowed to refine. 
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Chapter 4 
Datasets were collected on a SMART APEX or a SMART 1000 as noted. All datasets 
were collected using MoKα radiation and, where noted, were corrected for absorption using the 
multi-scan procedure implemented by SADABS. 
Data were collected using SMART.1  Initial cell constants were found by small widely 
separated “matrix” runs.  An entire hemisphere of reciprocal space was collected. Scan speed and 
scan width were chosen based on scattering power and peak rocking curves. 
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,2 using 
this improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT 
from the final merged dataset. Lorenz and polarization corrections were applied, and data were 
corrected for absorption. 
Data were reduced with SHELXTL.3 The structures were solved in all cases by direct 
methods without incident.  Unless otherwise noted, hydrogens were assigned to idealized 
positions and were allowed to ride. All non-hydrogen atoms were given anisotropic thermal 
parameters. 
8a Data were collected on a SMART APEX at -120 °C. Coordinates of the amine 
hydrogens H12A and H12B and carboxylic acid hydrogen H31 were allowed to refine. 
13a Data were collected on a SMART 1000 at -100 °C. 
8b Data were collected on a SMART APEX at -120 °C. 
13b Data were collected on a SMART APEX at -120 °C. Proton transfer from acid to 
amine was clearly observed, and the coordinates of the ammonium hydrogen H11 were allowed 
to refine. 
14a Data were collected on a SMART APEX at -120 °C. Proton transfer from acid to 
amine was clearly observed, and the coordinates of the ammonium hydrogen H11 and amine 
hydrogens H12A and H12B were allowed to refine. 
8c Data were collected on a SMART APEX at -120 °C. Coordinates of the carboxylic 
acid hydrogen H31 were allowed to refine. 
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14b Data were collected on a SMART APEX at -120 °C. Proton transfer from acid to 
amine was clearly observed, and the coordinates of the ammonium hydrogen H11 and amine 
hydrogens H12A and H12B were allowed to refine. 
Chapter 5 
Unless otherwise noted, X-ray data were collected on a Bruker SMART APEX three-
circle CCD diffractometer using molybdenum Kα radiation. Data were collected using 
SMART.1 Initial cell constants were found by small widely separated “matrix” runs.  An entire 
hemisphere of reciprocal space was collected. Scan speed and scan width were chosen based on 
scattering power and peak rocking curves. Unless otherwise noted, data was collected at -173 °C, 
using 0.3° scan width. 
Unit cell dimensions and orientation matrix were improved by least-squares refinement 
of reflections “thresholded” from the entire dataset. Integration was performed with SAINT,2 
using this improved unit cell as a starting point. Precise unit cell dimensions were calculated in 
SAINT from the final merged dataset. Lorenz and polarization corrections were applied, and data 
were corrected for absorption. 
Data were reduced with SHELXTL.3 The structures were solved in all cases by direct 
methods without incident.  In general, hydrogen atoms were assigned to idealized positions and 
were allowed to ride. Where possible, the coordinates of hydrogen-bonding hydrogen atoms 
were allowed to refine. Heavy atoms, other than those of the guests, were refined with 
anisotropic thermal parameters. 
1e Data were collected on a SMART APEX at 100 K. The copper complex sits on a 
crystallographic inversion center. Coordinates for the amine hydrogen atoms, H12A and H12B, 
were allowed to refine. 
1f Data were collected on a SMART 1000 at 100 K. The lattice contains two independent 
copper complexes, each sitting on a crystallographic inversion center. Two of the four 2­
fluorobenzoates existed in two nearly superimposable rotamers, differing in the relative 
placement of the fluorine substituent. Coordinates for the amine hydrogen atoms, H22A, H22B, 
H62A, and H62B, were allowed to refine. 
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15a Data were collected on a SMART 1000 at 100 K. The copper complex sits on a 
crystallographic inversion center. Coordinates for the amine hydrogen atoms, H12A and H12B, 
were allowed to refine. 
15b Data were collected on a SMART 1000 at 100 K. The copper complex sits on a 
crystallographic inversion center. Both 2-fluorobenzoates existed in two nearly superimposable 
rotamers, differing in the relative placement of the fluorine substituent. The two amine hydrogen 
atoms, H22A and H22B, were placed in idealized positions and were allowed to ride.  
6e Data were collected on a SMART APEX at 100 K. The copper complex sits on a 
crystallographic inversion center. The asymmetric unit contains a nearly superimposed 
disordered solvent pair of ethanol and acetonitrile. Occupancies for these two species were 
allowed to refine during initial model refinement and were fixed at 0.3 and 0.4 for final cycles. 
Coordinates for the amine hydrogen atoms, H12A and H12B, were allowed to refine.  
16a Data were collected on a SMART 1000 at 100 K. The copper complex sits on a 
crystallographic inversion center. Both 2-fluorobenzoates existed in two nearly superimposable 
rotamers, differing in the relative placement of the fluorine substituent. The (nonsymmetric) 
acetylene molecule sits on a crystallographic inversion center, with the 2-amino substituent 
having 50% site occupancy. The amino hydrogen atoms were located in calculated positions and 
were allowed to ride. 
16b Data were collected on a SMART APEX at 100 K. The copper complex sits on a 
crystallographic inversion center. The (nonsymmetric) acetylene molecule sits on a 
crystallographic inversion center, with the 2-amino substituent having 50% site occupancy. The 
amino hydrogen atoms were located in calculated positions and were allowed to ride. 
15c Two disordered chloroform sites were identified in the difference Fourier map. Two 
conformers were included for each site, with occupancy for each site set to sum to 1, with the 
minor conformer constrained to approximate the geometry of the major conformer, and with 
thermal parameters for similarly located atoms tied to each other. The lattice contains two 
complexes, each located on a crystallographic inversion center. Amine hydrogen atoms H27A, 
H27B, H57A, and H57B were included at calculated positions. Although the placement of these 
two species on special positions suggested the possibility of a sublattice, the chloroform 
molecules were not similarly positioned. 
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15d The cobalt complex sits on a crystallographic inversion center. Coordinates for the 
amine hydrogen atoms, H52A and H52B, were allowed to refine. 
1g The asymmetric unit contains a copper complex, located on an inversion center, and a 
disordered 1,2-dichloroethane species. The latter species contained two conformers (in an 
approximately 85:15 mixture), both of which straddled an inversion center. The unique carbon 
on both species was refined isotropically. For purposes of connectivity tables, two chlorine 
atoms, sharing atomic coordinates and thermal parameters, were included in the atom list. 
Atomic coordinates for the two amine hydrogen atoms, H22A and H22B, were allowed to refine. 
6f The copper complex sits on a general position. A slight bit of -CF3 disorder was 
modeled with two conformers (90:10 ratio). Geometry of the minor species was constrained to 
that of the major species, the isotropic thermal parameters of the two carbons were tied, and a 
free variable was employed to model isotropic thermal motion for the fluorine atoms on the 
minor conformer. Amine hydrogen atoms H12A and H12B were included in calculated 
positions. 
6g The cobalt complex sits on a crystallographic inversion center. Amine hydrogen atoms 
H12A and H12B were allowed to refine. 
6h Data were collected on a SMART 1000 CCD diffractometer at -100 °C, using a 0.2 ° 
scan width. The nickel complex sits on a crystallographic inversion center. Amine hydrogen 
atoms H22A and H22B were allowed to refine. 
Chapter 6 
X-ray data were collected, except 20b, using a fine-focus molybdenum Kα tube. Data 
were collected using SMART.1 Initial cell constants were found by small widely separated 
“matrix” runs. Preliminary Laué symmetry was determined from axial images.  For all structures 
an entire hemisphere of reciprocal space was collected. Scan speed and scan width were chosen 
based on scattering power and peak rocking curves. 
Unit cell constants and orientation matrix were improved by least-squares refinement of 
reflections thresholded from the entire dataset. Integration was performed with SAINT,2 using 
this improved unit cell as a starting point. Precise unit cell constants were calculated in SAINT 
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from the final merged dataset. Lorenz and polarization corrections were applied. Laué symmetry, 
space group, and unit cell contents were found with XPREP. 
Data were reduced with SHELXTL.3 The structures were solved in all cases by direct 
methods without incident.  Hydrogen atoms were assigned to idealized positions and were 
allowed to ride, except as noted. Heavy atoms were refined with anisotropic thermal parameters. 
19 Data were collected at 173 K on a Bruker SMART 1000 diffractometer. 
19(1) Data were collected at 100 K on a Bruker SMART 1000 diffractometer. 
20 Data were collected at 100 K on a Bruker SMART APEX 1000 diffractometer. 
20(1) Data were collected at 153 K on a Bruker SMART APEX 1000 diffractometer. 
20a The compound crystallizes in the tetragonal space groupP4/nnc. The cavitand 
molecule sits on a 4-fold special position and was fully ordered. The lattice also contained four 
molecules modelled as ethanol, with partial overlap among three of these four molecules. Site 
occupancy for these three molecules was restrained to sum to 1.0 by use of a SUMP command. 
Also present in the lattice were two partially occupied water sites. All solvent molecules were 
given isotropic thermal parameters. 
20b The X-ray intensity data were measured at 95(2) K on a Bruker SMART APEX II 
system equipped with Montel mirrors and a Cu Kα fine-focus sealed tube (λ = 1.54178 Å) 
operated at 1.5 kW power (50 kV, 30 mA).  The detector was placed at a distance of 5.1321 cm. 
from the crystal. 
A total of 5288 frames were collected with a scan width of 0.5º in ω or φ and an exposure 
time of 10.0 sec/frame.  The total data collection time was 17.62 hours.  The frames were 
integrated with the Bruker SAINT software package using a narrow-frame integration algorithm. 
The integration of the data using a triclinic unit cell yielded a total of 35498 reflections to a 
maximum θ angle of 64.94° (0.85 Å resolution), of which 19633 were independent (average 
redundancy 1.808, completeness = 94.7%, Rint= 2.07%, Rsig = 3.14%) and 18891 (96.22%) were 
greater than 2σ(F2). The final cell constants of a = 12.4743(2) Å, b = 15.3416(2) Å, c = 
21.9472(3) Å, α = 84.7880(10)°, β = 79.0650(10)°, γ = 83.7960(10)°, volume = 4089.09(10)Å3, 
are based upon the refinement of the XYZ-centroids of 9763 reflections above20 σ(I) with 
9.708°< 2θ < 129.243°. Analysis of the data showed negligible decay during data collection. 
Data were corrected for absorption effects using the multi-scan technique (SADABS).  The ratio 
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of minimum to maximum apparent transmission was 0.4377. The calculated minimum and 
maximum transmission coefficients (based on crystal size) are 0.2989 and 0.6762. 
            The structure was solved and refined using the Bruker SHELXTL (Version 6.1) Software 
Package, using the space group P1, with Z = 1 for the formula unit, C162H166N4O26I2. The final 
anisotropic full-matrix least-squares refinement on F2with 1845 variables converged at R1 = 
5.64%, for the observed data and wR2 = 16.47% for all data. The goodness-of-fit was 1.028. 
The largest peak on the final difference electron density synthesis was 1.112 e-/Å3 and the largest 
hole was -0.579 e-/Å3with an RMS deviation of 0.136 e-/Å3. On the basis of the final model, the 
calculated density was 1.153 g/cm3 and F(000), 1480 e-. 
21 The cavitand molecule was divided into four RESI parts for ease of labelling. Two of 
the four residues showed disorder for the two possible orientations of the 3-pyridyl fragment. 
One alkyl chain showed disorder and was modelled as two fragments, with occupancies 
summing to 1.0 and with the minor species (80% occupancy) given isotropic thermal parameters. 
The lattice contained a fully occupied 4-cyanobenzoic acid molecule, a partially occupied 
benzene molecule, and eight partially occupied methanol molecules. The benzene molecule was 
treated as an ideal hexagon with a common isotropic thermal parameter. All eight methanol 
molecules were idealized with DFIX commands and were given isotropic thermal parameters. 
Overlap among the solvent molecules was handled with SAME instructions. 
22 Data were collected on a SMART 1000 using MoKα radiation at 173 K and were 
uncorrected for absorption. Thermal parameters for the hydrogen atoms were constrained to 
150% (methyl groups) or 120% (all others) of their parent atom. Ordered heavy atoms on the 
cavitand molecule were refined with anisotropic thermal parameters. Disordered atoms, 
including those in solvent, were given isotropic thermal parameters. 
The cavitand molecule has chemical, but not crystallographical, 4-fold symmetry and was 
treated as four residues using the SHELXTL RESI command. One of the four borandioxolane 
fragments (in RESI 3) was disordered and was treated as three PARTs, each with four unique 
atoms (all ring atoms save the boron). The occupancies for these fragments converged to 
58:27:15; these values were constrained for the final refinement cycles. Isotropic thermal 
parameters were constrained with sets of threefold EADP instructions, and geometries were 
restrained with SAME instructions. 
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Another borandioxolane fragment (in RESI 4) exhibited disorder that was modeled by 
splitting a single ring atom (C24A/B) and its two riding methyl groups. Isotropic thermal 
parameters were constrained with sets of twofold EADP instructions, and relative occupancy was 
allowed to refine with a free variable. Geometries were restrained with DFIX commands. 
The pentyl chain in RESI 3 was disordered and was modeled with two species. Isotropic 
thermal parameters were constrained with sets of twofold EADP instructions, and relative 
occupancy was allowed to refine with a free variable. Geometries were restrained with DFIX 
commands. 
Hexane solvent molecules were contained in two sites in the asymmetric unit. The first 
site contained two species. Isotropic thermal parameters were constrained with sets of twofold 
EADP instructions, and relative occupancy was allowed to refine with a free variable. 
Geometries were restrained with DFIX commands. The second site contained three species. The 
occupancies for these fragments converged to 35:22:43; these values were constrained for the 
final refinement cycles. A single free variable was used to model the isotropic thermal motion for 
all carbon atoms in the three molecules. 
23 Data were collected at 173 K on a SMART 1000, and were corrected for absorption 
(μ=2.45 mm-1; Rmerge before / after = 5.75 % / 4.00 %; trans min/max = 0.704 / 1.000). All 
hydrogen atoms were included in idealized positions, and their geometries were not optimized. 
After initial atom assignment, a feature in the difference density map was assigned as 
acetonitrile, which was refined successfully with full occupancy and anisotropic thermal motion. 
24 Data were collected at 100 K on a SMART APEX, and were corrected for absorption 
(μ=0.08 mm-1; Rmerge before / after = 4.55 % / 3.88 %; trans min/max = 0.853 / 1.000). After data 
collection, the unit cell was re-defined in order to obtain the standard setting of the orthorhombic 
space group Pnna. After initial atom assignment, a feature in the difference density map very 
close to a 2-fold axis was assigned as acetonitrile, which was refined successfully as a single 
species with half occupancy and anisotropic thermal motion. The SHELXL ‘SPEC’ command 
was required to prevent the C2S carbon from jumping to the nearby 2-fold axis. Its methyl group 
geometry was optimized with DFIX distance restraints, since the standard SHELXL ‘AFIX 33’ 
command for idealizing a methyl group failed in combination with the ‘SPEC’ command. Two 
other features, both located on 2-fold axes, were assigned as two water molecules and were 
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successfully refined with half occupancy for the water atoms. The positional coordinates of the 
individual unique hydrogen atom on each water molecule were allowed to refine. 
25a One of the four alkyl chains was disordered and was treated with two PARTs with 
anisotropic thermal parameters constrained with pairwise EADP commands. The occupancies, 
which were constrained to 100%, refined to an ~55% / 45% ratio. The set of solvent molecules 
consisted of one fully-occupied isotropic acetonitrile, two superimposed acetonitriles with a 
single isotropic temperature factor (occupancies ~80% / 20% constrained to 100%), and a 
superimposed isotropic methanol / acetonitrile pair, with occupancies for each molecule fixed for 
the final refinement. 
25b The molecule sits on a mirror plane bisecting two pairs of the saturated carbon atoms 
(C41/C47 and C51/C57) in the cavitand cylinder. These four atoms and the alkyl chains attached 
to them were all given half occupancy due to their location on a special position. One of these 
two alkyl chains showed signs of disorder and was treated as two isotropic PARTs, with total 
occupancy constrained to 50%, with idealized geometries enforced by DFIX commands. The 
remaining (fully occupied) alkyl chain also showed signs of disorder and was treated as two 
anisotropic PARTs, with total occupancy constrained to 100%, with idealized geometries 
enforced by DFIX commands. The set of solvent molecules consisted of two p-xylene molecules. 
The first was given an overall isotropic thermal parameter (which was allowed to refine) and was 
constrained to 35% occupancy. The second was given a fixed overall thermal parameter of 0.15, 
and was constrained to 25% occupancy. Because of their location near special positions, the 
PART -1 command was used to suppress bond generation between unique and equivalent 
species. As a result of this PART command, the standard AFIX 33 command for methyl 
hydrogen generation was unstable, and explicit bond length and angle constraints were imposed 
(using DFIX commands) to generate ideal methyl geometries. The latter p-xylene molecule was 
overlapped by two partially occupied isotropic acetonitrile molecules. Occupancy for these two 
molecules were constrained to 25%. 
Chapter 7 
Single crystals were obtained as colorless plates and blades from toluene. For X-ray 
examination and data collection, a suitable crystal, approximate dimensions 0.16 x 0.10 x 0.07 
219 
mm, was mounted in a loop with paratone-N and transferred immediately to the goniostat bathed 
in a cold stream. 
Intensity data were collected at 173K on a Kappa goniostat equipped with a Bruker 
Platinum200 CCD detector at Beamline 11.3.1 at the Advanced Light Source (Lawrence 
Berkeley National Laboratory) using synchrotron radiation tuned to λ=0.77500 Å. The detector 
was set at a distance of 7.4 cm from the crystal. A series of 1-s data frames measured at 0.2° 
increments of ω were collected to calculate a unit cell. For data collection frames were measured 
for a duration of 1-s at 0.3° intervals of ω with a maximum θ value of ~56°. The data frames 
were collected using the program APEX2 and processed using the program SAINT routine 
within APEX2. The data were corrected for absorption and beam corrections based on the 
multiscan technique as implemented in SADABS. 
All hydrogens were included in calculated positions and were allowed to ride. All non-
hydrogen atoms were given anisotropic thermal parameters with the exception of C87, which 
was refined isotropically. 
            A solvent toluene molecule was located in the difference Fourier map as two closely 
located species. The molecules were refined anisotropically using idealized hexagonal geometry 
for the benzene ring. Occupancies for the two species were constrained to sum to 1.0 with use of 
a free variable. 
(1) Crystallographic data were collected through the SCrALS (Service Crystallography at 
Advanced Light Source) program at the Small-Crystal Crystallography Beamline 11.3.1 
(developed by the Experimental Systems Group) at the Advanced Light Source (ALS). The ALS 
is supported by the U.S. Department of Energy, Office of Energy Sciences Materials Sciences 
Division, under contract DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. 
(2) APEX2 v1.0-27 and SAINT v7.06A data collection and data processing programs, 
respectively. Bruker Analytical X-ray Instruments, Inc., Madison, WI; SADABS v2.10 
semiempirical absorption and beam correction program. G.M. Sheldrick, University of 
Göttingen, Germany; SHELXTL v6.14 for structure solution, figures and tables, neutral-atom 
scattering factors as stored in this package. G.M. Sheldrick, University of Göttingen, Germany 
and Bruker Analytical X-ray Instruments, Inc., Madison, WI. 
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Table B.1 Crystal data and structure refinement for 1, 2, 6, 1a-1d, 2a-2e, and 6a-6d 
1 
Identification code ns0401 
Empirical formula C10 H10 N4 
Formula weight 186.22 
Temperature  
Wavelength  
203(2) K 
0.71073 Å 
Crystal system Triclinic 
Space group 
Unit cell dimensions 
Volume
P-1 
a = 6.9426(4) Å 
b = 7.2048(5) Å 
c = 9.3201(6) Å 
 444.31(5) Å3 
α= 92.459(4)°. 
β= 91.380(4)°. 
γ = 107.319(4)°. 
Z 2 
Density (calculated) 
Absorption coefficient 
1.392 g/cm3 
0.090 mm-1 
F(000) 
Crystal size 
196 
0.35 x 0.25 x 0.20 mm3 
Theta range for data collection 2.19 to 27.86°. 
Index ranges -9<=h<=9, -9<=k<=9, -11<=l<=10 
Reflections collected 3137 
Independent reflections 1937 [R(int) = 0.0454] 
Completeness to theta = 27.86° 91.5 % 
Absorption correction 
Refinement method 
None 
Full-matrix least-squares on F2 
Data / restraints / parameters 
Goodness-of-fit on F2
1937 / 0 / 133 
 1.119 
Final R indices [I>2sigma(I)] R1 = 0.0500, wR2 = 0.1507 
R indices (all data) 
Largest diff. peak and hole 
R1 = 0.0625, wR2 = 0.1613 
0.258 and -0.284 e.Å-3 
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Crystal data and structure refinement for 2 
Identification code ns0402 
Empirical formula C11 H12 N4 O 
Formula weight 216.25 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Orthorhombic 
Space group Pbca 
Unit cell dimensions a = 11.6093(10) Å α= 90°. 
b = 7.2822(7) Å β= 90°. 
c = 24.604(2) Å γ = 90°. 
Volume 2080.0(3) Å3 
Z 8 
Density (calculated) 1.381 g/cm3 
Absorption coefficient 0.094 mm-1 
F(000) 912 
Crystal size 0.35 x 0.20 x 0.15 mm3 
Theta range for data collection 2.41 to 28.28°. 
Index ranges -15<=h<=15, -9<=k<=8, -32<=l<=32 
Reflections collected 14559 
Independent reflections 2469 [R(int) = 0.1334] 
Completeness to theta = 28.28° 95.5 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2469 / 0 / 153 
Goodness-of-fit on F2 0.941 
Final R indices [I>2sigma(I)] R1 = 0.0566, wR2 = 0.1229 
R indices (all data) R1 = 0.1229, wR2 = 0.1490 
Extinction coefficient 0.0068(13) 
Largest diff. peak and hole 0.254 and -0.265 e.Å-3 
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Crystal data and structure refinement for 6 
Identification code ns0414 
Empirical formula C13.50 H13 Cl N4 O 
Formula weight 282.73 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 7.2432(8) Å α= 107.292(2)°. 
b = 7.7893(8) Å β= 91.059(2)°. 
c = 12.6950(13) Å γ = 98.566(2)°. 
Volume 674.75(12) Å3 
Z 2 
Density (calculated) 1.392 g/cm3 
Absorption coefficient 0.282 mm-1 
F(000) 294 
Crystal size 0.42 x 0.32 x 0.10 mm3 
Theta range for data collection 1.68 to 29.98°. 
Index ranges -10<=h<=9, -10<=k<=10, -17<=l<=17 
Reflections collected 7714 
Independent reflections 3831 [R(int) = 0.0219] 
Completeness to theta = 29.98° 97.6 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.691 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3831 / 3 / 191 
Goodness-of-fit on F2 1.253 
Final R indices [I>2sigma(I)] R1 = 0.0677, wR2 = 0.1755 
R indices (all data) R1 = 0.0887, wR2 = 0.1922 
Largest diff. peak and hole 0.709 and -0.392 e.Å-3 
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Crystal data and structure refinement for 1a 
Identification code ns0403 
Empirical formula C17 H15 N5 O4 
Formula weight 353.34 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 6.8245(5) Å α= 77.174(4)°. 
b = 9.5538(7) Å β= 84.400(4)°. 
c = 12.6278(9) Å γ = 82.637(4)°. 
Volume 794.13(10) Å3 
Z 2 
Density (calculated) 1.478 g/cm3 
Absorption coefficient 0.109 mm-1 
F(000) 368 
Crystal size 0.30 x 0.25 x 0.10 mm3 
Theta range for data collection 2.46 to 28.27°. 
Index ranges -8<=h<=9, -12<=k<=12, -16<=l<=16 
Reflections collected 5974 
Independent reflections 3581 [R(int) = 0.0577] 
Completeness to theta = 28.27° 90.9 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3581 / 0 / 245 
Goodness-of-fit on F2 0.960 
Final R indices [I>2sigma(I)] R1 = 0.0506, wR2 = 0.1267 
R indices (all data) R1 = 0.0835, wR2 = 0.1485 
Extinction coefficient 0.017(4) 
Largest diff. peak and hole 0.278 and -0.246 e.Å-3 
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Crystal data and structure refinement for 1b 
Identification code ns0533m 
Empirical formula C22 H26 N4 O2 
Formula weight 378.47 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.2088(7) Å α= 92.767(5)°. 
b = 8.7891(6) Å β= 105.536(4)°. 
c = 15.3371(12) Å γ = 115.332(4)°. 
Volume 946.59(13) Å3 
Z 2 
Density (calculated) 1.328 g/cm3 
Absorption coefficient 0.087 mm-1 
F(000) 404 
Crystal size 0.40 x 0.40 x 0.20 mm3 
Theta range for data collection 1.40 to 27.90°. 
Index ranges -9<=h<=10, -10<=k<=11, -19<=l<=19 
Reflections collected 6992 
Independent reflections 4181 [R(int) = 0.0957] 
Completeness to theta = 27.90° 92.3 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4181 / 0 / 271 
Goodness-of-fit on F2 1.325 
Final R indices [I>2sigma(I)] R1 = 0.0738, wR2 = 0.1959 
R indices (all data) R1 = 0.0915, wR2 = 0.2100 
Extinction coefficient 0.040(9) 
Largest diff. peak and hole 0.471 and -0.391 e.Å-3 
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Crystal data and structure refinement for 1c 
Identification code ns0617 
Empirical formula C17 H16 N4 O3 
Formula weight 324.34 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.3089(6) Å α= 85.733(4)°. 
b = 8.9991(7) Å β= 69.174(4)°. 
c = 11.1671(7) Å γ = 77.699(5)°. 
Volume 762.52(9) Å3 
Z 2 
Density (calculated) 1.413 g/cm3 
Absorption coefficient 0.100 mm-1 
F(000) 340 
Crystal size 0.370 x 0.280 x 0.220 mm3 
Theta range for data collection 1.95 to 26.43°. 
Index ranges -10<=h<=10, -11<=k<=11, -13<=l<=13 
Reflections collected 22047 
Independent reflections 3129 [R(int) = 0.1494] 
Completeness to theta = 26.43° 99.5 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3129 / 0 / 229 
Goodness-of-fit on F2 1.161 
Final R indices [I>2sigma(I)] R1 = 0.0863, wR2 = 0.2031 
R indices (all data) R1 = 0.1129, wR2 = 0.2161 
Largest diff. peak and hole 0.590 and -0.683 e.Å-3 
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Crystal data and structure refinement for 1d 
Identification code ns0611 
Empirical formula C17 H14 F2 N4 O2 
Formula weight 344.32 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 7.7430(8) Å α= 90°. 
b = 26.469(3) Å β= 108.8810(10)°. 
c = 7.7443(8) Å γ = 90°. 
Volume 1501.8(3) Å3 
Z 4 
Density (calculated) 1.523 g/cm3 
Absorption coefficient 0.120 mm-1 
F(000) 712 
Crystal size 0.30 x 0.17 x 0.09 mm3 
Theta range for data collection 2.88 to 28.28°. 
Index ranges -9<=h<=10, -34<=k<=34, -10<=l<=10 
Reflections collected 13073 
Independent reflections 3590 [R(int) = 0.0291] 
Completeness to theta = 28.28° 96.6 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3590 / 0 / 236 
Goodness-of-fit on F2 1.064 
Final R indices [I>2sigma(I)] R1 = 0.0487, wR2 = 0.1241 
R indices (all data) R1 = 0.0558, wR2 = 0.1286 
Largest diff. peak and hole  0.429 and -0.218 e.Å-3 
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Crystal data and structure refinement for 2a 
Identification code ns0533 
Empirical formula C22 H26 N4 O2 
Formula weight 378.47 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.2088(7) Å α= 92.767(5)°. 
b = 8.7891(6) Å β= 105.536(4)°. 
c = 15.3371(12) Å γ = 115.332(4)°. 
Volume 946.59(13) Å3 
Z 2 
Density (calculated) 1.328 g/cm3 
Absorption coefficient 0.087 mm-1 
F(000) 404 
Crystal size 0.40 x 0.40 x 0.20 mm3 
Theta range for data collection 1.40 to 27.90°. 
Index ranges -9<=h<=10, -10<=k<=11, -19<=l<=19 
Reflections collected 6992 
Independent reflections 4181 [R(int) = 0.0957] 
Completeness to theta = 27.90° 92.3 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4181 / 0 / 271 
Goodness-of-fit on F2 1.325 
Final R indices [I>2sigma(I)] R1 = 0.0738, wR2 = 0.1959 
R indices (all data) R1 = 0.0915, wR2 = 0.2100 
Extinction coefficient 0.040(9) 
Largest diff. peak and hole 0.471 and -0.391 e.Å-3 
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Crystal data and structure refinement for 2b 
Identification code ns0604 
Empirical formula C18 H16 F2 N4 O3 
Formula weight 374.35 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group C2/c 
Unit cell dimensions a = 33.158(4) Å α= 90°. 
b = 7.3848(7) Å β= 106.439(6)°. 
c = 14.1634(16) Å γ = 90°. 
Volume 3326.4(6) Å3 
Z 8 
Density (calculated) 1.495 g/cm3 
Absorption coefficient 0.119 mm-1 
F(000) 1552 
Crystal size 0.310 x 0.140 x 0.080 mm3 
Theta range for data collection 2.56 to 27.18°. 
Index ranges -42<=h<=41, -9<=k<=9, -18<=l<=18 
Reflections collected 68430 
Independent reflections 3690 [R(int) = 0.2039] 
Completeness to theta = 27.18° 99.2 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3690 / 0 / 260 
Goodness-of-fit on F2 0.876 
Final R indices [I>2sigma(I)] R1 = 0.0558, wR2 = 0.1233 
R indices (all data) R1 = 0.1522, wR2 = 0.1514 
Largest diff. peak and hole 0.259 and -0.229 e.Å-3 
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Crystal data and structure refinement for 2c 
Identification code	 ns0610 
Empirical formula 	 C23 H28 N4 O3 
Formula weight	 408.49 
Temperature  	 100(2) K 
Wavelength  	 0.71073 Å 
Crystal system	 Triclinic 
Space group 	 P-1 
Unit cell dimensions 	 a = 5.3534(5) Å α= 87.7550(10)°. 
b = 12.6941(12) Å β= 82.9210(10)°. 
c = 15.1880(14) Å γ = 87.542(2)°. 
Volume	 1022.72(17) Å3 
Z 	2 
Density (calculated)	 1.327 g/cm3 
Absorption coefficient	 0.090 mm-1 
F(000) 	436 
Crystal size 	 0.42 x 0.14 x 0.06 mm3 
Theta range for data collection 	2.06 to 28.31°. 
Index ranges	 -7<=h<=7, -16<=k<=16, -20<=l<=19 
Reflections collected	 8494 
Independent reflections	 4648 [R(int) = 0.0204] 
Completeness to theta = 28.31° 	 91.4 % 
Absorption correction 	 None 
Refinement method 	 Full-matrix least-squares on F2 
Data / restraints / parameters	 4648 / 0 / 280 
Goodness-of-fit on F2	 1.041 
Final R indices [I>2sigma(I)] 	 R1 = 0.0519, wR2 = 0.1352 
R indices (all data)	 R1 = 0.0711, wR2 = 0.1483 
Largest diff. peak and hole	 0.397 and -0.263 e.Å-3 
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Crystal data and structure refinement for 2d 
Identification code ns0514 
Empirical formula C18 H16 N6 O7 
Formula weight 428.37 
Temperature  203(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 9.5040(9) Å α= 90°. 
b = 21.8091(17) Å β= 111.671(5)°. 
c = 9.9770(8) Å γ = 90°. 
Volume 1921.8(3) Å3 
Z 4 
Density (calculated) 1.481 g/cm3 
Absorption coefficient 0.117 mm-1 
F(000) 888 
Crystal size 0.30 x 0.20 x 0.10 mm3 
Theta range for data collection 1.87 to 28.27°. 
Index ranges -12<=h<=12, -28<=k<=28, -13<=l<=13 
Reflections collected 25722 
Independent reflections 4447 [R(int) = 0.2018] 
Completeness to theta = 28.27° 93.0 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4447 / 0 / 289 
Goodness-of-fit on F2 0.928 
Final R indices [I>2sigma(I)] R1 = 0.0659, wR2 = 0.1451 
R indices (all data) R1 = 0.1673, wR2 = 0.1951 
Largest diff. peak and hole 0.314 and -0.408 e.Å-3 
233 
Crystal data and structure refinement for 2e 
Identification code ns0601 
Empirical formula C18 H16 Cl2 N4 O3 
Formula weight 407.25 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 7.0311(6) Å α= 90°. 
b = 28.119(2) Å β= 99.5930(10)°. 
c = 9.0170(8) Å γ = 90°. 
Volume 1757.8(3) Å3 
Z 4 
Density (calculated) 1.539 g/cm3 
Absorption coefficient 0.398 mm-1 
F(000) 840 
Crystal size 0.36 x 0.30 x 0.19 mm3 
Theta range for data collection 2.40 to 28.27°. 
Index ranges -7<=h<=9, -37<=k<=37, -11<=l<=11 
Reflections collected 11408 
Independent reflections 4125 [R(int) = 0.0316] 
Completeness to theta = 28.27° 94.7 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.758 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4125 / 0 / 255 
Goodness-of-fit on F2 1.196 
Final R indices [I>2sigma(I)] R1 = 0.0444, wR2 = 0.1085 
R indices (all data) R1 = 0.0560, wR2 = 0.1131 
Largest diff. peak and hole 0.448 and -0.359 e.Å-3 
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Crystal data and structure refinement for 6a 
Identification code ns0523 
Empirical formula C20 H16 N6 O7 
Formula weight 452.39 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 7.374(11) Å α= 93.51(10)°. 
b = 8.385(13) Å β= 96.29(7)°. 
c = 17.56(3) Å γ = 104.50(11)°. 
Volume 1040(3) Å3 
Z 2 
Density (calculated) 1.444 Mg/m3 
Absorption coefficient 0.113 mm-1 
F(000) 468 
Crystal size 0.40 x 0.15 x 0.10 mm3 
Theta range for data collection 2.34 to 27.14°. 
Index ranges -9<=h<=9, -10<=k<=10, -20<=l<=22 
Reflections collected 7011 
Independent reflections 4228 [R(int) = 0.2098] 
Completeness to theta = 27.14° 91.7 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4228 / 0 / 301 
Goodness-of-fit on F2 1.042 
Final R indices [I>2sigma(I)] R1 = 0.1139, wR2 = 0.2495 
R indices (all data) R1 = 0.2841, wR2 = 0.3299 
Extinction coefficient 0.057(12) 
Largest diff. peak and hole 0.607 and -0.723 e.Å-3 
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Crystal data and structure refinement for 6b 
Identification code	 ns0602 
Empirical formula 	 C20 H17 N5 O5 
Formula weight	 407.39 
Temperature  	 100(2) K 
Wavelength  	 0.71073 Å 
Crystal system	 Triclinic 
Space group 	 P-1 
Unit cell dimensions 	 a = 6.9157(12) Å α= 87.646(3)°. 
b = 6.9405(12) Å β= 80.636(3)°. 
c = 19.854(4) Å γ = 81.138(3)°. 
Volume	 928.9(3) Å3 
Z 	2 
Density (calculated)	 1.457 g/cm3 
Absorption coefficient	 0.108 mm-1 
F(000) 	424 
Crystal size 	 0.23 x 0.16 x 0.01 mm3 
Theta range for data collection 	2.08 to 26.02°. 
Index ranges 	 -8<=h<=8, -8<=k<=7, -23<=l<=24 
Reflections collected	 4809 
Independent reflections	 3438 [R(int) = 0.0277] 
Completeness to theta = 26.02° 	 93.9 % 
Absorption correction 	 None 
Refinement method 	 Full-matrix least-squares on F2 
Data / restraints / parameters	 3438 / 0 / 282 
Goodness-of-fit on F2	 1.001 
Final R indices [I>2sigma(I)] 	 R1 = 0.0532, wR2 = 0.1136 
R indices (all data)	 R1 = 0.1084, wR2 = 0.1382 
Largest diff. peak and hole	 0.307 and -0.250 e.Å-3 
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Crystal data and structure refinement for 6c 
Identification code ns0609 
Empirical formula C22 H23 N5 O3 
Formula weight 405.45 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 10.5742(19) Å α= 90°. 
b = 14.599(3) Å β= 102.453(11)°. 
c = 13.519(3) Å γ = 90°. 
Volume 2037.9(7) Å3 
Z 4 
Density (calculated) 1.322 g/cm3 
Absorption coefficient 0.091 mm-1 
F(000) 856 
Crystal size ? x ? x ? mm3 
Theta range for data collection 2.42 to 27.22°. 
Index ranges -13<=h<=13, -18<=k<=17, -17<=l<=17 
Reflections collected 44586 
Independent reflections 4534 [R(int) = 0.1870] 
Completeness to theta = 27.22° 99.4 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4534 / 0 / 280 
Goodness-of-fit on F2 1.019 
Final R indices [I>2sigma(I)] R1 = 0.0773, wR2 = 0.1753 
R indices (all data) R1 = 0.1809, wR2 = 0.2304 
Largest diff. peak and hole 0.268 and -0.375 e.Å-3 
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Crystal data and structure refinement for 6d 
Identification code	 ns0526 
Empirical formula 	 C20 H13 F5 N4 O3 
Formula weight	 452.34 
Temperature  	 100(2) K 
Wavelength  	 0.71073 Å 
Crystal system	 Triclinic 
Space group 	 P-1 
Unit cell dimensions 	 a = 6.9203(7) Å α= 79.868(2)°. 
b = 7.3200(8) Å β= 84.1760(10)°. 
c = 19.283(2) Å γ = 77.8480(10)°. 
Volume	 937.90(17) Å3 
Z 	2 
Density (calculated)	 1.602 g/cm3 
Absorption coefficient	 0.143 mm-1 
F(000) 	460 
Crystal size 	 0.32 x 0.30 x 0.12 mm3 
Theta range for data collection 	2.15 to 28.28°. 
Index ranges 	 -8<=h<=8, -9<=k<=9, -25<=l<=25 
Reflections collected 	 10218 
Independent reflections	 4358 [R(int) = 0.0182] 
Completeness to theta = 28.28° 	 93.7 % 
Absorption correction 	 None 
Refinement method 	 Full-matrix least-squares on F2 
Data / restraints / parameters	 4358 / 0 / 300 
Goodness-of-fit on F2	 1.031 
Final R indices [I>2sigma(I)] 	 R1 = 0.0388, wR2 = 0.1010 
R indices (all data)	 R1 = 0.0466, wR2 = 0.1060 
Largest diff. peak and hole	 0.323 and -0.235 e.Å-3 
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Table B.2 Crystal data and structure refinement for 7, 7a-7f 
7 
Identification code ns0603 
Empirical formula C10 H10 N4 
Formula weight 186.22 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Orthorhombic 
Space group P2(1)2(1)2(1) 
Unit cell dimensions a = 5.5629(4) Å α= 90°. 
b = 7.4679(6) Å β= 90°. 
c = 22.1080(18) Å γ = 90°. 
Volume 918.44(12) Å3 
Z 4 
Density (calculated) 1.347 Mg/m3 
Absorption coefficient 0.087 mm-1 
F(000) 392 
Crystal size 0.10 x 0.24 x 0.25 mm3 
Theta range for data collection 1.84 to 28.29°. 
Index ranges -7<=h<=7, -9<=k<=9, -29<=l<=29 
Reflections collected 8151 
Independent reflections 1333 [R(int) = 0.0259] 
Completeness to theta = 28.29° 98.2 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1333 / 0 / 134 
Goodness-of-fit on F2 1.050 
Final R indices [I>2sigma(I)] R1 = 0.0365, wR2 = 0.1003 
R indices (all data) R1 = 0.0383, wR2 = 0.1022 
Absolute structure parameter 1(3) 
Largest diff. peak and hole 0.291 and -0.172 e.Å-3 
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Crystal data and structure refinement for 7(1) 
Identification code ns0641 
Empirical formula C10 H10 N4 
Formula weight 186.22 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 12.7944(9) Å α= 90°. 
b = 12.9712(9) Å β= 90.246(4)°. 
c = 23.1035(15) Å γ = 90°. 
Volume 3834.2(5) Å3 
Z 16 
Density (calculated) 1.290 g/cm3 
Absorption coefficient 0.083 mm-1 
F(000) 1568 
Crystal size 0.560 x 0.440 x 0.220 mm3 
Theta range for data collection 1.57 to 26.58°. 
Index ranges -16<=h<=16, -16<=k<=16, -29<=l<=29 
Reflections collected 81780 
Independent reflections 7976 [R(int) = 0.1643] 
Completeness to theta = 26.58° 99.6 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7976 / 0 / 510 
Goodness-of-fit on F2 1.260 
Final R indices [I>2sigma(I)] R1 = 0.1079, wR2 = 0.2650 
R indices (all data) R1 = 0.1495, wR2 = 0.3066 
Largest diff. peak and hole 1.030 and -0.680 e.Å-3 
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Crystal data and structure refinement for 7a 
Identification code ns0625 
Empirical formula C17 H16 N4 O3 
Formula weight 324.34 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 9.3896(7) Å α= 90°. 
b = 9.5195(7) Å β= 93.833(4)°. 
c = 17.5881(12) Å γ = 90°. 
Volume 1568.6(2) Å3 
Z 4 
Density (calculated) 1.373 g/cm3 
Absorption coefficient 0.097 mm-1 
F(000) 680 
Crystal size 0.450 x 0.410 x 0.260 mm3 
Theta range for data collection 2.39 to 27.19°. 
Index ranges -12<=h<=12, -12<=k<=12, -22<=l<=22 
Reflections collected 39361 
Independent reflections 3480 [R(int) = 0.1389] 
Completeness to theta = 27.19° 99.8 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3480 / 0 / 229 
Goodness-of-fit on F2 1.093 
Final R indices [I>2sigma(I)] R1 = 0.0678, wR2 = 0.1705 
R indices (all data) R1 = 0.0830, wR2 = 0.1794 
Largest diff. peak and hole 0.591 and -0.515 e.Å-3 
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Crystal data and structure refinement for 7b 
Identification code ns0628 
Empirical formula C17 H16 N4 O3 
Formula weight 324.34 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.1179(5) Å α= 63.121(4)°. 
b = 10.2654(6) Å β= 78.189(4)°. 
c = 10.3655(6) Å γ = 80.757(4)°. 
Volume 751.86(8) Å3 
Z 2 
Density (calculated) 1.433 g/cm3 
Absorption coefficient 0.101 mm-1 
F(000) 340 
Crystal size 0.340 x 0.160 x 0.120 mm3 
Theta range for data collection 3.10 to 27.53°. 
Index ranges -10<=h<=10, -13<=k<=13, -13<=l<=12 
Reflections collected 18176 
Independent reflections 3442 [R(int) = 0.2027] 
Completeness to theta = 27.54° 99.3 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3442 / 0 / 230 
Goodness-of-fit on F2 0.857 
Final R indices [I>2sigma(I)] R1 = 0.0707, wR2 = 0.1392 
R indices (all data) R1 = 0.1771, wR2 = 0.1749 
Largest diff. peak and hole 0.304 and -0.339 e.Å-3 
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Crystal data and structure refinement for 7c 
Identification code ns0614 
Empirical formula C17 H14 N6 O6 
Formula weight 398.34 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system Orthorhombic 
Space group P2(1)2(1)2(1) 
Unit cell dimensions a = 6.2321(14) Å α= 90°. 
b = 11.369(2) Å β= 90°. 
c = 25.320(5) Å γ = 90°. 
Volume 1794.0(7) Å3 
Z 4 
Density (calculated) 1.475 g/cm3 
Absorption coefficient 0.115 mm-1 
F(000) 824 
Crystal size 0.500 x 0.220 x 0.170 mm3 
Theta range for data collection 2.41 to 26.35°. 
Index ranges -7<=h<=7, -14<=k<=14, -31<=l<=30 
Reflections collected 22642 
Independent reflections 2119 [R(int) = 0.1936] 
Completeness to theta = 26.35° 99.2 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2119 / 0 / 263 
Goodness-of-fit on F2 0.891 
Final R indices [I>2sigma(I)] R1 = 0.0637, wR2 = 0.1529 
R indices (all data) R1 = 0.1287, wR2 = 0.1739 
Absolute structure parameter -5(3) 
Largest diff. peak and hole 0.259 and -0.295 e.Å-3 
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Crystal data and structure refinement for 7d 
Identification code ns0607 
Empirical formula C24 H18 N8 O12 
Formula weight 610.46 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 7.7509(6) Å α= 98.7900(10)°. 
b = 11.8158(8) Å β= 102.3690(10)°. 
c = 14.5927(10) Å γ = 101.4610(10)°. 
Volume 1252.46(15) Å3 
Z 2 
Density (calculated) 1.619 g/cm3 
Absorption coefficient 0.133 mm-1 
F(000) 628 
Crystal size 0.36 x 0.32 x 0.27 mm3 
Theta range for data collection 1.80 to 28.28°. 
Index ranges -10<=h<=10, -15<=k<=15, -18<=l<=19 
Reflections collected 11132 
Independent reflections 5761 [R(int) = 0.0172] 
Completeness to theta = 28.28° 92.7 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5761 / 0 / 409 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0394, wR2 = 0.1028 
R indices (all data) R1 = 0.0464, wR2 = 0.1078 
Largest diff. peak and hole 0.322 and -0.389 e.Å-3 
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Crystal data and structure refinement for 7e 
Identification code ns0612 
Empirical formula C26 H24 Br2 N4 O4 
Formula weight 616.31 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1) 
Unit cell dimensions a = 8.8985(15) Å α= 90°. 
b = 12.542(2) Å β= 93.343(10)°. 
c = 11.395(2) Å γ = 90°. 
Volume 1269.6(4) Å3 
Z 2 
Density (calculated) 1.612 Mg/m3 
Absorption coefficient 3.233 mm-1 
F(000) 620 
Crystal size 0.460 x 0.200 x 0.140 mm3 
Theta range for data collection 2.42 to 27.33°. 
Index ranges -11<=h<=11, -16<=k<=16, -14<=l<=14 
Reflections collected 65470 
Independent reflections 5645 [R(int) = 0.1296] 
Completeness to theta = 27.33° 98.8 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5645 / 1 / 329 
Goodness-of-fit on F2 0.952 
Final R indices [I>2sigma(I)] R1 = 0.0620, wR2 = 0.1494 
R indices (all data) R1 = 0.1436, wR2 = 0.1809 
Absolute structure parameter 0.191(18) 
Largest diff. peak and hole 1.053 and -0.479 e.Å-3 
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Crystal data and structure refinement for 7f 
Identification code ns0621 
Empirical formula C29 H27 F5 N4 O4 
Formula weight 590.55 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.7406(5) Å α= 97.769(3)°. 
b = 9.2684(5) Å β= 92.821(4)°. 
c = 17.1083(9) Å γ = 106.978(3)°. 
Volume 1307.63(12) Å3 
Z 2 
Density (calculated) 1.500 g/cm3 
Absorption coefficient 0.125 mm-1 
F(000) 612 
Crystal size 0.250 x 0.140 x 0.120 mm3 
Theta range for data collection 2.45 to 27.15°. 
Index ranges -11<=h<=11, -11<=k<=11, -21<=l<=21 
Reflections collected 50487 
Independent reflections 5737 [R(int) = 0.2262] 
Completeness to theta = 27.15° 99.1 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5737 / 0 / 398 
Goodness-of-fit on F2 0.980 
Final R indices [I>2sigma(I)] R1 = 0.0829, wR2 = 0.1694 
R indices (all data) R1 = 0.1913, wR2 = 0.2177 
Largest diff. peak and hole 0.405 and -0.376 e.Å-3 
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Table B.3 Crystal data and structure refinement for 14, 8a, 13a, 8b, 13b, 14a, 8c, 14b 
14 
Identification code ns0624 
Empirical formula C7 H Br F4 O2 
Formula weight 272.99 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 4.3494(5) Å α= 90°. 
b = 15.8920(18) Å β= 100.463(8)°. 
c = 11.3932(14) Å γ = 90°. 
Volume 774.41(16) Å3 
Z 4 
Density (calculated) 2.341 g/cm3 
Absorption coefficient 5.347 mm-1 
F(000) 520 
Crystal size 0.45 x 0.40 x 0.15 mm3 
Theta range for data collection 2.22 to 28.22°. 
Index ranges -5<=h<=5, -20<=k<=20, -15<=l<=14 
Reflections collected 8772 
Independent reflections 1811 [R(int) = 0.0767] 
Completeness to theta = 28.22° 94.9 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.267 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1811 / 0 / 127 
Goodness-of-fit on F2 1.072 
Final R indices [I>2sigma(I)] R1 = 0.0547, wR2 = 0.1333 
R indices (all data) R1 = 0.0949, wR2 = 0.1670 
Largest diff. peak and hole 1.449 and -1.031 e.Å-3 
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Crystal data and structure refinement for 8a 
Identification code	 ns0636 
Empirical formula 	 C41 H38 I2 N8 O4 
Formula weight	 960.59 
Temperature  	 293(2) K 
Wavelength  	 0.71073 Å 
Crystal system	 Triclinic 
Space group 	 P-1 
Unit cell dimensions 	 a = 6.5689(2) Å α= 102.542(2)°. 
b = 9.5508(4) Å β= 99.117(2)°. 
c = 16.4413(6) Å γ = 96.534(2)°. 
Volume	 982.34(6) Å3 
Z 	1 
Density (calculated)	 1.624 g/cm3 
Absorption coefficient	 1.653 mm-1 
F(000) 	478 
Crystal size 	 0.200 x 0.180 x 0.160 mm3 
Theta range for data collection 	3.18 to 27.50°. 
Index ranges	 -8<=h<=8, -12<=k<=12, -21<=l<=21 
Reflections collected 	 38388 
Independent reflections	 4495 [R(int) = 0.0384] 
Completeness to theta = 27.50° 	 99.5 % 
Absorption correction 	 Semi-empirical from equivalents 
Max. and min. transmission 	 1.000 and 0.930 
Refinement method 	 Full-matrix least-squares on F2 
Data / restraints / parameters	 4495 / 0 / 290 
Goodness-of-fit on F2	 1.056 
Final R indices [I>2sigma(I)] 	 R1 = 0.0216, wR2 = 0.0517 
R indices (all data)	 R1 = 0.0241, wR2 = 0.0532 
Largest diff. peak and hole	 0.873 and -0.772 e.Å-3 
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Crystal data and structure refinement for 13a 
Identification code ns0626 
Empirical formula C17 H11 F4 I N4 O2 
Formula weight 506.20 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 6.6313(15) Å α= 90°. 
b = 34.494(8) Å β= 103.151(16)°. 
c = 7.6535(18) Å γ = 90°. 
Volume 1704.8(7) Å3 
Z 4 
Density (calculated) 1.972 g/cm3 
Absorption coefficient 1.943 mm-1 
F(000) 984 
Crystal size 0.45 x 0.15 x 0.05 mm3 
Theta range for data collection 1.18 to 28.76°. 
Index ranges -8<=h<=8, -44<=k<=45, -10<=l<=9 
Reflections collected 12690 
Independent reflections 4007 [R(int) = 0.1594] 
Completeness to theta = 28.76° 90.6 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4007 / 0 / 254 
Goodness-of-fit on F2 0.944 
Final R indices [I>2sigma(I)] R1 = 0.0664, wR2 = 0.1606 
R indices (all data) R1 = 0.0999, wR2 = 0.1768 
Largest diff. peak and hole 1.721 and -3.059 e.Å-3 
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Crystal data and structure refinement for 8b 
Identification code ns0618 
Empirical formula C17 H15 I N4 O2 
Formula weight 434.23 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 7.9304(7) Å α= 109.850(3)°. 
b = 10.0937(9) Å β= 96.640(4)°. 
c = 11.1149(10) Å γ = 96.096(4)°. 
Volume 821.10(13) Å3 
Z 2 
Density (calculated) 1.756 Mg/m3 
Absorption coefficient 1.968 mm-1 
F(000) 428 
Crystal size 0.460 x 0.300 x 0.280 mm3 
Theta range for data collection 1.97 to 27.48°. 
Index ranges -10<=h<=10, -12<=k<=13, -14<=l<=14 
Reflections collected 25406 
Independent reflections 3768 [R(int) = 0.0787] 
Completeness to theta = 27.48° 99.7 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3768 / 0 / 218 
Goodness-of-fit on F2 1.076 
Final R indices [I>2sigma(I)] R1 = 0.0360, wR2 = 0.0947 
R indices (all data) R1 = 0.0385, wR2 = 0.0966 
Largest diff. peak and hole 1.103 and -0.868 e.Å-3 
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Crystal data and structure refinement for 13b 
Identification code ns0629 
Empirical formula C17 H11 F4 I N4 O2 
Formula weight 506.20 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 3.9153(3) Å α= 90°. 
b = 24.016(2) Å β= 92.995(4)°. 
c = 18.1909(15) Å γ = 90°. 
Volume 1708.1(2) Å3 
Z 4 
Density (calculated) 1.968 g/cm3 
Absorption coefficient 1.939 mm-1 
F(000) 984 
Crystal size 0.580 x 0.140 x 0.080 mm3 
Theta range for data collection 2.78 to 27.13°. 
Index ranges -5<=h<=5, -30<=k<=29, -23<=l<=22 
Reflections collected 40104 
Independent reflections 3737 [R(int) = 0.1383] 
Completeness to theta = 27.13° 99.7 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3737 / 0 / 257 
Goodness-of-fit on F2 1.019 
Final R indices [I>2sigma(I)] R1 = 0.0433, wR2 = 0.1079 
R indices (all data) R1 = 0.0599, wR2 = 0.1189 
Largest diff. peak and hole  0.796 and -0.991 e.Å-3 
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Crystal data and structure refinement for 14a 
Identification code ns0639 
Empirical formula C17 H11 Br F4 N4 O2 
Formula weight 459.21 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 3.79850(10) Å α= 90°. 
b = 24.2190(7) Å β= 93.6890(10)°. 
c = 18.1436(5) Å γ = 90°. 
Volume 1665.68(8) Å3 
Z 4 
Density (calculated) 1.831 Mg/m3 
Absorption coefficient 2.534 mm-1 
F(000) 912 
Crystal size 0.500 x 0.210 x 0.140 mm3 
Theta range for data collection 3.36 to 27.12°. 
Index ranges -4<=h<=4, -31<=k<=30, -23<=l<=23 
Reflections collected 42293 
Independent reflections 3662 [R(int) = 0.0370] 
Completeness to theta = 27.12° 99.7 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.882 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3662 / 0 / 263 
Goodness-of-fit on F2 1.050 
Final R indices [I>2sigma(I)] R1 = 0.0243, wR2 = 0.0628 
R indices (all data) R1 = 0.0304, wR2 = 0.0655 
Largest diff. peak and hole 0.356 and -0.353 e.Å-3 
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Crystal data and structure refinement for 8c 
Identification code	 ns0633 
Empirical formula 	 C20 H17 I N4 O3 
Formula weight	 488.28 
Temperature  	 293(2) K 
Wavelength  	 0.71073 Å 
Crystal system	 Triclinic 
Space group 	 P-1 
Unit cell dimensions 	 a = 6.7820(5) Å α= 103.905(4)°. 
b = 8.9813(7) Å β= 95.254(4)°. 
c = 16.6932(11) Å γ = 100.313(5)°. 
Volume	 961.37(12) Å3 
Z 	2 
Density (calculated)	 1.687 g/cm3 
Absorption coefficient	 1.695 mm-1 
F(000) 	484 
Crystal size 	 0.380 x 0.120 x 0.080 mm3 
Theta range for data collection 	2.39 to 27.62°. 
Index ranges	 -8<=h<=8, -11<=k<=11, -21<=l<=21 
Reflections collected 	 39877 
Independent reflections	 4426 [R(int) = 0.2269] 
Completeness to theta = 27.62° 	 98.8 % 
Absorption correction 	 Semi-empirical from equivalents 
Max. and min. transmission 	 1.000 and 0.671 
Refinement method 	 Full-matrix least-squares on F2 
Data / restraints / parameters	 4426 / 0 / 258 
Goodness-of-fit on F2	 1.017 
Final R indices [I>2sigma(I)] 	 R1 = 0.0745, wR2 = 0.1835 
R indices (all data)	 R1 = 0.0954, wR2 = 0.1928 
Largest diff. peak and hole	 1.095 and -1.139 e.Å-3 
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Crystal data and structure refinement for 14b 
Identification code	 ns0632 
Empirical formula 	 C20 H13 Br F4 N4 O3 
Formula weight	 513.25 
Temperature  	 293(2) K 
Wavelength  	 0.71073 Å 
Crystal system	 Triclinic 
Space group 	 P-1 
Unit cell dimensions 	 a = 6.8878(2) Å α= 80.331(2)°. 
b = 7.4613(2) Å β= 88.064(2)°. 
c = 19.6275(7) Å γ = 77.591(2)°. 
Volume	 971.13(5) Å3 
Z 	2 
Density (calculated)	 1.755 g/cm3 
Absorption coefficient	 2.187 mm-1 
F(000) 	512 
Crystal size 	 0.360 x 0.290 x 0.100 mm3 
Theta range for data collection 	2.11 to 27.10°. 
Index ranges 	 -8<=h<=8, -9<=k<=9, -25<=l<=25 
Reflections collected 	 24991 
Independent reflections	 4292 [R(int) = 0.0374] 
Completeness to theta = 27.10° 	 99.9 % 
Absorption correction 	 Semi-empirical from equivalents 
Max. and min. transmission 	 1.000 and 0.921 
Refinement method 	 Full-matrix least-squares on F2 
Data / restraints / parameters	 4292 / 0 / 300 
Goodness-of-fit on F2	 1.213 
Final R indices [I>2sigma(I)] 	 R1 = 0.0246, wR2 = 0.0765 
R indices (all data)	 R1 = 0.0293, wR2 = 0.0968 
Largest diff. peak and hole	 0.396 and -0.370 e.Å-3 
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Table B.4 Crystal data and structure refinement for 16, 1e, 1f, 15a, 15b, 6e, 16a, 16b, 
15c, 15d, 1g, 6f, 6g, and 6h 
16 
Identification code ns0413 
Empirical formula 
Formula weight 
Temperature  
Wavelength  
Crystal system 
Space group 
Unit cell dimensions 
Volume
Z 
C12 H9 N3 
195.22 
100(2) K 
0.71073 Å 
Monoclinic 
P2(1)/c 
a = 8.6286(6) Å 
b = 15.3249(10) Å 
c = 8.1780(6) Å 
 976.00(12) Å3 
4 
α= 90°. 
β= 115.5070(10)°. 
γ = 90°. 
Density (calculated) 
Absorption coefficient 
F(000) 
Crystal size 
Theta range for data collection 
1.329 g/cm3 
0.083 mm-1 
408 
0.56 x 0.50 x 0.24 mm3 
2.62 to 30.02°. 
Index ranges -12<=h<=12, -21<=k<=21, -11<=l<=11 
Reflections collected 11007 
Independent reflections 2834 [R(int) = 0.0195] 
Completeness to theta = 30.02° 99.3 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.832 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2834 / 0 / 142 
Goodness-of-fit on F2 1.464 
Final R indices [I>2sigma(I)] R1 = 0.0563, wR2 = 0.1780 
R indices (all data) R1 = 0.0624, wR2 = 0.1887 
Largest diff. peak and hole 0.381 and -0.505 e.Å-3 
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Crystal data and structure refinement for 1e 
Identification code ns0409 
Empirical formula C28 H32 Cu2 N8 O8 
Formula weight 735.70 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 8.0282(5) Å α= 90°. 
b = 10.6399(7) Å β= 99.3600(10)°. 
c = 18.9041(13) Å γ = 90°. 
Volume 1593.27(18) Å3 
Z 2 
Density (calculated) 1.534 g/cm3 
Absorption coefficient 1.396 mm-1 
F(000) 756 
Crystal size 0.16 x 0.28 x 0.38 mm3 
Theta range for data collection 2.18 to 30.00°. 
Index ranges -11<=h<=11, -14<=k<=14, -26<=l<=26 
Reflections collected 17891 
Independent reflections 4630 [R(int) = 0.0237] 
Completeness to theta = 30.00° 99.8 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4630 / 0 / 217 
Goodness-of-fit on F2 1.052 
Final R indices [I>2sigma(I)] R1 = 0.0276, wR2 = 0.0751 
R indices (all data) R1 = 0.0301, wR2 = 0.0767 
Largest diff. peak and hole 0.553 and -0.315 e.Å-3 
256 
Crystal data and structure refinement for 1f 
Identification code ns0426 
Empirical formula  C48 H36 Cu2 F4 N8 O8 
Formula weight  1055.93 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 21.3553(18) Å α= 90°. 
b = 17.9389(15) Å β= 90.742(5)°. 
c = 11.4887(9) Å γ = 90°. 
Volume 4400.8(6) Å3 
Z 4 
Density (calculated) 1.594 g/cm3 
Absorption coefficient 1.050 mm-1 
F(000) 2152 
Crystal size 0.40 x 0.20 x 0.10 mm3 
Theta range for data collection 1.48 to 28.30°. 
Index ranges -26<=h<=27, -23<=k<=23, -15<=l<=14 
Reflections collected 31431 
Independent reflections 9998 [R(int) = 0.0734] 
Completeness to theta = 28.30° 91.3 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9998 / 0 / 658 
Goodness-of-fit on F2 0.984 
Final R indices [I>2sigma(I)] R1 = 0.0470, wR2 = 0.1060 
R indices (all data) R1 = 0.0965, wR2 = 0.1240 
Largest diff. peak and hole 0.486 and -0.534 e.Å-3 
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Crystal data and structure refinement for 15a 
Identification code ns0405 
Empirical formula C28 H32 Cu2 N8 O10 
Formula weight 767.70 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.2800(6) Å α= 71.144(4)°. 
b = 9.3983(6) Å β= 81.585(4)°. 
c = 11.2233(7) Å γ = 79.240(4)°. 
Volume 808.49(9) Å3 
Z 1 
Density (calculated) 1.577 g/cm3 
Absorption coefficient 1.383 mm-1 
F(000) 394 
Crystal size 0.40 x 0.15 x 0.10 mm3 
Theta range for data collection 2.32 to 28.24°. 
Index ranges -10<=h<=9, -12<=k<=12, -13<=l<=14 
Reflections collected 6060 
Independent reflections 3638 [R(int) = 0.0224] 
Completeness to theta = 28.24° 91.2 % 
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3638 / 0 / 223 
Goodness-of-fit on F2 1.300 
Final R indices [I>2sigma(I)] R1 = 0.0376, wR2 = 0.0935 
R indices (all data) R1 = 0.0482, wR2 = 0.0999 
Largest diff. peak and hole 0.371 and -0.707 e.Å-3 
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Crystal data and structure refinement for 15b 
Identification code ns0425 
Empirical formula  C48 H36 Cu2 F4 N8 O10 
Formula weight  1087.93 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 10.1310(9) Å α= 64.853(5)°. 
b = 10.5499(8) Å β= 86.149(5)°. 
c = 12.2936(9) Å γ = 67.896(4)°. 
Volume 1095.24(15) Å3 
Z 1 
Density (calculated) 1.649 g/cm3 
Absorption coefficient 1.061 mm-1 
F(000) 554 
Crystal size 0.20 x 0.15 x 0.10 mm3 
Theta range for data collection 2.18 to 27.85°. 
Index ranges -13<=h<=13, -13<=k<=13, -16<=l<=15 
Reflections collected 7872 
Independent reflections 4793 [R(int) = 0.0785] 
Completeness to theta = 27.85° 91.9 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4793 / 4 / 335 
Goodness-of-fit on F2 1.043 
Final R indices [I>2sigma(I)] R1 = 0.0580, wR2 = 0.1523 
R indices (all data) R1 = 0.0725, wR2 = 0.1635 
Largest diff. peak and hole 0.736 and -0.759 e.Å-3 
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Crystal data and structure refinement for 6e 
Identification code ns0509 
Empirical formula C36.80 H41.40 Cu2 N8.80 O10.60 
Formula weight 903.67 
Temperature  95.2(2) K 
Wavelength  1.54178 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 12.4743(2) Å α= 84.7880(10)°. 
b = 15.3416(2) Å β= 79.0650(10)°. 
c = 21.9472(3) Å γ = 83.7960(10)°. 
Volume 4089.09(10) Å3 
Z 1 
Density (calculated) 1.153 g/cm3 
Absorption coefficient 3.538 mm-1 
F(000) 1480 
Crystal size 0.45 x 0.45 x 0.12 mm3 
Theta range for data collection 3.83 to 64.94°. 
Index ranges -13<=h<=14, -17<=k<=17, -25<=l<=25 
Reflections collected 35498 
Independent reflections 19633 [R(int) = 0.0207] 
Completeness to theta 94.7 % 
Absorption correction empirical multi-scans (SADABS) 
Max. and min. transmission 0.6762 and 0.2989 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 19633 / 3031 / 1845 
Goodness-of-fit on F2 0.967 
Final R indices [I>2sigma(I)] R1 = 0.0564, wR2 = 0.1617 
R indices (all data) R1 = 0.0579, wR2 = 0.1647 
Largest diff. peak and hole 1.112 and -0.579 e.Å-3 
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Crystal data and structure refinement for 16a 
Identification code ns0428 
Empirical formula  C40 H25 Cu2 F4 N3 O8 
Formula weight 878.71 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 9.3471(9) Å α= 90°. 
b = 15.5850(15) Å β= 104.714(7)°. 
c = 12.9025(11) Å γ = 90°. 
Volume 1817.9(3) Å3 
Z 2 
Density (calculated) 1.605 g/cm3 
Absorption coefficient 1.250 mm-1 
F(000) 888 
Crystal size 0.15 x 0.15 x 0.05 mm3 
Theta range for data collection 2.09 to 28.30°. 
Index ranges -12<=h<=12, -19<=k<=18, -14<=l<=16 
Reflections collected 12614 
Independent reflections 4188 [R(int) = 0.1368] 
Completeness to theta = 28.30° 92.4 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4188 / 0 / 271 
Goodness-of-fit on F2 0.894 
Final R indices [I>2sigma(I)] R1 = 0.0598, wR2 = 0.1275 
R indices (all data) R1 = 0.1077, wR2 = 0.1457 
Extinction coefficient 0.0081(10) 
Largest diff. peak and hole 0.703 and -0.653 e.Å-3 
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Crystal data and structure refinement for 16b 
Identification code ns0508 
Empirical formula C20 H21 Cu2 N3 O8 
Formula weight 558.48 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.1368(11) Å α= 86.244(3)°. 
b = 8.3062(11) Å β= 80.480(3)°. 
c = 8.7490(12) Å γ = 80.539(3)°. 
Volume 574.79(13) Å3 
Z 1 
Density (calculated) 1.613 g/cm3 
Absorption coefficient 1.900 mm-1 
F(000) 284 
Crystal size 0.09 x 0.10 x 0.30 mm3 
Theta range for data collection 2.36 to 30.08°. 
Index ranges -11<=h<=11, -11<=k<=11, -12<=l<=12 
Reflections collected 11035 
Independent reflections 11035 [R(int) = 0.0000] 
Completeness to theta = 30.08° 96.3 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11035 / 0 / 155 
Goodness-of-fit on F2 0.969 
Final R indices [I>2sigma(I)] R1 = 0.0553, wR2 = 0.1354 
R indices (all data) R1 = 0.0655, wR2 = 0.1398 
Largest diff. peak and hole 1.186 and -0.576 e.Å-3 
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Crystal data and structure refinement for 15c 
Identification code ns0411 
Empirical formula C32 H24 Cl6 Cu F12 N8 O6 
Formula weight  1120.83 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 10.4149(6) Å α= 105.6980(10)°. 
b = 12.1682(7) Å β= 105.8970(10)°. 
c = 18.2488(10) Å γ = 93.1160(10)°. 
Volume 2120.6(2) Å3 
Z 2 
Density (calculated) 1.755 g/cm3 
Absorption coefficient 1.000 mm-1 
F(000) 1118 
Crystal size 0.38 x 0.18 x 0.12 mm3 
Theta range for data collection 1.76 to 30.00°. 
Index ranges -14<=h<=14, -17<=k<=16, -25<=l<=25 
Reflections collected 24652 
Independent reflections 12133 [R(int) = 0.0257] 
Completeness to theta = 30.00° 98.1 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.840 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12133 / 36 / 615 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.0459, wR2 = 0.1182 
R indices (all data) R1 = 0.0572, wR2 = 0.1263 
Largest diff. peak and hole 1.594 and -0.565 e.Å-3 
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Crystal data and structure refinement for 15d 
Identification code ns0410 
Empirical formula C50 H42 Co N8 O6 
Formula weight 909.85 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 9.3368(7) Å α= 85.536(2)°. 
b = 10.3686(8) Å β= 79.677(2)°. 
c = 11.0609(8) Å γ = 83.026(2)°. 
Volume 1043.95(14) Å3 
Z 1 
Density (calculated) 1.447 g/cm3 
Absorption coefficient 0.475 mm-1 
F(000) 473 
Crystal size 0.04 x 0.09 x 0.38 mm3 
Theta range for data collection 1.87 to 30.00°. 
Index ranges -13<=h<=12, -14<=k<=14, -15<=l<=14 
Reflections collected 12145 
Independent reflections 5980 [R(int) = 0.0228] 
Completeness to theta = 30.00° 98.1 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.79 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5980 / 0 / 301 
Goodness-of-fit on F2 1.060 
Final R indices [I>2sigma(I)] R1 = 0.0462, wR2 = 0.1079 
R indices (all data) R1 = 0.0536, wR2 = 0.1121 
Largest diff. peak and hole 0.673 and -0.271 e.Å-3 
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Crystal data and structure refinement for 1g 
Identification code ns0412 
Empirical formula C32 H26 Cl2 Cu F12 N8 O4 
Formula weight 949.05 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 8.2843(4) Å α= 113.0810(10)°. 
b = 10.8750(5) Å β= 94.4120(10)°. 
c = 11.7573(6) Å γ = 103.8330(10)°. 
Volume 928.75(8) Å3 
Z 1 
Density (calculated) 1.697 g/cm3 
Absorption coefficient 0.843 mm-1 
F(000) 477 
Crystal size 0.20 x 0.36 x 0.53 mm3 
Theta range for data collection 2.13 to 30.03°. 
Index ranges -11<=h<=11, -15<=k<=15, -16<=l<=15 
Reflections collected 10734 
Independent reflections 5322 [R(int) = 0.0160] 
Completeness to theta = 30.03° 97.9 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.816 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5322 / 0 / 274 
Goodness-of-fit on F2 1.036 
Final R indices [I>2sigma(I)] R1 = 0.0376, wR2 = 0.1055 
R indices (all data) R1 = 0.0405, wR2 = 0.1077 
Largest diff. peak and hole 0.866 and -0.358 e.Å-3 
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Crystal data and structure refinement for 6f 
Identification code ns0415 
Empirical formula C23 H14 Cu F12 N4 O5 
Formula weight 717.92 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 9.6243(11) Å α= 85.905(2)°. 
b = 10.4481(12) Å β= 86.300(2)°. 
c = 13.8822(15) Å γ = 74.690(2)°. 
Volume 1341.4(3) Å3 
Z 2 
Density (calculated) 1.777 g/cm3 
Absorption coefficient 0.941 mm-1 
F(000) 714 
Crystal size 0.32 x 0.28 x 0.18 mm3 
Theta range for data collection 2.02 to 30.08°. 
Index ranges -13<=h<=13, -14<=k<=14, -17<=l<=19 
Reflections collected 15237 
Independent reflections 7644 [R(int) = 0.0260] 
Completeness to theta = 30.08° 96.9 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.698 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7644 / 6 / 420 
Goodness-of-fit on F2 1.029 
Final R indices [I>2sigma(I)] R1 = 0.0467, wR2 = 0.1261 
R indices (all data) R1 = 0.0583, wR2 = 0.1333 
Largest diff. peak and hole 1.243 and -0.649 e.Å-3 
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Crystal data and structure refinement for 6g 
Identification code ns0416 
Empirical formula C56 H46 Co N8 O6 
Formula weight 985.94 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 10.5076(5) Å α= 68.9160(10)°. 
b = 10.7568(6) Å β= 82.6200(10)°. 
c = 11.9544(6) Å γ = 69.1900(10)°. 
Volume 1178.48(10) Å3 
Z 1 
Density (calculated) 1.389 g/cm3 
Absorption coefficient 0.427 mm-1 
F(000) 513 
Crystal size 0.35 x 0.20 x 0.10 mm3 
Theta range for data collection 2.07 to 30.02°. 
Index ranges -14<=h<=14, -15<=k<=15, -16<=l<=16 
Reflections collected 13759 
Independent reflections 6762 [R(int) = 0.0238] 
Completeness to theta = 30.02° 98.2 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.823 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6762 / 0 / 328 
Goodness-of-fit on F2 1.037 
Final R indices [I>2sigma(I)] R1 = 0.0429, wR2 = 0.1081 
R indices (all data)     R1 = 0.0470, wR2 = 0.1111 
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Crystal data and structure refinement for 6h 
Identification code ns0429 
Empirical formula C56 H46 N8 Ni O6 
Formula weight 985.72 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 10.4666(7) Å α= 68.678(4)°. 
b = 10.6669(7) Å β= 82.626(4)°. 
c = 11.9828(8) Å γ = 69.230(3)°. 
Volume 1165.27(13) Å3 
Z 1 
Density (calculated) 1.405 g/cm3 
Absorption coefficient 0.480 mm-1 
F(000) 514 
Crystal size 0.45 x 0.20 x 0.10 mm3 
Theta range for data collection 1.82 to 27.84°. 
Index ranges -13<=h<=12, -13<=k<=13, -15<=l<=15 
Reflections collected 11668 
Independent reflections 5170 [R(int) = 0.1241] 
Completeness to theta = 27.84° 93.4 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5170 / 0 / 329 
Goodness-of-fit on F2 0.982 
Final R indices [I>2sigma(I)] R1 = 0.0570, wR2 = 0.1355 
R indices (all data) R1 = 0.0788, wR2 = 0.1470 
Extinction coefficient 0.022(3) 
Largest diff. peak and hole 0.427 and -0.495 e.Å-3 
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Table B.5 Crystal data and structure refinement for 19, 19(1), 20, 20(1), 20a, 20b, 21-24, 
25a and 25b 
19 
Identification code ns0501 
Empirical formula 
Formula weight  
Temperature  
Wavelength  
Crystal system 
Space group 
Unit cell dimensions 
Volume
Z 
C54 H63 Br4 O8 N 
1173.69 
100(2) K 
0.71073 Å 
Triclinic 
Pī 
a = 10.7767(7) Å 
b = 11.6740(7) Å 
c = 20.8192 Å 
 2510.8(3) Å3 
2 
α= 80.392(4)°. 
β= 97.977(3)°. 
γ = 76.503(3)°. 
Density (calculated) 
Absorption coefficient 
Crystal size 
Theta range for data collection 
Reflections collected 
1.552 g/cm3 
3.261 mm-1 
0.30 x 0.25 x 0.20 mm3 
1.82 to 28.28°. 
18907 
Independent reflections 
Absorption correction 
Refinement method 
Goodness-of-fit on F2
9466 
None 
Full-matrix least-squares on F2 
 1.097 
Final R indices [I>2sigma(I)] 
R indices (all data) 
R1 = 0.0287 
R1 = 0.0330, wR2 = 0.0877 
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Crystal data and structure refinement for 19(1) 
Identification code ns0510 
Empirical formula C53 H62 Br4 Cl2 O8 
Formula weight  1217.57 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1) 
Unit cell dimensions a = 10.4432(15) Å α= 90°. 
b = 15.049(2) Å β= 97.977(3)°. 
c = 16.320(2) Å γ = 90°. 
Volume 2540.0(6) Å3 
Z 2 
Density (calculated) 1.592 g/cm3 
Absorption coefficient 3.328 mm-1 
F(000) 1236 
Crystal size 0.22 x 0.19 x 0.02 mm3 
Theta range for data collection 2.39 to 30.09°. 
Index ranges -14<=h<=14, -21<=k<=21, -22<=l<=22 
Reflections collected 22914 
Independent reflections 13646 [R(int) = 0.0610] 
Completeness to theta = 30.09° 98.2 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 13646 / 7 / 602 
Goodness-of-fit on F2 0.735 
Final R indices [I>2sigma(I)] R1 = 0.0447, wR2 = 0.0596 
R indices (all data) R1 = 0.1046, wR2 = 0.0674 
Absolute structure parameter -0.011(6) 
Largest diff. peak and hole 0.790 and -0.656 e.Å-3 
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Crystal data and structure refinement for 20 
Identification code ns0605 
Empirical formula C78 H85 N7 O8 
Formula weight  1248.53 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Tetragonal 
Space group P4(3)2(1)2 
Unit cell dimensions a = 18.3708(7) Å α= 90°. 
b = 18.3708(7) Å β= 90°. 
c = 19.8745(15) Å γ = 90°. 
Volume 6707.4(6) Å3 
Z 4 
Density (calculated) 1.236 g/cm3 
Absorption coefficient 0.080 mm-1 
F(000) 2664 
Crystal size 0.24 x 0.10 x 0.10 mm3 
Theta range for data collection 1.87 to 28.31°. 
Index ranges -22<=h<=23, -11<=k<=24, -25<=l<=26 
Reflections collected 30563 
Independent reflections 4615 [R(int) = 0.0582] 
Completeness to theta = 28.31° 97.8 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4615 / 34 / 486 
Goodness-of-fit on F2 1.059 
Final R indices [I>2sigma(I)] R1 = 0.0514, wR2 = 0.1234 
R indices (all data) R1 = 0.0744, wR2 = 0.1353 
Absolute structure parameter 1.1(16) 
Largest diff. peak and hole 0.362 and -0.219 e.Å-3 
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Crystal data and structure refinement for 20(1) 
Identification code ns0608 
Empirical formula  C151 H180 N8 O23 
Formula weight  2475.03 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 23.4463(17) Å α= 90°. 
b = 22.2094(16) Å β= 94.2510(10)°. 
c = 25.5712(19) Å γ = 90°. 
Volume 13279.0(17) Å3 
Z 4 
Density (calculated) 1.238 g/cm3 
Absorption coefficient 0.083 mm-1 
F(000) 5304 
Crystal size 0.32 x 0.30 x 0.23 mm3 
Theta range for data collection 1.26 to 28.29°. 
Index ranges -31<=h<=30, -28<=k<=28, -32<=l<=34 
Reflections collected 117595 
Independent reflections 31461 [R(int) = 0.0306] 
Completeness to theta = 28.29° 95.4 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 31461 / 9 / 1628 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0628, wR2 = 0.1609 
R indices (all data) R1 = 0.0835, wR2 = 0.1771 
Largest diff. peak and hole 1.504 and -0.847 e.Å-3 
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Crystal data and structure refinement for 20a 
Identification code ns0524 
Empirical formula  C84.75 H93.05 N5 O14.15 
Formula weight  1408.09 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 17.9287(15) Å α= 90°. 
b = 22.5778(18) Å β= 110.3500(10)°. 
c = 20.4821(17) Å γ = 90°. 
Volume 7773.5(11) Å3 
Z 4 
Density (calculated) 1.203 g/cm3 
Absorption coefficient 0.082 mm-1 
F(000) 2999 
Crystal size 0.08 x 0.44 x 0.48 mm3 
Theta range for data collection 2.91 to 26.78°. 
Index ranges -21<=h<=21, -25<=k<=28, -25<=l<=25 
Reflections collected 52203 
Independent reflections 15450 [R(int) = 0.0414] 
Completeness to theta = 26.78° 93.2 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.719 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 15450 / 18 / 935 
Goodness-of-fit on F2 1.664 
Final R indices [I>2sigma(I)] R1 = 0.0902, wR2 = 0.2577 
R indices (all data) R1 = 0.1534, wR2 = 0.2835 
Largest diff. peak and hole 0.796 and -1.187 e.Å-3 
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Crystal data and structure refinement for 20b 
Empirical formula  C162 H166 N4 O26 I2 
Formula weight  2752.70 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 23.4463(17) Å α= 90°. 
b = 22.2094(16) Å β= 94.2510(10)°. 
c = 25.5712(19) Å γ = 90°. 
Volume 13279.0(17) Å3 
Z 4 
Density (calculated) 1.238 g/cm3 
Absorption coefficient 0.083 mm-1 
F(000) 5304 
Crystal size 0.32 x 0.30 x 0.23 mm3 
Theta range for data collection 1.26 to 28.29°. 
Index ranges -31<=h<=30, -28<=k<=28, -32<=l<=34 
Reflections collected 117595 
Independent reflections 31461 [R(int) = 0.0306] 
Completeness to theta = 28.29° 95.4 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 31461 / 9 / 1628 
Goodness-of-fit on F2 1.025 
Final R indices [I>2sigma(I)] R1 = 0.0628, wR2 = 0.1609 
R indices (all data) R1 = 0.0835, wR2 = 0.1771 
Largest diff. peak and hole 1.504 and -0.847 e.Å-3 
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Crystal data and structure refinement for 21 
Identification code ns0511 
Empirical formula C45 H50.50 O11.10 
Formula weight 768.95 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Tetragonal 
Space group P4/nnc 
Unit cell dimensions a = 13.7676(6) Å α= 90°. 
b = 13.7676(6) Å β= 90°. 
c = 47.476(4) Å γ = 90°. 
Volume 8999.0(10) Å3 
Z 8 
Density (calculated) 1.135 Mg/m3 
Absorption coefficient 0.081 mm-1 
F(000) 3274 
Crystal size 0.26 x 0.30 x 0.36 mm3 
Theta range for data collection 1.54 to 25.70°. 
Index ranges -16<=h<=16, -16<=k<=15, -57<=l<=57 
Reflections collected 51431 
Independent reflections 4198 [R(int) = 0.0429] 
Completeness to theta = 25.70° 97.4 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4198 / 13 / 262 
Goodness-of-fit on F2 3.653 
Final R indices [I>2sigma(I)] R1 = 0.1638, wR2 = 0.4419 
R indices (all data) R1 = 0.1835, wR2 = 0.4497 
Largest diff. peak and hole 1.541 and -0.858 e.Å-3 
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Crystal data and structure refinement for 22 
Identification code ns0627 
Empirical formula C88 H136 B4 O16 
Formula weight  1493.21 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 15.0290(12) Å α= 90°. 
b = 21.2864(17) Å β= 102.322(5)°. 
c = 28.579(2) Å γ = 90°. 
Volume 8932.2(13) Å3 
Z 4 
Density (calculated) 1.110 g/cm3 
Absorption coefficient 0.074 mm-1 
F(000) 3248 
Crystal size 0.40 x 0.35 x 0.10 mm3 
Theta range for data collection 1.20 to 27.53°. 
Index ranges -19<=h<=18, -26<=k<=27, -37<=l<=36 
Reflections collected 64051 
Independent reflections 20283 [R(int) = 0.1710] 
Completeness to theta = 27.53° 98.5 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 20283 / 125 / 958 
Goodness-of-fit on F2 0.953 
Final R indices [I>2sigma(I)] R1 = 0.0970, wR2 = 0.2583 
R indices (all data) R1 = 0.2082, wR2 = 0.3080 
Largest diff. peak and hole 0.565 and -0.578 e.Å-3 
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Crystal data and structure refinement for 23 
Identification code ns0503 
Empirical formula C54 H63 I4 N O8 
Formula weight  1361.65 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/c 
Unit cell dimensions a = 19.045(3) Å α= 90°. 
b = 16.627(2) Å β= 118.047(8)°. 
c = 18.618(3) Å γ = 90°. 
Volume 5203.3(13) Å3 
Z 4 
Density (calculated) 1.738 g/cm3 
Absorption coefficient 2.449 mm-1 
F(000) 2680 
Crystal size 0.40 x 0.10 x 0.10 mm3 
Theta range for data collection 1.72 to 28.38°. 
Index ranges -24<=h<=23, -21<=k<=20, -24<=l<=24 
Reflections collected 38563 
Independent reflections 12203 [R(int) = 0.0585] 
Completeness to theta = 28.38° 93.5 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.704 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12203 / 0 / 604 
Goodness-of-fit on F2 1.013 
Final R indices [I>2sigma(I)] R1 = 0.0449, wR2 = 0.0956 
R indices (all data) R1 = 0.1000, wR2 = 0.1200 
Largest diff. peak and hole 0.860 and -1.547 e.Å-3 
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Crystal data and structure refinement for 24 
Identification code ns0515 
Empirical formula C82 H83 N5 O10 
Formula weight  1298.53 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system Orthorhombic 
Space group Pnna 
Unit cell dimensions a = 25.359(2) Å α= 90°. 
b = 22.2099(19) Å β= 90°. 
c = 12.1129(10) Å γ = 90°. 
Volume 6822.2(10) Å3 
Z 4 
Density (calculated) 1.264 g/cm3 
Absorption coefficient 0.083 mm-1 
F(000) 2760 
Crystal size 0.34 x 0.32 x 0.20 mm3 
Theta range for data collection 2.44 to 29.29°. 
Index ranges -33<=h<=34, -30<=k<=30, -15<=l<=16 
Reflections collected 59454 
Independent reflections 8904 [R(int) = 0.0420] 
Completeness to theta = 29.29° 95.3 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8904 / 9 / 467 
Goodness-of-fit on F2 1.076 
Final R indices [I>2sigma(I)] R1 = 0.0558, wR2 = 0.1338 
R indices (all data) R1 = 0.0638, wR2 = 0.1401 
Largest diff. peak and hole 0.519 and -0.239 e.Å-3 
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Crystal data and structure refinement for 25a 
Identification code ns0616 
Empirical formula  C114 H106.10 N18.45 O32.55 
Formula weight  2255.37 
Temperature  143(2) K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group P-1 
Unit cell dimensions a = 14.636(3) Å α= 76.787(10)°. 
b = 17.062(3) Å β= 85.972(12)°. 
c = 25.079(4) Å γ = 64.566(9)°. 
Volume 5503.3(16) Å3 
Z 2 
Density (calculated) 1.361 g/cm3 
Absorption coefficient 0.102 mm-1 
F(000) 2359 
Crystal size 0.30 x 0.15 x 0.10 mm3 
Theta range for data collection 1.35 to 27.65°. 
Index ranges -18<=h<=19, -20<=k<=22, -32<=l<=29 
Reflections collected 41304 
Independent reflections 24410 [R(int) = 0.1944] 
Completeness to theta = 27.65° 95.2 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 24410 / 22 / 1471 
Goodness-of-fit on F2 0.762 
Final R indices [I>2sigma(I)] R1 = 0.1084, wR2 = 0.2468 
R indices (all data) R1 = 0.3967, wR2 = 0.3484 
Largest diff. peak and hole 0.700 and -0.489 e.Å-3 
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Crystal data and structure refinement for 25b 
Identification code ns0619 
Empirical formula  C101.60 H111 N9 O16 
Formula weight  1714.19 
Temperature  85(2) K 
Wavelength  0.71073 Å 
Crystal system Orthorhombic 
Space group Pnma 
Unit cell dimensions a = 12.7783(9) Å α= 90°. 
b = 24.5634(18) Å β= 90°. 
c = 29.317(2) Å γ = 90°. 
Volume 9202.1(11) Å3 
Z 4 
Density (calculated) 1.237 g/cm3 
Absorption coefficient 0.084 mm-1 
F(000) 3646 
Crystal size 0.14 x 0.19 x 0.38 mm3 
Theta range for data collection 1.39 to 28.37°. 
Index ranges -16<=h<=16, -32<=k<=30, -24<=l<=37 
Reflections collected 48646 
Independent reflections 11429 [R(int) = 0.0618] 
Completeness to theta = 28.37° 97.1 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 11429 / 86 / 651 
Goodness-of-fit on F2 1.020 
Final R indices [I>2sigma(I)] R1 = 0.0945, wR2 = 0.2654 
R indices (all data) R1 = 0.1589, wR2 = 0.3114 
Largest diff. peak and hole 1.222 and -0.659 e.Å-3 
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Table B.6 Crystal data and structure refinement for 31 
Identification code ns0535 
Empirical formula C49 H47 N3 O6 
Formula weight 773.90 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group P2(1)/n 
Unit cell dimensions a = 14.985(2) Å α= 90°. 
b = 9.9790(16) Å β= 90.627(4)°. 
c = 26.990(4) Å γ = 90°. 
Volume 4035.8(11) Å3 
Z 4 
Density (calculated) 1.274 Mg/m3 
Absorption coefficient 0.084 mm-1 
F(000) 1640 
Crystal size 0.16 x 0.10 x 0.07 mm3 
Theta range for data collection 1.51 to 28.45°. 
Index ranges -19<=h<=19, -13<=k<=13, -34<=l<=35 
Reflections collected 37766 
Independent reflections 9832 [R(int) = 0.0678] 
Completeness to theta = 28.45° 96.6 % 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9832 / 6 / 546 
Goodness-of-fit on F2 1.331 
Final R indices [I>2sigma(I)] R1 = 0.0690, wR2 = 0.1988 
R indices (all data) R1 = 0.1047, wR2 = 0.2225 
Extinction coefficient 0.0142(15) 
Largest diff. peak and hole 0.627 and -0.340 e.Å-3 
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